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ABSTRACT
THE ROLE OF SOCIAL SUPPORTS ON THE FINANCIAL TOXICITY OF CANCER
Lisa C. Smith
April 10, 2019
Background It is evident that health care costs in the United States are astronomical and
are expected to continue to rise. Cancer is one of the most expensive diseases to treat. As
medical care costs continue to increase, so do insurance premiums, co-payments, and outof-pocket health-related expenses. Consequently, the cancer experience can have a
negative impact on an individual’s financial stability. Although literature exists on the
impact of cancer-related financial burden and its effects on quality of life, we do not have
a full understanding of the nature of the financial burden on individuals and their
families. Likewise, research on social supports has concentrated on social, emotional,
functional, and physical well-being but not on the financial well-being of individuals with
cancer.
The purpose of this study, driven by the theoretical frameworks of the Transactional
Model of Stress and Coping Theory (Lazarus & Folkman, 1984), Stress-buffering
Hypothesis (Cohen & Wills, 1985), and the Financial Toxicity Framework (Carrera &
Zafar, 2018) is to understand the role of social support in the relationship between
financial toxicity and quality of life of individuals living with cancer.
Methods This research project used a multiple methods approach composed of two
studies. Study 1 was a secondary analysis of data from a study exploring the lived
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experiences of 26 cancer survivors who self-reported financial hardship due to the costs
of their cancer experience. Interview transcripts were analyzed using a theory-based
direct approach to Qualitative Content Analysis. Study 2 recruited 126 participants who
had a diagnosis of blood (Leukemia, Lymphoma or Myeloma) or breast cancer within the
past 5 years. Using the Introduction to Mediation, Moderation, and Conditional Process
Analysis (PROCESS) macro for SPSS, moderator and mediator analyses were conducted
to determine the specific path by which social support intervenes in and on the
relationship between financial toxicity and quality of life.
Summary of Finding Findings confirm the existence, use and need for social support
that addresses financial toxicity. Three categories were identified from the qualitative
analyses of Study 1: Helpful Supports, Unhelpful Supports, and Gaps in Support.
Although there was representation of several key aspects of social supports (emotional,
informational, instrumental, and social constraint), barriers to accessing support and
missing support emerged from the data analysis process. Further evidence from Study 2
provides empirical support for the importance of social support on the relations between
financial toxicity of cancer and quality of life. Received social support moderated and
perceived social support mediated the relationship between financial toxicity and quality
of life.
Conclusions Social support plays a critical role in helping to protect patients from
cancer-related financial toxicity. More needs to be done to address the financial needs of
patients. Oncology social workers can play an essential role in assisting patients in
averting financial toxicity.

vii

TABLE OF CONTENTS

DEDICATION .................................................................................................................... iii
ACKNOWLEDGMENTS .................................................................................................... iv
ABSTRACT......................................................................................................................... vi
LIST OF TABLES.............................................................................................................. xii
LIST OF FIGURES ............................................................................................................ xv
CHAPTER I: INTRODUCTION ......................................................................................... 1
Significance ................................................................................................................................. 2
Purpose....................................................................................................................................................3

Project Overview ......................................................................................................................... 4
Multiple methods rational. ......................................................................................................................6
Multiple method verses mixed method ...................................................................................................7

Implications ................................................................................................................................. 8
Summary ...................................................................................................................................... 8

CHAPTER 2: LITERATURE REVIEW ............................................................................. 10
Financial Toxicity of Cancer ..................................................................................................... 10
The Situation. ........................................................................................................................................11
Inadequate Insurance ............................................................................................................................13
Out-of-pocket expenses ........................................................................................................................13
Time away from work...........................................................................................................................14
Bankruptcy ............................................................................................................................................15
Psychosocial impact ..............................................................................................................................15
Who Is at Risk for Financial Hardship?................................................................................................18
Impact on family ...................................................................................................................................19

Social Support in the Literature ................................................................................................. 19
Social Support in Cancer ......................................................................................................................20
Social Support: An Influential Variable ...............................................................................................22

Gaps in the Literature ................................................................................................................ 24
Summary .................................................................................................................................... 24

CHAPTER 3: MULTIPLE METHOD APPROACH, RESEARCH PARADIGMS, AND
THEORETICAL PERSPECTIVES .................................................................................... 26
Multiple Method Design ............................................................................................................ 27

viii

Philosophical Foundations ......................................................................................................... 31
Pragmatic Worldview ...........................................................................................................................32
Postpositivist Worldview ......................................................................................................................34

Theoretical Perspectives ............................................................................................................ 34
Financial Toxicity .................................................................................................................................35

Social Support Theories............................................................................................................. 36
Stress and Coping Theory .....................................................................................................................40
Stress-Buffering Hypothesis .................................................................................................................45

Conceptual Model...................................................................................................................... 47
Summary .................................................................................................................................... 50

CHAPTER 4: STUDY 1 METHODS ................................................................................. 52
Study 1 - Qualitative .................................................................................................................. 52
Purpose ...................................................................................................................................... 53
Pragmatism and CGT............................................................................................................................53
Study Sample ........................................................................................................................................55
Data Saturation......................................................................................................................................55
Data Management .................................................................................................................................56
Study Procedures ..................................................................................................................................56
Social Support Analysis ........................................................................................................................59
Trustworthiness .....................................................................................................................................67
Ethical Considerations ..........................................................................................................................70

Summary .................................................................................................................................... 71

CHAPTER 5: STUDY 1 RESULTS ................................................................................... 72
Characteristics of Participants ................................................................................................... 72
Qualitative Findings .................................................................................................................. 75
Helpful Support ......................................................................................................................... 78
Received Emotional Support ................................................................................................................78
Received Informational Support ...........................................................................................................82
Received Instrumental Support .............................................................................................................85
Perceived Instrumental Support ............................................................................................................93

Non-helpful Support .................................................................................................................. 93
Social Constraint ...................................................................................................................................93
Good intentions with financial consequences .......................................................................................95
Good intentions that are not helpful......................................................................................................96
Bad support ...........................................................................................................................................97

Gaps in Support ......................................................................................................................... 98
Barriers to Support ................................................................................................................................98
Missing Support ..................................................................................................................................103

Brief Interpretation .................................................................................................................. 108
Summary .................................................................................................................................. 110

CHAPTER 6: STUDY 2 METHODS ............................................................................... 111
Purpose .................................................................................................................................... 111
Study Design............................................................................................................................ 113
Human Subjects Protection .................................................................................................................113

ix

Study sample .......................................................................................................................................113

Study Procedure ....................................................................................................................... 115
Data management................................................................................................................................116
Measures .............................................................................................................................................116

Data analysis ............................................................................................................................ 120
Data cleaning ......................................................................................................................................120
Descriptive statistics ...........................................................................................................................120

Bivariate Analysis.................................................................................................................... 120
Specific aim 1 .....................................................................................................................................121
Specific aim 2 .....................................................................................................................................124

Dissemination .......................................................................................................................... 126
Summary .................................................................................................................................. 127

CHAPTER 7: STUDY 2 RESULTS ................................................................................. 128
Sample Characteristics ............................................................................................................ 129
Cancer characteristics .........................................................................................................................131
Financial toxicity characteristics.........................................................................................................132
Univariate analysis ..............................................................................................................................133
Bivariate Analysis ...............................................................................................................................136

Aim 1 ....................................................................................................................................... 139
Hypothesis 1.1.....................................................................................................................................140
Hypothesis 1.2.....................................................................................................................................148
Hypothesis 1.3.....................................................................................................................................149
Hypothesis 1.4.....................................................................................................................................157

Specific Aim 2 ......................................................................................................................... 158
Hypothesis 2.1.....................................................................................................................................159
Hypothesis 2.2.....................................................................................................................................160
Hypothesis 2.3.....................................................................................................................................165
Hypothesis 2.4.....................................................................................................................................165

Summary .................................................................................................................................. 168

CHAPTER 8: DISCUSSION & CONCLUSIONS ........................................................... 171
Discussion ................................................................................................................................ 172
Study 1. ...............................................................................................................................................172
Study 2 ................................................................................................................................................176
Bringing it All Together......................................................................................................................179

Implications for Practice .......................................................................................................... 187
Implications for Policy ............................................................................................................ 191
Future Research ....................................................................................................................... 194
Limitations ............................................................................................................................... 195
Conclusion ............................................................................................................................... 197

REFERENCES ................................................................................................................ 200
APPENDIX A: STUDY 1 CONSENT PREAMBLE......................................................... 220
APPENDIX B: STUDY 1 INTERVIEW GUIDE ............................................................. 222

x

APPENDIX C: STUDY 1 QUESTIONNAIRE................................................................. 224
APPENDIX D: FAMILY PARTIALLY ORDERED META-MATRIX .............................. 231
APPENDIX E: STUDY 1 TEMPLATE & EXAMPLE OF MEMOS ............................... 233
APPENDIX F: SITUATIONAL MAPPING .................................................................... 238
APPENDIX G: STUDY 1 REFLEXIVITY ....................................................................... 240
APPENDIX H: CONSENT PREAMBLE ........................................................................ 243
APPENDIX I: STUDY 2 CALL FOR PARTICIPANTS................................................... 244
APPENDIX J: STUDY 2 QUESTIONNAIRE ................................................................. 245
APPENDIX K: QUANTITATIVE STRAND TABLE OF VARIABLES ............................ 261
APPENDIX L: PREPARING DATASET ......................................................................... 263
APPENDIX M: PEARSON BIVARIATE CORRELATIONS ........................................... 270
APPENDIX N: ANALYSIS OF VARIANCE .................................................................... 271
APPENDIX O: MODERATION ANALYSES IN PROCESS ........................................... 273
APPENDIX P: MEDIATION ANALYSIS IN PROCESS ................................................. 277
APPENDIX Q: NON-SIGNIFICANT ANALYSIS TABLES............................................. 281
CURRICULUM VITA ..................................................................................................... 285

xi

LIST OF TABLES
Table 3. 1Philosophical Assumptions of Two Worldviews (adapted from Creswell et al.,
2011). ................................................................................................................................ 32
Table 4. 1 Theory-based Codebook Used in DedooseTM .................................................. 61
Table 5. 1 Demographics (Head et. al., 2018). ................................................................. 73
Table 5. 2 Job Status, Occupation, Insurance Status (Head et. al., 2018). ....................... 74
Table 5. 3 Characteristics by Participant Number (Head et. al., 2018). ........................... 75
Table 5. 4 Social Support Comments by Social Network ................................................ 76
Table 5. 5 Social Network Categories. ............................................................................. 77
Table 5. 6 Received Emotional Support. .......................................................................... 78
Table 5. 7 Received Informational Support ...................................................................... 83
Table 5. 8 Received Instrumental Support ........................................................................ 85
Table 5. 9 Social Constraint .............................................................................................. 94
Table 5. 10 Barriers to Support ......................................................................................... 98
Table 5. 11 Missing Support ........................................................................................... 103
Table 6. 1 Dissemination Methods and Responses by Agency. ..................................... 114
Table 7. 1 Demographics of Participants. ....................................................................... 129
Table 7. 2 Employment Status at Diagnosis and Current Status. ................................... 131
Table 7. 3 Insurance Status at Diagnosis and Current. ................................................... 131
Table 7. 4 Description of Clinical Characteristics. ......................................................... 132

xii

Table 7. 5 Level of Financial Toxicity by Demographics. ............................................. 133
Table 7. 6 Descriptive Statistics by Type of Cancer. ...................................................... 135
Table 7. 7 Differences in Quality of Life (FACT-G) by Cancer Treatment and
Demographics. ................................................................................................................ 136
Table 7. 8 Group Differences in Quality of Life Plus SEW (FACT-G Plus). ................ 137
Table 7. 9 Pearson's Bivariate Correlations (r) of Support, Quality of Life and Financial
Toxicity Variables. .......................................................................................................... 138
Table 7. 10 Received Social Support and Financial Toxicity as Predictors of Quality of
Life (FACT-G). ............................................................................................................... 142
Table 7. 11 Conditional Effects of Financial Toxicity at Levels of the Moderator. ....... 143
Table 7. 12 Predictors of Quality of Life (FACT-G) with Control Variables. ............... 144
Table 7. 13 Conditional Effects of Financial Toxicity at Levels of the Moderator with
Control Variables. ........................................................................................................... 145
Table 7. 14 Financial Toxicity, Received Social Support, and Social Constraint as
Predictors of Quality of Life (FACT-G). ........................................................................ 147
Table 7. 15 Three-way Moderation Conditional Effects of Financial Toxicity. ............ 148
Table 7. 16 Predictors of Quality of Life (FACT-G Plus). ............................................. 151
Table 7. 17 Conditional Effects of Financial Toxicity at Levels of the Moderator. ....... 152
Table 7. 18 Predictors of Quality of Life (FACT-G Plus) with Control Variables. ....... 153
Table 7. 19Conditional Effects of Financial Toxicity at Levels of the Moderator with
Control Variables. ........................................................................................................... 154
Table 7. 20 Three-way Moderation of Quality of Life (FACT-G). ................................ 155
Table 7. 21 Three-way Moderation Conditional Effects of Financial Toxicity. ............ 157
Table 7. 22 Correlations Among Mediation Variables. .................................................. 161
Table 7. 23 Summarized Mediation Regression Analysis for Financial Toxicity,
Perceived Social Support and Quality of Life. ............................................................... 163

xiii

Table 7. 24 Perceived Support Mediation on Financial Toxicity and Quality of Life
without Moderation of Social Constraint. ....................................................................... 164
Table 7. 25 Mediation by Perceived Social Support with Control Variables. ................ 167
Table 7. 26 Mediation without Moderation of Social Constraint ................................... 168
Table 7. 27 Analyses Outcome by Hypothesis. .............................................................. 169
Table 8. 1 Checklist for Engaging Patients in Financial Toxicity Conversations .......... 184

xiv

LIST OF FIGURES
Figure 1. 1 Multiple Method Design................................................................................... 5
Figure 3. 1 Multiple Method Design Theoretical Focus ................................................... 29
Figure 3. 2 Framework on Financial Toxicity (Carrera & Zafar, 2018). .......................... 35
Figure 3. 3 Financial toxicity illustrated through the Stress and Coping Theory (Lazarus
& Folkman 1984). ............................................................................................................. 41
Figure 3. 4 Social support on financial toxicity interpreted by Stress and Coping Theory
and Stress-buffering Hypothesis. ...................................................................................... 46
Figure 3. 5 Social support as a moderator variable, adapted from the work of Hayes
(2017). ............................................................................................................................... 48
Figure 3. 6 Social Support as a Mediator Pathways. ........................................................ 49
Figure 6. 1 Diagram of mediation model, adapted from Hayes (2017). ......................... 125
Figure 7. 1 Social Support Moderation Pathways (Hayes, 2018). .................................. 139
Figure 7. 2 Moderation of Financial Toxicity and QoL (FACT-G). .............................. 142
Figure 7. 3 Moderation of Financial Toxicity and Quality of Life (FACT-G) in presence
of control variables. ........................................................................................................ 145
Figure 7. 4 Three-way moderation predicts Quality of Life (FACT-G). ........................ 147
Figure 7. 5 Moderates of Financial Toxicity and QoL (FACT-G Plus). ........................ 151
Figure 7. 6 Moderates of Financial Toxicity and QoL (FACT-G Plus) with Control
Variables. ........................................................................................................................ 153

xv

Figure 7. 7 Three-way Moderation of QoL (FACT-G Plus). ......................................... 156
Figure 7. 8 Social Support in Mediation Pathways......................................................... 159
Figure 7. 9 Perceived Social Support Mediates Financial Burden as a Predictor of Quality
of Life (QoL)................................................................................................................... 161
Figure 7. 10 Mediation of financial toxicity when quality of life (QoL) is assessed by
Functional Assessment of Cancer Therapy plus Socioeconomic Wellbeing.................. 166
Figure 8. 1 Depiction of social support informed by the Stress and Copying Theory and
the Stress-buffering Hypothesis (Cohn & Wills, 1985). ................................................. 182
Figure 8. 2 Social support moderating and mediating the relationship between financial
toxicity and quality of life. .............................................................................................. 182
Figure 8. 3 Moderator and mediator interactions of social support using the Financial
Toxicity Framework (Carrera & Zafar, 2018). ............................................................... 183

xvi

CHAPTER I: INTRODUCTION
“You treat a disease, you win, you lose. You treat a person, I guarantee you,
you’ll win, no matter what the outcome.”
– Patch Adams
While the systematic diagnosis and treatment of diseases such as cancer are
obviously crucial in saving lives, they can impact a patient’s life beyond their health and
physical well-being. People do not simply separate their health and health care into silos;
instead, their health is deeply intertwined with their overall well-being and quality of life.
Physical, social, emotional, and economic aspects of life can all suffer health-related
consequences. Subsequently, patient care needs to go beyond the medical treatment of the
disease which requires a complex understanding of attitudes and beliefs, psychosocial
needs, the financial impact, and preferences for communication and information. It
compels the medical field to meet the patient where the patient is currently functioning
emotionally, socially, economically, and physically. It necessitates treating the whole
patient and not just a fraction thereof.
From a traditional standpoint, the goal of our medical system has been to identify,
triage, and cure medical aliments. However, delivering a better experience leading to
positive overall outcomes requires a multi-faceted design of patient care. Whole patient
care, (i.e., patient-centered care) seeks to provide care that is responsive to each
individual’s needs and preferences. Transitioning from the traditional model to a patientcentered one, putting psychosocial needs on par with medical needs, has been an ongoing
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effort of the Institute of Medicine (IOM). Standards proposed for patient-centered care
and distress screening brought attention to the importance of treating the whole patient,
emphasizing the importance of addressing psychosocial needs and concerns in the
treatment process. Of particular interest for this work, the IOM standards highlight
identifying those patients at risk for financial hardship (Institute of Medicine, 2013), thus,
recognizing the impact that financial distress can have on patients.
As the costs of medical care continue to rise, particular attention has been given to
the financial burden and distress resulting from cancer care costs - so much so that it has
been termed financial toxicity. The term financial toxicity encompasses both the objective
burden and subjective distress brought on by the costs of cancer care. Objectively,
patients face astronomical medical costs and unexpected out-of-pocket expenses.
Subjectively, they experience overwhelming feelings of distress (Zafar et al., 2013). This
septic situation can result in negative outcomes for patients and their families. (See the
literature review in Chapter 2 and the framework proposed by Carrera and Zafar (2018)
in Chapter 3 for a more detailed examination of financial toxicity.)
In this first Chapter, I provide the significance and purpose of conducting this
research. This includes a brief overview of the study design as well as the specific aims,
research questions and implications for healthcare professionals, patients and the field of
social work.
Significance
In the United States, a staggering estimate of 1,735,350 new cases of cancer will
be diagnosed this year (NCI, 2018). The exact number of those patients who will
experience financial toxicity (objective burden and subjective distress) as a result of their
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cancer experience is difficult to surmise. However, a systematic review exploring the
extent of financial burden concluded that a “substantial amount of cancer survivors” are
affected by the objective financial burden of cancer care (Gorden, Merollini, Lowe, &
Chan, 2017). More specifically, two nationwide surveys reported a third (Kent et al.,
2013) to half (Pisu et al., 2015) of their participants experienced financial burden. This
number is staggering and suggests that a substantial number of people may indeed face
financial hardship as a result of their cancer experience.
While there is growing empirical evidence of the financial toxicity (objective
burden and subjective distress) faced by many cancer patients, gaps in our understanding
of the issue still remain. Studies have attempted to better understand and describe this
issue, yet a thorough literature search found two studies that have attempted to intervene
on the impact of financial toxicity through an influencing variable. In one study
researchers attempted to address financial toxicity through the use of patient navigation
(Shankaran et al., 2018). The second study implemented the Care Payment program
which provided patients with 0% APR lines of credit (Lessard & Solomon, 2017). This is
indicative of a gap in knowledge regarding influences of variables that may alleviate
financial toxicity. Further knowledge is needed to develop interventions and standardized
practice procedures for identifying and assisting those at risk of cancer-related financial
toxicity. It is therefore the goal of this study to provide insight into the lived experiences
of cancer patients by understanding their use of social support and the impact of social
support on the patients’ experience with financial toxicity.
Purpose. The purpose of this project is to explore the role of social support in the
context of cancer-related financial toxicity (objective burden and subjective distress).
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This research project attempts to address the lack of information regarding factors that
may alleviate or positively impact the experience of cancer patients and their families.
The following overarching research question guided the development of this project:
What role does social support play in the experience of cancer-related financial
toxicity?
In order to answer this overarching question, the following two sub-questions
were developed:
1. For individuals who have had cancer, what is their experience with social support
in the context of cancer-related financial toxicity?
2. How does social support influence cancer-related financial toxicity and patients’
quality of life?

Project Overview
To address these research questions, a multiple method paradigm was used.
Multiple method designs are driven by an overarching question that is answered by two
or more studies. The results of these studies are intricately intertwined to provide an indepth understanding of the inquiry, yet each study remains relatively independent of the
other (Morse, 2003). For this project the overarching question was addressed using two
studies conducted sequentially but each had equal merit (see Figure 1.1 for the design
overview). First, a study using qualitative methods was conducted identifying the
existence, use, and need for social support in the given context. This study was followed
by a quantitative study that sought to statistically identify the role social support played in
the experience.
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Overarching
Research
Question

Study 1

Study 2

Qualitative
Design
Abductive
Theoretical Drive

Quantitative
Design
Pragmatic
Worldview

Deductive
Theoretical Drive

26 Participants

126 Participants

In-depth Semistructured
Interviews

Computer Based
Survey

Post-Positivist
Worldview

Moderater &
Mediator
Analyses

Grounded Theory
Technicques

Theoretical
Sensitizing Lens Social Support
Theories

Stress and Coping
Theory - StressBuffering
Hypothsis

Figure 1. 1 Multiple Method Design
The data for Study 1 derived from a study that used a qualitative design involving
semi-structured, in-depth interviews with 26 participants who reported to have
experienced financial burden during their cancer experience. Interviews were audio
recorded and transcribed verbatim. Transcripts were initially analyzed using
constructivist grounded theory (CGT) techniques. From the findings, social support
emerged as a primary theme.
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For Study 1, a secondary data analysis used a generic qualitative approach (Caelli,
Ray, & Mill, 2003). Theories of social support provided an analytic lens to view
transcripts. Social supports were identified through the use of a theory-based direct
approach to Qualitative Content Analysis. In-depth descriptions of types and uses of
social support in the context of cancer-related financial toxicity were developed. (See
Chapters 4 and 5 for Study 1 methods and results, respectively.)
Deriving from the preliminary findings of Study 1, Study 2 was created to further
explain the presence of social support and patients’ experiences statistically. Study 2 used
a quantitative approach and relied on the theoretical foundations of the Transactional
Model of Stress and Coping Theory (Lazarus & Folkman, 1984) and the Stress-buffering
Hypothesis (Cohn & Wills, 1985). This study involved the development of a survey using
reliable and valid scales as well as questions created from the qualitative study. Using an
online platform, the survey was disseminated through several cancer-related
organizations. A sample of 126 participants was obtained between July 2017 and
December 2018. Moderator and mediator analyses were then performed using SPSS v25
statistical software with the Introduction to Mediation, Moderation, and Conditional
Process Analysis (PROCESS) macro. The purpose of the analyses was to determine if
social support played a statistically significant role in influencing the objective burden
and subjective distress caused by cancer care and treatment costs. (See chapters 6 and 7
for Study 2 methods and results, respectively).
Multiple methods rationale. The multiple method design selected for this project
is an equally weighted qualitative then quantitative approach. The approach is driven by
an overarching inductive drive and is geared toward answering a descriptive overarching
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question. This design can be used to gain more insight into a topic and can eventually
lead to the development of a framework or theory (Morse, 2003). Since little is known
about cancer-related financial burden and social support, this approach provided a more
comprehensive understanding of the role social support plays in the given context.
Although the purpose of this project is not to create theory, it may inform and expand on
the current framework of financial toxicity as described by Carrera et al. (2018) and
social support theories. (See Chapter 3 for an in-depth discussion of these theories.)
Multiple method verses mixed method. Although they sound similar, few
commonalities exist between mixed method and multiple method designs. According to
Morse (2003), a mixed method design is when qualitative and quantitative methods are
being used with-in a single project. The same question(s) is(are) being answered by both
the qualitative and quantitative strand of the study. Important to the distinction between
the two designs, the research in a mixed method design is driven by one theoretical
assumption. Thus, one strand of the study is dependent on the other, neither being
considered whole without the other. It is also the expectation that one set of data be used
to complement and then build on the information obtained from another (Terrell, 2016).
Alternatively, multiple method designs contain relatively complete qualitative
and/or quantitative studies within a larger project (Morse, 2003). Multiple method
designs are defined as a series of studies that are interrelated by topic with an overarching
question that defines the project goal. In order to answer this overarching question, each
component of the project is driven by its own sub-questions and maintains its own
worldview and assumptions. Unlike mixed method designs, multiple method designs are
not limited to using one sample population. Using the multiple method designs allows for
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more flexibility in design allowing the researcher to obtain a broader perspective of the
phenomena they are researching (Morse, 2003).
Implications
The overall aim for this study is to better understand the experience of cancer in
regard to financial toxicity and social support. Through exploring this experience, we
may be better able to identify and address financial issues that may result in unnecessary
burden and distress. It is hoped that the results of this study will further inform patientcentered care, giving healthcare professionals insight into the influencing effects of social
support on financial barriers faced by cancer patients. Social work practice is driven by
ethical standards to ensure the use and implementation of services that will enhance and
improve the lives of clients served. It is therefore my desire to inform social work
practice on the impact social support may have on cancer-related financial toxicity to
further assist in the development of effective and efficient interventions. Lastly, it is my
hope that this work will inform healthcare research, practice, and policy by adding to the
existing framework of Financial Toxicity.
Summary
This chapter provided a brief overview of this project which identifies the
function social support plays in easing the impact cancer-related financial burden has on
patients and their families. It first introduced the problem and purpose geared toward
exploring the role of social support. Then, with justification for the use of a multiple
method design, it briefly described the studies that were used to address the overarching
question.
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Chapter 2 presents the literature review on cancer-related financial burden
explaining this multifaceted phenomenon. Then it provides a definition for social support
relying on the operationalization of social support theories. This is followed by a brief
literature review on social support in cancer care, thus pointing out the vast array of
literature existing in this area. Lastly, it introduces the literature on social support as a
moderator or mediator variable, providing support and justification for proposing that
social support may play a similar role in cancer-related financial burden.
The outline for the remainder of this manuscript follows. Chapter 3 provides a
more in-depth explanation of the Multiple Method Paradigm as well as introduces the
theoretical perspectives relied on throughout this project. Chapter 4 provides a detailed
description of the methods for Study 1 with the findings presented in Chapter 5. Then
Chapter 6 details the methods for Study 2 with the results for Study 2 in Chapter 7.
Finally, Chapter 8 brings the results from both studies together in an attempt to answer
the overarching question. It concludes with a summary addressing the limitations of this
project as well as offering suggestions for further research and implications for current
social work and healthcare practices.
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CHAPTER 2: LITERATURE REVIEW
‘Too many people are forced into a situation of whatever they do have, they bankrupt
themselves with a medical disaster. It destroys every single cent that they have, because
they have no resources or ability to counter balance the cost of good health.”
- Study 1 #26 (66-year-old man, Prostate & Bladder Cancer)
This chapter presents the literature as it relates to the overarching research
questions: What role does social support play in the experience of cancer-related
financial toxicity? Due to the multidimensional aspects of the variables used in this
research, the chapter is divided into two separate parts. The first part examines cancerrelated financial burden as a social problem due to the exorbitant and rising costs of
medical care. It presents literature on cancer-related financial toxicity (i.e., objective
burden and subjective distress), the resulting impact it has on patient care, and addresses
who is at-risk. In the second part, the literature on social support in cancer research is
reviewed, which is followed by a literature review of social support as a moderator or
mediator variable as social support has been shown to have more than a direct effect in
other situations.
Financial Toxicity of Cancer
The financial toxicity of cancer has been a hot topic over the last decade and
related research has grown exponentially. The following literature review is extensive,
but not exhaustive. The primary purpose is to provide a foundational understanding of
this complex, multifaceted issue.
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The Situation. In the United States, cancer is among the most expensive diseases
to treat (American Cancer Society, 2012). Cancer patients can expect to pay thousands of
dollars more in medical expenditures than those who have never had cancer. In 2007, the
average yearly medical expenses for a newly diagnosed cancer patient was $16,910 with
an out-of-pocket cost of $2,149 compared to $3,303 with $679 out-of-pocket expense for
those without cancer (American Cancer Society, 2012). Furthermore, expenses associated
with cancer continue into the survivorship phase. The post-treatment phase can be riddled
with expensive follow-up tests, screenings, and costly medications that may last a
lifetime. Cancer survivors pay $3,293 -$4,187 more per year for health care than those
without a cancer history (Ekwueme et al., 2014). Consequently, the trajectory of cancer
treatment-related expenditures may span years, thereby putting cancer patients at risk of
experiencing long-term financial consequences.
Indeed, patients face high costs in care for in-patient/out-patient hospital and
clinic visits, surgery, prescription drugs, medical treatments, lab tests, and home health
services. These costs are alarmingly on the rise. One study suggests cancer treatment
costs have nearly doubled in the past few decades (Tangka et al., 2010). A report on
anticancer drug costs suggests a much greater increase. In 1995, the average cost of
anticancer drugs for one extra year of life was $54,100; this jumped to $207,000 by 2013
(Howard, Bach, Berndt, & Conti, 2015). A second study reported similar increases in
costs associated with treatment duration. Before 2000, treatment costs were less than
$10,000; by 2012, these costs escalated to over $100,000 (Kantarjian, Steensma, Sanjuan,
Eishaug, & Light, 2014). The costs associated with cancer are astronomical and are
expected to continue to increase (Mariotto et al., 2011; Trogdon et al., 2010).
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Several reasons have been suggested for the rise in costs. Advocates justifying
higher drug prices indicate the high prices are due to free market demand, as well as
research and development costs (Kantarjian et al., 2014). Increasing demand,
improvements in cancer awareness, screenings, and treatment lead to increases in
diagnoses and survival rates. Currently there are nearly 14.5 million cancer survivors
(ACS-NCI, 2014). This number is expected to grow to nearly 18 million by 2020 (Weir,
Thompson, Soman, Moller, & Leadbetter, 2015; Mariotto, Yabroff, Shao, Feuer, &
Brown, 2011) and 19 million by 2024 (Simon, 2014). With the increase in diagnosis and
survivorship the demand for oncology services is expected to escalate, taxing the
healthcare system and resulting in a shortage of oncologists (Yang et al., 2014). This
increased demand and lack of available services is suggestive of a supply-demand
situation leading to rising costs of care.
Increases are also suggested to be due to research and development costs. The
average cost of development for a new drug is estimated to be $802 million before
approval and $900 million after approval (DiMasi, Hansen, & Grabowski, 2002).
Improvements in current treatment, such as the development of targeted chemotherapies,
are estimated to increase costs (Mariotto et al., 2011). As new drugs and improved
treatments become available, these costs are passed down to patients (Howard, Back,
Berndt, & Conti, 2016).
Regardless of the reason for higher costs, the costs are ultimately passed down to
patients through higher cost-sharing insurance plans. Insurance providers shift the direct
medical care costs to patients through higher premiums, deductibles, and copayments.
Out-of-pocket caps for many insurance plans have been mandated through policy.
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Although the cap is set for $7150 per individuals and $14,300 per family (ACS, 2017),
this is still a hefty expense for many American families. In 2015, the Federal Reserve
reported nearly half of Americans had to borrow or sell something in order to cover an
unexpected $400 medical emergency (ACS, 2017).
Inadequate Insurance. Due to the astronomical costs of care, many cancer
patients are faced with mounting bills. Even patients with insurance can expect to pay a
significant amount for their cancer treatment. With the passage of the Patient Protection
and Affordable Care Act (ACA), citizens in the United States were required to have
insurance; however, this requirement was overturned by the following Presidential
Administration. Still, the number of those who had insurance increased from before the
ACA was passed. Nonetheless, possessing insurance does not necessarily equate to
affordable cancer treatment. An 80/20-medical plan offers decent health coverage with
the insurance company covering 80% of medical costs and the patient responsible for
20%. Yet for some cancer treatments, 20% can mean tens of thousands of dollars. Indeed
12 of the 13 new cancer drugs released in 2012 cost upwards of $100,000 per year (Light
& Kantarjian, 2013). This could result in a $20,000 out of pocket expense for a patient
with an 80/20-medical plan. Consequently, patients experience objective burden as the
extreme costs of their health care are passed down to them through inadequate insurance
policies.
Out-of-pocket expenses. In addition to high costs of care and inadequate
insurance plans, cancer patients are often caught unaware of the out of pocket expenses
(OOPE) that result from direct and indirect costs of treatment. Patients may experience
increases in indirect costs such as insurance co-payments, monthly premiums and
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medications costs. In addition, indirect care costs can accumulate, including childcare,
housekeeping, prosthetic, over-the-counter medications, and travel expenses (Lange et
al., 2004; Darby, Davis, Likes, & Bell, 2009). These are costs that are not directly related
to paying for medical expenses, but are expenses associated with having cancer. Patients
can expect their OOPE to double what a person without cancer would pay for medical
care (Short, Moran, & Punekar, 2011). OOPE have been found to augment the experience
of related financial (objective) burden and lead to increased long-term financial debt
(Lange et al., 2004; Finelstein et al., 2009; Markman & Luce, 2010; Pisu et al., 2010). In
this respect, patients are experiencing objective burden as expenditures increase by way
of increased insurance costs and unexpected out-of-pocket expenses.
Time away from work. To complicate the situation, patients may need to take
time away from work to receive medical care resulting in lost wages (Chrikos, RussellJacobs, & Cantor, 2002; Lauzier, Maunsell, De Koninck, Drolet, & Robert, 2004;
Bradley et al, 2007; Mehnert, 2010; Zajacova, Dowd, Schoeni, & Wallace, 2015). A
national study reported that patients experience a decline in employment and income up
to two years before their cancer diagnosis (Zajacova et al., 2015). This may be indicative
of a patient’s need to work less due to an impending diagnosis and needing to take time
off for being sick. They also determined that the likelihood of being employed after a
cancer diagnosis decreased for up to three years post-diagnosis. The study noted that it
could take patients four to five years to recover from the financial effects and return to
their pre-diagnosis economic state. Under these circumstances a family’s income could
decrease by 20-40% of their annual earnings (Zajacova et al., 2015). Additionally, some
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patients are unable to return to work after their cancer experience due to treatment effects
and physical decline (Stepanikova, Powroznik, Cook, Tierney, & Laport, 2015).
Bankruptcy. Facing this financially toxic situation, patients may be forced to file
bankruptcy in order to get out from under the accumulating medical bills (Amir, Wilson,
Hennings, & Young, 2012). In 2007, medical debt attributed to 62% of bankruptcies.
Most of these patients were middle-class, well educated, and owned their own home
(Himmelstein, Thorne, Warren, & Woolhandler, 2007). Another study found that cancer
patients are 2.65 times more likely to file for bankruptcy then those without cancer
(Ramsey et al., 2013). Patients have also noted losing possessions including their homes
as a result of their experience (Amir et al., 2012). Inevitably cancer can increase a
person’s risk of financial ruin that could take decades to overcome.
With costs of cancer treatment increasing, lack of adequate health insurance
coverage, costs of OOPE, need for long-term follow-up care, and lost wages, many
cancer patients are faced with astronomical medical expenses. It is undeniable that these
costs can result in financial ruin for many individuals and their families. This toxic
condition can then negatively impact patient’s quality of life (QoL) and feelings of wellbeing.
Psychosocial impact. It is evident that the costs of cancer diagnosis, treatment,
and follow-up care can cause subjective distress. Further review of the literature indicates
the detrimental effects on patients’ psychosocial well-being due to the costs of care. The
following section reviews the psychosocial impact on patients as well as methods used by
patients to offset cancer care expenses.
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Effects of stress. It is well known in health-related research that chronic stress and
depression can negatively affect a person’s immune system, increase inflammation,
impede the healing process (Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002) and lead
to more severe infections or chronic health conditions (Schneiderman, Ironson, & Siegel,
2005; Godbout & Glaser, 2006; Mohd, 2008). In particular, a study with breast cancer
patients determined that chronic stress was associated with DNA repair, immune
function, and tumor growth processes (McGregor, & Antoni, 2009). Furthermore, studies
with cancer patients have found that patients who experience cancer-related financial
burden are more likely to experience higher anxiety and depression levels then those who
do not (Wong et al., 2010; Sharp, Carsin, & Timmons, 2013). As cancer-related financial
burden increased so did anxiety and distress. Left unaddressed, cancer-related financial
burden may lead to psychological distress, further health problems and slower recovery
from cancer treatment.
Non-adherence. Another related issue affecting patient health and recovery is
non-adherence to the treatment plan. It is estimated that more than 2 million Americans
do not abide by recommended treatment due to costs (Weaver, Rowland, Bellizzi, &
Azia, 2010). Non-adherence to medical treatment is defined as not taking prescribed
medication, taking less medication than prescribed, or not filling or partially filling
prescriptions. Many cancer patients reported that associated financial burden influenced
their medical decision-making and treatment choices forcing them to make financial
sacrifices to offset the costs of treatment (Wong et al., 2010). Patients have reported nonadherence with medical advice and treatment, further jeopardizing their health. In fact, a
quarter of participants in a national study reported that they did not follow recommended
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treatment because of the costs associated with that treatment (Weaver, Rowland, Bellizzi,
& Azia, 2010; Markman et al., 2015). Patients chose to skip medications or only partially
fill prescriptions (Markman et al., 2015) and forgo other non-essential health care such as
dental and eye care (Kent et. al., 2013; Bernard et al., 2011; Bullock, Hofstatter, Yushak,
& Buss, 2012; Shankara et al., 2012; Zafar et al., 2013). Indeed, patients are being faced
with difficult financial decisions that can adversely affect their general health, nutrition,
and recovery, potentially affecting long-term survival.
Strategies to offset costs. Faced with financial burden, patients use a variety of
strategies to offset the costs of treatment and defray expenses. To help pay for their
medical expenditures, patients resort to using their savings, selling possessions,
borrowing from others, and relying on credit cards (Bernard, Farr, & Fang, 2011). These
efforts may result in the patient feeling indebted to others and/or trapped in increasing
credit card or loan debt. Similarly, patients have sold stocks and investments, and
withdrawn money from their retirement accounts (Shankara et al., 2012). Other strategies
used involved cutting back on discretional spending such as decreased spending on
leisure activities, food, and clothing (Bernard, Farr, & Fang, 2011; Wong et al., 2010;
Zullig et al., 2013). Although these efforts may be financially beneficial, cutting out
items an individual enjoys may negatively affect their emotional and social well-being.
Consequentially, these methods may add to the experienced subjective distress.
Furthermore, financial toxicity (objective burden and subjective distress) has been
shown to negatively affect a patient’s psychosocial well-being and QoL (Ell et al., 2007;
Meneses, Azuero, Hassey, McNeew, & Pisu, 2012; Gupta, Lis, & Grutsch, 2007; Fenn et
al., 2014). Patients are forced to make sacrifices that can negatively affect themselves and
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their families. These compounding effects can negatively affect the overall experience
and place patients under further stress, thereby complicating their general health and
financial situation.
Who Is at Risk for Financial Hardship? Determining exactly which cancer
patients are at risk for financial toxicity is challenging. The National Cancer Institute
reports that the type of cancer, it’s level of severity, and treatment type as well as age,
race, income, job and insurance status can all make an individual susceptible to financial
toxicity. More specifically, a recent systematic review of 25 peer-reviewed articles found
that being female, younger aged, lower income, extended therapies and time since
diagnosis were associated with financial toxicity (Gordon et al., 2017).
The literature reviewed for this chapter suggest other factors can put patients at
risk as well. Insurance status showed those with private non-group insurance (Bernard,
Farr, & Fang, 2011), Medicaid or lacking insurance coverage (Shankaran et al., 2012)
were at risk. Being older middle-aged (55-64 years old) (Bernard el al., 2011) or older
then 65 (Negut et al., 2011) put patients at risk. Shankaran et al. (2012) found other
variables placed patients at higher risk. These included lower educational level, rural
residency, multiple chronic health conditions, never married or widowed, and one or no
children. In addition, Kent et al. (2013) reported risk was associated with a history of
prior cancer treatment, and a shorter time since initial diagnosis. Furthermore, several
studies agreed that individuals from minority racial groups were more likely to report
financial burden as well as experience worse health outcomes (Bernard et al., 2011;
Shankaran et al., 2012; Kent et al., 2013; Chirikos, Roetzheim, McCarthy, & Iezzoni,
2008). Two studies also reported that work-related status of disability, unemployment, or
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leaves of absence from work predicted financial burden (Bernard et al., 2011; Shankaran
et al., 2012). Evidently, attempting to clearly define who is at risk of financial toxicity
(objective burden and subjective distress) is complicated as few commonalities exist
among studies. Conceivably the costs of cancer care can affect anyone depending on the
type of cancer, treatment expenses, resources available, and personal circumstances.
Impact on family. It is generally accepted that cancer does not only affect the
individual but can negatively impact the entire family (Bradley et al., 2007; Amir et al.,
2012). Similarly, cancer-related financial toxicity can also plague the patient’s family.
Family members may need to quit their jobs or take time off to become caregivers (Carey
et al., 2011). Individuals may need to give up outside employment to take care of their
loved one. This can have a direct impact on the family member’s financial well-being
(Grunfeld et al., 2004). The family members may experience loss of access to resources.
This has been shown to negatively affect a family member’s health and access to health
care as they may delay their own health concerns or general check-ups due to a lack of
funds or insurance to access care (Grunfeld et al., 2004). The financial situation therefore
contributes to the experience of caregiver burden.
Social Support in the Literature
Up to this point, I have cited the literature providing evidence for the impact of
financial toxicity. The next half of this chapter will cover social support in cancer. The
breadth and depth of literature on social support is vast and covers a plethora of
situations. For the purposes of this part of the literature review, articles were retrieved
that consider social support as a direct influence on health-related outcomes in cancer
patients and survivors. Then another search was conducted to obtain articles that focused
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on social support as a moderator or mediator variable in both cancer studies and other
health-related studies.
Social Support in Cancer. It is well known that adequate social support serves as
a protective factor for people facing crisis or traumatic experiences (Cobb, 1976). The
cancer experience is no exception to this. Several studies have identified social support as
an important component having a direct relationship with health-related consequences
over the cancer trajectory.
In the literature, low social support or lack of social support is associated with
negative health-related outcomes. Social support has been shown to have a direct
relationship on cancer disease progression in patients with breast cancer (Nausheen,
Gidron, Peveler, & Moss-Morris, 2008) and acute myelogenous leukemia patients
(Pinquart, Hoffken, Silbereisen, & Wedding, 2006). Lower levels of social support were
found to predict patient mortality in acute myelogenous leukemia patients (Pinquart et.al.,
2006). Furthermore, another study found that patients with lower social support at
diagnosis were at risk of developing negative physical symptoms such as pain and
inflammation (Hughes, 2014).
Social support has also been associated with the emotional well-being of patients.
Those with lower levels of social support were more likely to experience higher
depression (Uchitomi et al., 2000; Schroevers, Ranchor, & Sanderman, 2003; Eom, 2012;
Hughes, 2014) and anxiety levels (Uchitomi et al., 2000). In a longitudinal study with
cancer patients, those with lower levels of problem-focused emotional support displayed
higher levels of depression (Schroevers, 2003). Moreover, perceived social support and a
desire for social support were strong predictors of anxiety and depression symptoms in
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newly diagnosed cancer patients (Linden, 2009). For those patients with a lower desire
for support, if support was not present, they experienced increased depression. These
studies support that the lack of support can be detrimental to patient’s mental and
emotional well-being.
Conversely, patients with higher levels of social support appear to gain healthrelated benefits. The more emotional support cancer patients had post diagnosis was a
significant predictor of positive outcomes of treatment up to 8 years post treatment.
(Schroevers, Helgeson, Sanderman, & Ranchor, 2010). Furthermore, social support has
had a direct positive relationship with physical exercise and nutrition in cancer survivors
(Barber, 2012; Coleman, 2014). More specifically, increased perceived social support
positively influenced physical and mental health related QoL (Westby, 2016) and overall
QoL (Eom, 2012). Emotional and information support have also been associated with
increased social, emotional and functional well-being (Kroenke, 2013). In this same
study, increased tangible supports were related to increased physical, and social wellbeing as well as overall QoL (Kroenke, 2013). Interestingly and in support of theory, the
level of satisfaction with social support was found to be a predictor of patients’ QoL but
the size of their social network was not (Cheng et al., 2013). This suggests that perceived
or received social support is more important than the number of individuals available in
one’s network to provide the support. Furthermore, although no study was found to
determine the best types of social support, one study showed that received social support
had a stronger influence and satisfaction than perceived (Schroevers et al., 2010)
Lastly, in a qualitative study of patients undergoing chemotherapy, several
benefits of social support emerged in their data. Social support assisted patients in
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focusing on the bigger picture and adapting to living with cancer. It helped them steer
from negative thoughts and aspects of cancer as it enabled them to engage in normal
everyday activities. Furthermore, social support was instrumental in patients finding hope
and support (Mattioli, 2008).
Social Support: An Influential Variable. For decades social support has been
shown to have an influence on QoL by helping to maintain and promote emotional and
physical well-being (Cobb, 1976; Cohen & Syme, 1985). To further this discussion the
following section reviews the social support literature in the context of moderator or
mediator variables. These articles are not specific to cancer although many of them are.
The purpose of this review is to support the concept that social support can interact as an
influential variable between the relationships of other variables.
Social support has been found to be a significant factor in coping with cancerrelated stress. In the prior section social support was shown to have a direct effect on
health and QoL but it also can moderate or mediate aspects within the cancer experience.
In breast cancer patients, perceived social support was shown to moderate the effects of
cancer-related negative thoughts on patient QoL (Lewis et al., 2001). In gynecological
cancer patients, received social support was shown to moderate the effects of cancerrelated traumatic stress on physical symptomatology; patients with greater perceived
social supports reported fewer cancer-specific symptoms than those with poorer
perceived social supports (Carpenter, Fowler, Maxwell, & Andersen, 2010). In a second
study with breast cancer patients, social support mediated the negative association
between optimism and distress (Trunzo, & Pinto, 2003). Perceived social support was
found to mediate optimism and positive affect in non-cancer specific survivors, thus,
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social supports protected against negative psychological outcomes. This study also
showed that social supports had a direct effect on positive affect (Hodges, & Winstanley,
2012).
Another study considered the impact of social constraint which occurs when
social support is interpreted by the support received to be negative or non-help. In the
literature reviewed social constraint was explored in breast and colon cancer patients. In
this study, social constraint was seen as a mediator variable between optimism and
patient affect. They also determined that patients who were more optimistic had fewer
social constraints but did not necessarily have more social support (Lepore et al., 1999).
In studies focused on general health, received social support has been found to
buffer the experience of financial stress on psychological well-being in general health
research. Aslung, Larm, Starring and Nilsson (2014) examined the effects of financial
stress on the psychological well-being and psychosomatic symptoms of individuals in the
general population in Sweden. Although financial stress still had a substantial impact on
emotional and physical well-being, those with more tangible social supports were
significantly better off than those with less. Additionally, the level of stress increased
significantly for those who had low social support (Aslung et. al., 2014). These findings
are indicative of the buffering effect social support provided for the psychological wellbeing of those experiencing financial stress.
The literature reviewed discussed the importance and value of social support and
how it can make an impact, both positive and negative, on an individual’s experience. We
have also observed how social support can act as a direct or indirect variable which can
interact as a moderator or mediator variable in different situations.
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Gaps in the Literature
There have been several studies conducted on the financial burden of cancer.
Although this is not an exhaustive review of the literature, it provides us with an intricate
view of this complex issue. Still, there is much to be learned. There remains an inability
to truly identify those at-risk. This lack of understanding may lead to unmet patient
needs, and further exasperate the lack of access to financial assistance. Another issue is
the lack of understanding of the process by which financial burden occurs. By better
identifying key time periods in the cancer trajectory, interventions may be employed
strategically. Another piece to the puzzle may be understanding help-seeking behaviors
as they relate to financial aspects. Socially, taboo issues have long constrained people
from talking about such issues as politics, religion, sex, and money. Furthermore, in my
literature search, I was only able to identify two interventions that have been tested for
effectiveness in addressing cancer-related financial burden.
It is apparent that more information is needed to fully understand this
phenomenon and variables which may play a positive role in relieving the negative
impact. As viewed through the literature on social support, it is apparent that it plays an
important role in the cancer experience and has been shown to be a stress-buffer for
financial strain in other contexts. In response to these findings, it is my intention to
expand on the given literature by examining the role of social support in the context of
cancer-related financial burden.
Summary
Despite awareness and efforts to improve patient care, little is being done to
address the financial burden that cancer patients endure. Although literature exists on the
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impact of cancer-related financial toxicity and its effects on QoL, it is evident that we do
not have a full understanding of the experience faced by many cancer patients. This
research study strives to add to the literature by exploring the impact of social support as
an influential factor in the lived experience of cancer. By gaining this knowledge, social
work practice and research will be better informed to identify and work with those
individuals at risk.
As presented in the literature reviewed, social support can have positive effects on
health and wellness. Furthermore, it can act as a direct or indirect variable having a
moderator or mediator effect. Nonetheless, there is a lack of knowledge regarding the
influence of social support on experienced financial toxicity during and after cancer
treatment. It is apparent that social support has a relationship with patient survival and
QoL. In addition, social support has also been shown to have an impact on the perception
of financial stress in another context. However, it is unclear how social support may
impact an individual’s experienced financial toxicity throughout the cancer trajectory.
The next chapter will present the theoretical perspectives and frameworks that
support this project suggesting that social support may indeed play an important role.
Chapters 4 and 5 provide the methods and results for Study 1 respectively. Likewise,
chapters 6 and 7 provide the methods and results for Study 2. A final discussion bringing
the results of both studies to address the overarching questions will conclude in Chapter
8.
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CHAPTER 3: MULTIPLE METHOD APPROACH, RESEARCH PARADIGMS, AND
THEORETICAL PERSPECTIVES
It is human nature to be inquisitive about the world that surrounds us. We have a
strong desire to understand why, where, what, and how. We strive to comprehend a
problem and find solutions. These questions and our desire to find answers to them is the
driving force behind our research inquiry. In order to answer these questions researchers
are faced with deciding how best to accomplish this task and are reliant on the
philosophical and theoretical perspectives with which they align.
Research is deeply intertwined with these perspectives and the role they assume
has been much debated with varying degrees of agreement. It has been my experience, in
attempting to navigate this philosophical maze, there are multiple ways to philosophically
approach a research question. This poses a task for the researcher to identify the best way
to logically approach their question. Furthermore, they must be able to justify their
decisions to align with a given design, philosophy, or theoretical perspective.
In order to address the overarching research question that drives this project: What
role does social support play in the experience of cancer-related financial toxicity
(objective burden and subjective distress)? I selected a multiple methods approach. This
chapter will first present the Multiple Method design and justify its use. The Multiple
Method approach is structured differently from other research designs as multiple
independent studies are used to answer the overarching question. Therefore, it is
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important to understand the overall design of the project before presenting the
philosophical assumptions for each study component.
Our philosophical assumptions consist of a basic set of beliefs used to approach a
study. They suggest how we understand what reality is and dictates our role as a
researcher to observe or interact intimately with the study. Philosophical assumptions
guide our values and ethics suggesting an acknowledgement of presence or absence of
bias. Furthermore, the philosophical alignment we take dictates the research methods we
use (Guba & Lincoln, 2005). After presenting the foundational design of this Multiple
Method project and the use of multiple studies, this chapter will cover the philosophical
assumptions for each study component.
The final step in laying down the foundational pieces of this project will cover the
theoretical perspectives and frameworks that gave steady footing to the project. Theories
provide us with a way of understanding and explaining human behavior. They can serve
multiple roles in the research process, such as, guiding the development, implementation,
analysis procedures, and interpretation of a study (Bradbury-Jones et al., 2014). These
theories and the work of Hayes (2017) give rise to a conceptual model which will be
reviewed at the end of this chapter.
Multiple Method Design
Mixed Method and Multiple Method approaches are considered to be “in the
middle of a boom” as an increasing number of researchers are relying on them
(Seawright, 2016, p.42). Creswell and Clark (2011) suggest such methods are appropriate
to further understand a phenomenon when using one data source is insufficient, if there is
a desire to generalize findings, or a second method will further enhance the study’s
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findings. The use of multiple research strategies will help broaden the breadth and scope
of understanding and provide a more complete picture of the phenomena (Morse, 2003).
By combining different research strategies, it is suggested that the strengths of one
method will compensate for the weaknesses of another leading to more credible outcomes
(Hunter & Brewer, 2015). However, due to the novelty of this relatively emerging
approach to research, terminology and methodological expectations are still murky. This
section will attempt to provide clarification to the Multiple Method approach relied on for
this project.
As presented in Chapter 1, Multiple Method approach begins with an overarching
question and is composed of multiple individual studies that attempt to answer that
question. Each study is considered to be interrelated with another in that they attempt to
answer the same question, but they are separate and whole. Each study has its own subquestion and is guided by its own philosophical assumptions (Morse, 2003). For this
project, two studies were conducted sequentially but had equal importance: first the
qualitative and then the quantitative. From the qualitative study, social support was
identified as an important concept. This led to a desire to understand more about the role
social support played and informed the development of the quantitative study. More
details about the methods of each study a presented in Chapter 4 (Study 1 Methods) and
Chapter 6 (Study 2 Methods).
When designing a Multiple Method project each study component must be
methodologically independent and executed separately. They must adhere to the specific
methodological assumptions for each (Morse, 2003). Therefore, the qualitative will meet
the assumptions consistent with qualitative research and likewise for the quantitative. In
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addition, the study samples are typically independent from one another adding to the
concept that these studies are separate from one another. The final step of a Multiple
Method design involves bridging the results to form a comprehensive understanding in
response to the overarching question. (See Figure 3.1 for a depiction of the overall
Multiple Method design showing the differences in methodology, and philosophical
assumptions.)
Overarching
Research
Question

Study 1

Study 2

Qualitative
Design
Abductive
Theoretical Drive

Quantitative
Design
Pragmatic
Worldview

Deductive
Theoretical Drive

26 Participants

126 Participants

In-depth Semistructured
Interviews

Computer Based
Survey

Grounded Theory
Technicques

Moderater &

Post-Positivist
Worldview

Mediator
Analyses

Theoretical
Sensitizing Lens Social Support
Theories

Stress and Coping
Theory - StressBuffering
Hypothsis

Figure 3. 1 Multiple Method Design Theoretical Focus

There are several benefits of using a multiple method approach. As stated earlier,
multiple method approach allows for a comprehensive picture of the phenomenon that is
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under investigation. This approach allows for different perspectives on the topic by
providing opportunities for the use of different theoretical lens and worldviews. By
collecting multiple forms and different levels of data, a wider variety of conclusions can
be ascertained. This approach will provide insight into the personal experiences of
individuals exploring what types of social support helped them during their cancer
experience. It will also provide statistical significance of social support in this context
either by moderating or mediating the experience of financial toxicity on quality of life
(QoL). In turn, this may inform and expand on the current framework of financial toxicity
presented later in this chapter.
Weaknesses of the multiple method approach include the risk of placing too much
credence or weighting to heavily on the results of the studies (Morse, 2003). Therefore,
similar to other methods, the researcher should not overexaggerate the study finding but
instead approach them modestly. In addition, Morse (2003) warns of the importance of
being aware of the theoretical drive at all times in the process. This is dictated by the
overarching question and design; however, each study component is driven by inductive
or deductive reasoning depending on the particular aspect and sub-questions of each
study. Specifically put, if using qualitative methods then inductive reasoning is the
driving force; whereas, if using quantitative methods then deductive reasoning is relied
on. In order to maintain methodological integrity each method must stay intact. It is
important to not allow the studies to contaminate each other by ensuring their
independence. Likewise, each study sample should be appropriate for the method used
and adequate data analysis performed. Morse (2003) also stresses the importance of not
violating assumptions.

30

In light of these warnings, each component of this project will be conducted
separately and will align with each respective assumptions and theoretical lenses. Each
will be driven by their separate theoretical drive and will address appropriate subquestion(s) for the given method. The qualitative study will use subjective data and an
abductive theoretical drive involving iterative cycles of deductive and inductive
reasoning (Graneheim, Lindgren, & Lundman, 2017). The quantitative will use objective
data, deductive reasoning, standardized measures, and statistical analysis. The following
section will present the philosophical assumptions relied on for each component of the
project.
Philosophical Foundations
Philosophical assumptions are deeply rooted in the way we think about the world.
They are ingrained in our thoughts and instilled in us through our education and training.
Philosophical assumptions used depend on our approach to address a particular problem
or social phenomenon. There are four philosophical assumptions used in the research
process: ontology, axiology, methodology and epistemology. Ontology refers to reality
and how it is the researcher knows and understands what reality is. Axiology conveys the
role values and ethics play in the research process. This helps the researcher understand
the use or hindrance of their biases. The stance the researcher takes in regard to Ontology
and Axiology dictates the epistemology. The epistemology refers to the researcher’s role
and their understanding of the interaction between themselves and what is being studied.
These philosophical assumptions lead to the way the research is conducted, namely the
methodology and the specific methods used (Creswell et al., 2011). Each of these four
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elements (ontology, axiology, epistemology, and methodology) are woven together and
provide a philosophical foundation referred to as an interpretive framework.
An interpretive framework conveys a basic set of philosophical assumptions.
Heeding the warnings presented by Morse (2003) in the prior section, each study will be
conducted separately using the interpretive framework that best serves the aims of each
study. The overarching question and Study 1 will use a pragmatic interpretive framework
and Study 2 will rely on the post-positivist stance. See Table 3.1 for an at-a-glance view
of the philosophical assumption for each interpretive framework used.
Table 3. 1Philosophical Assumptions of Two Worldviews (adapted from Creswell et al.,
2011).

Pragmatism
(Overarching
Project,
Study 1)
PostPositivism
(Study 2)

Ontology
(what is
real)
Both Single
& Multiple
Realities

Axiology
(values &
ethics)
Multiple
Values &
Perspectives

Epistemology
(role)

Methodology
(theoretical drive)

Focuses on
Whatever
Answers the
Question

Focused on
Single
Reality

Researcher
Eliminates
Biases

Quantitative
Methods

Dependent on the
Question
(Inductive or
Deductive
Reasoning)
Deductive
Reasoning

Pragmatic Worldview. The pragmatic worldview is primarily focused on finding
answers to the research question. In regard to Ontology, the pragmatist takes the view
that reality can be both a single reality and/or multiple (Creswell et. al., 2011). Reality is
a creation between what is in the world and how we react to it; therefore, what we know
and understand of the world is based on what we have found to be proven useful (Ritzer
& Stepnisky, 2013). Similarly, pragmatic axiology (role of values) proposes that an idea
is neither good nor bad, but value depends instead on the success of its outcome
(Hookway, 2016). The researcher can therefore use whichever epistemological design
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will answer the question. Methodologically a pragmatist is not limited to viewing a
phenomenon one directionally but instead is open to the any possibility the data presents
(Hookway, 2016). Essentially, the pragmatic worldview appears to be sitting on a
proverbial fence selecting from either side of the continuum what will best help them
answer their question.
Due to a seemingly flexible stance, the pragmatic approach works well for the
Multiple Method design. The focus is therefore on the question being asked and the
respective outcomes of the individual studies, not necessarily on the methods used to
obtain them (Creswell et al., 2011). In this project the results from both the qualitative
and quantitative studies are triangulated to answer the overarching question. The
theoretical drive, methodological stance, is inductive which is in line with the
overarching question format and conception of bringing the findings from both studies
together to form an overall interpretation.
Pragmatism also informs the philosophical beliefs for Study 1. A generic
qualitative approach allows for the use of varying epistemologies and methodologies.
Caelli et al. (2003) propose that each qualitative approach be evaluated in congruence
with its epistemological and methodological stance. Qualitative research should aim to
address: 1) the theoretical position, 2) methodology and methods, 3) rigor and
trustworthiness, and 4) the analytic lens used to examine the data (Caelli et al., 2003). A
pragmatic perspective supports drawing from both deductive and inductive theoretical
views using an abductive theoretical stance. Similarly, a pragmatism allows for multiple
analyses methods and tool to be incorporated and used. Rigor and trustworthiness in a
generic qualitative approach can be established by similar efforts used in other forms of
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qualitative approaches as well. Furthermore, a pragmatic worldview allows for the
reliance on multiple theories informing the analytic lens.
Postpositivist Worldview. The post-positivistic worldview is a logical stance for
quantitative research (Creswell et. al., 2013) and will be relied on for Study 2. It seeks to
establish causal relationships by concentrating on established variables. The ontology is
focused on a singular reality which can be derived through scientific methodology and
driven by a deductive process (Creswell et al., 2013). Using measures that are proven
reliable and valid helps the research to establish claim that a phenomenon does exist as a
common, singular reality. Established measures also assist the researcher in eliminating
biases (axiology) which can also be addressed through the study design and aspects of
rigor. This, therefore, allows the research to remain impartial and allowing the
presentation of the data to dictate the findings. Through the use of structured theoretical
perspective/frameworks, this quantitative study relied on philosophical assumptions of
Post-positivism: deductive reasoning, standardized measures, and statistical analysis.
Theoretical Perspectives
Theories are intimately interwoven into the research process. They serve as
frameworks for understanding what we observe and how we make sense of it. They guide
our research development leading us to ask important questions. They can postulate a
basic concept and lead us in a common direction. Theories can also be created and
emerge from our own research findings. The way theories are used in the research
process is determined by the goals of the research project, and the methods used
(Bradbury-Jones, Taylor, & Herber, 2014).
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The theories I relied on can be classified as substantive and formal theories.
Substantive theories are those that are specific to a given topic and based on empirical
findings; whereas, formal theories are conceptually derived (Glaser, & Strauss, 1967).
These theoretical perspectives were relied on to develop, implement, and interpret the
findings of this project.
Financial Toxicity. The Financial Toxicity framework (Carrera & Zafar, 2018)
was used in both studies of this project. In a recent publication, Carrrera et al. (2018)
present their framework for the financial toxicity of cancer care. (See Figure 3.2 for a
replication of Carrera’s et al. (2018) interpretation of the financial toxicity framework.)
This framework provides a conceptual understanding of the objective burden and
subjective distress associated with the costs of cancer care. This framework served as a
foundational piece for conceptualizing the problem and understanding how social
supports fits into the process.

Financial Toxicity

Attributes

Objective
Financial Burden

Expenditures

Impact

Non-adherence

Subjective
Financial Distress

Anxiety &
Discomfort

Wealth

Direct Costs

Savings

Indirect Costs

Assets

Worse Outcomes

Worse QoL

Figure 3. 2 Framework on Financial Toxicity (Carrera & Zafar, 2018).
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Financial Toxicity refers to the financial objective burden and subjective distress
experienced as a result of a cancer diagnosis and treatment. From an objective standpoint,
patients face financial burden due to direct and indirect costs associated with their cancer
care (Carrera et. al., 2018). As presented before, the costs of cancer care are astronomical,
and many patients are faced with unexpected out-of-pocket expenses. Financial barriers
exist such as being underinsured or uninsured which can be further complicated by forced
changes in employment status. Patients make financial sacrifices such as selling
belongings, reducing household spending and using savings. They may borrow money
and use credit cards leading to increased financial debt which may result in bankruptcy.
Subjectively the costs of care impact the patients experience and psycho-social wellbeing (Carrera et. al., 2018). Research has shown that patients report feelings of anxiety
and distress. Furthermore, this multi-complex phenomenon (financial toxicity) not only
impacts the patient, but it adversely effects the family as well.
These subjective and objective experiences of financial toxicity lead to potentially
overall worse outcomes for patients and their families. As a result, a patient may choose
to be non-adherence to medical treatment which may result in poorer health-related
outcomes (Carrera et. al., 2018). Furthermore, financial toxicity can lead to worse quality
of life. (Details on financial toxicity and supportive literature are presented in Chapter 2.)
Social Support Theories. Social support is a term used to describe the product of
one’s support network and interactions. It is well known in the cancer literature that
social support plays a critical role in physical health, psychological well-being, social
functioning and emotional adjustment among survivors and those living with cancer. For
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the purposes of this research project it is conceptualized as: the emotional, informational,
and instrumental supports perceived and/or received from formal and informal support
networks.
According to Sarason, Sarason, and Piece (1990) there are three models of social
support: 1) network of support, 2) received supports, and 3) perceived supports. Each of
these models describes important information about social support and helps to provide a
more comprehensive conceptualization of the concept. The first model, network of
support, often looks at the number of people who surround the individual and the types of
those relationships. This is a laborious process for the study participant, time consuming
for the researcher, and does not necessarily yield a connection between social support and
health outcomes (Sarason et al., 1990). Given these concerns, I focus attention on the
other two models: received and perceived supports. The extent to which networks are
explored in this project is limited to whom the participant receives support from or
perceives to be supported by.
A support network is made up of the social relationships that surround the
individual and is composed of family, friends and community members (Laireiter, & Urs,
2013). This is composed of the people an individual interacts with. These relationships
are considered formal or informal depending on the social role the network member
plays. Formal support network members are typically from distant roles including
individuals such as health care professionals and organizations. They typically perform
more informational or instrumental support services (Cohen, 2013). Informal supports, on
the other hand, are intimately close relationships consisting of family members and
friends. They may provide informational, instrumental and emotional types of support.
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Interestingly, whether or not a behavior is perceived as supportive is dependent on the
provider of the support as well as the timing of when the support occurs (Cohen, 2013). It
is important to be aware of the social role the supporter plays, the timing of the received
social support and the support receiver’s perception of the supportive act.
As noted, social support can be perceived or received. The perception that social
support exists is based on the viewpoint of the receiver. In general, the receiver thinks or
feels that support is available. Received support can be objectively measured either by
self-report or reported by others (Laireiter et al., 2013). From the receiver’s perspective
these are social supports that are actually received. Both perceived and received supports
can be in the form of emotional, informational, or instrumental.
Emotional support refers to the understanding that one is accepted, cared for and
valued (Cohen & Syme, 1985). It can exist in the form of empathy, encouragement,
reassurance, or feelings of being understood, accepted and loved (Langford, Bowsher,
Maloney, & Lillis, 1997; Wong et al., 2016). Emotional supports may be received
through others communicating support or having someone who is willing to listen and
understand. It can also be a perception of knowing someone cares and would be available
if needed.
Another category of support is informational support. This is defined by Cohen
and Syme (1985) as one’s ability to find knowledge and information to better understand
the problematic event. Informational supports are most needed when a stressful event,
such as a cancer diagnosis, exceeds the knowledge and problem-solving abilities of that
individual. Therefore, the individual is required to seek advice, knowledge, and guidance
from others. Examples of received informational support are problem-solving advice,
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receiving resource information and referrals. Informational support can be a perceived
sense of support in the form of knowing that access to information or advice is available
if requested (Langford et al., 1997; Wong et al., 2016). Ultimately, individuals need to
know where to find the information or who to ask.
The final form of support that will be considered is instrumental support which
consist of provided assistance with tasks, tangible, and material support (Cohen & Syme,
1985). Instrumental support for the issue of cancer-related financial toxicity may be in the
form of financial assistance, providing material goods such as food and other daily-living
necessities, or assistance with completing household chores. Similar to the other two
forms of support, access to instrumental support can be a perception that this type of
assistance and resource is available if needed, or it can be actually received.
Conditions of social support. To add another layer of complexity, certain
conditions need to be met before social support is requested by the individual or provided
by a network member. For a person to request assistance the request cannot be something
that would potentially harm the relationship and the individual must feel comfortable in
the relationship to make a request. The network member must know enough about the
stressor, be capable of providing support and not overreact to the request being made. If
the network member overreacts, the individual may feel embarrassed or ashamed of
asking. The need for the request must be socially acceptable and perceived as a legitimate
stressor. Socially taboo stressors may cause feelings of guilt or shame which may prevent
the individual from requesting help or the network member from providing it.
Additionally, if social norms dictate the necessity of providing support, then support will
likely be provided. (Cohen, 2013). Therefore, the giver feels on obligation to provide
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support. Lastly, in order for social support to be most effective the support received must
match the need (Cutrona & Russell, 1990). If the support does not match the need, the
need will still remain leaving the individual feeling unsupported.
Social constraints. Ideally, social support provides one with positive elements that
help to provide feelings of comfort, encouragement, helpful information or usable items;
however, social support can also be perceived or interpreted as negative (Lepore &
Ituarte, 1997; Lepore & Revenson, 2007). Network members may say or do things that
are interpreted by the individual as inappropriate, critical, or insensitive (Hobfoll, &
Stephens, 1990; Cohen, 2013). They may attempt to minimize the stress-event or perhaps
avoid and abandon the individual all together (Hobfoll et al., 1990; Veiel & Baumann,
2013). Life events such as having cancer may elicit avoidant or minimizing behaviors
from network members (Veiel et al., 2013). This may complicate the situation further
making it difficult for individuals to talk about their problem or ask for help.
Feeling socially constrained, patients keep their thoughts and feelings private.
They become less likely to share or disclose their emotional and physical needs. They
may feel they cannot talk to anyone about what is causing them distress (Veiel et al.,
2013). This leads to the individuals feeling isolated and unsupported. Ultimately, the
individual may experience mental health issues (Lepore et al., 2007) such as depression
(Schroevers et al., 2003), increased distress and mood disturbances (Norton, 2005).
Stress and Coping Theory. The Transactional Model of Stress and Coping
Theory (referred to as Stress and Coping Theory) developed by Lazarus and Folkman
(1984) was designed to explain how individuals experience a stressful event, assess
related risks, and select coping methods. This is a process-oriented approach for dealing
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with stress that involves cognitive assessment of a stressful event through the appraisal
process and then selection of the best coping method. The effectiveness of the coping
mechanism, in turn, dictates the outcome (Lazarus, & Folkman, 1984; Folkman, 1997;
Folkman & Greer, 2000; Folkman, 2010). When new information is acquired, reappraisal of the event occurs creating the reselection of coping mechanisms and potential
effects on outcome (Folkman, 1997; Folkman, 2010). The following section will briefly
review components of this theory within the context of cancer-related financial toxicity
(objective burden and subjective distress). Refer to Figure 3.3 for a depiction of the Stress
and Coping Theory in the context of cancer-related financial toxicity.

Primary
Appraisal

Stress
Event

Coping
Response

-Financial Toxicity
(Objective Burden
& Subjective
Distress)

-Use of Credit
Card
-Cut back on
expenditures
-Avoidance
-Medical noncompliance

-Costs of
Cancer Care

Secondary
Appraisal

Patient
Outcome
- Quality of
Life
-Subjective
distress

-Assessment of
Coping Resources
New Information Leads to Re-Appraisal
-Objective Burden Experiences
-Subjective Distress

Figure 3. 3 Financial toxicity illustrated through the Stress and Coping Theory (Lazarus
& Folkman 1984).
Stress event. According to Lazarus and Folkman (1984), stress is a response to a
stimulus that induces a stressful physiological and behavioral response. It results when
these demands overburden the individual, exceeding their available resources, and
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potentially risk the person’s sense of stability and well-being. For example, the stresscausing event may be a risk of harm, or unexpected demand placed on the individual. In
the context of this study, the initial stress events are cancer and the costs of cancer care.
Initially, patients experience increased expenditures related to their cancer care (objective
burden). The actual costs or an anticipation of the costs of care may become
overwhelming and result in effects on psycho-social well-being (subjective distress).
In time, the patient may experience a secondary stress event which occur through
the feedback loop. Objectively, patients may be unable to work resulting in reduced
income and potential job loss causing an additional stress event. Furthermore, a job loss
could impact insurance availability and ability to cover medical and basic daily needs.
Cancer patients may also face an accumulation of medical bills and related expenses.
These stress events may then be interpreted to cause harm which in turn leads to use of
coping mechanism resulting in an outcome.
In addition, the outcome can result in the subjective distress aspect of financial
toxicity. The effects of stress on cancer patients have been well supported in the
literature. As noted in Chapter I, research has shown that cancer patients who experience
financial burden have increased anxiety, depression (Sharp et al., 2013) and distress
(Markman et al., 2010; Lange et al., 2004). Patients have also reported long-term
financial strain as a result of related OOPE (Darby, Davis, Likes, & Bell, 2009). The
subjective distress could also lead back to the appraisal process through the feedback
loop and becoming another stress event.
Appraisal. Once a person experiences a stress event, he/she engages in the
appraisal processes. This is a cognitive process where the individual contemplates the
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stress event and desired outcome. During the appraisal process a person gains an
understanding of a given situation and assesses whether the stress event is benign or
threatening to their feelings of well-being (Lazarus et al., 1984; Folkman, Lazarus,
Gruen, & DeLongis, 1986).
The appraisal of a stress event occurs during three phases: primary, secondary,
and re-appraisal (Folkman, 1997). The primary and secondary appraisal processes can
occur simultaneously. During the primary appraisal a person will assess if a situation is
irrelevant, benign-positive or stressful. Then during the secondary appraisal, the
individual determines what, if anything can be done. The individual assesses what coping
options are available, and which will be effective. Then they determine if they have the
ability to effectively execute that particular coping method. The final phase of appraisal
occurs when the individual becomes aware of any new information that may affect the
situation. This is referred to as the re-appraisal process since the individual re-assesses
the situation through both the primary and secondary processes.
In the context of this study, individuals experience the stressor (initial cancer and
cost, secondary objective burden and subjective distress) and then in the first appraisal
process they assess the stress event as harmful or overwhelming. This may follow or
occur simultaneously with the second appraisal process where the individual determines
the best course of action to gain the best possible outcome given their available coping
mechanisms and resources.
Coping. Once the stress event has been appraised, the individual engages in a
coping response. Coping responses include anything a person thinks or does to manage
the stress-event. Coping responses are influenced by the uniqueness of the individual and

43

may be good or bad depending on the interaction between the individual and their
environment (Lazarus et al., 1984; Folkman et al., 1986; Folkman and Greer, 2000;
Folkman, 2010).
Coping responses for those experiencing cancer-related financial toxicity are well
documented in the literature. Many of these responses are not beneficial to a patient’s
overall health and mental wellness. In one study, patients reported skipping or delaying
medical treatments (Darby et al., 2009). Medical non-adherence is not uncommon among
individuals who experience cancer-related financial toxicity. Patients will also base
medical decisions based on the costs associated with the doctors’ appointments and
medical treatment (Markman et al., 2010; Wong et al., 2010; Shankaran et al., 2012).
Other coping methods used by patients involved cutting back discretionary spending,
selling possessions, using saving and retirement funds (Shankaran et al., 2012),
borrowing money, and increasing debt (Bernard et al., 2011). Although these types of
coping methods may temporarily alleviate the stress allowing the patient to get through
the cancer experience, arguably they can result in negative outcomes impacting overall
quality of life.
Outcome. The outcome is the result of the appraisal and coping processes
(Lazarus et al., 1984). Depending on the effectiveness and the available coping resources,
individuals may be able to carry on with their everyday activities or they may be
immobilized and in a state of crisis. For the purpose of this proposed study, quality of life
will be used as the outcome variable.
Understandably financial toxicity can impact multiple domains of quality of life:
social, emotional, functional, physical and economical. For example, social well-being
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may be affected when individuals cut back on discretionary spending. They may not be
able to afford to engage in social activities causing them to potentially lose social
relationships. Likewise, this could affect their functional well-being. Individuals may not
be able to afford to do things they once enjoyed doing. In the emotional domain, financial
toxicity may cause an increase in sad or hopeless feelings when coping strategies are not
effective. Individuals may feel powerless as their financial situation negatively affects
their economic well-being.
Quality of life is often used as an outcome variable in research on cancer-related
financial toxicity. Several articles have shown that cancer-related financial burden has a
negative relationship with quality of life (Ell et al., 2007; Gupta, Lis, & Grutsch, 2007;
Fenn et al., 2014). As patient financial strain increases, their quality of life decreases.
Stress, coping and financial toxicity. The stress and coping theory provides a
basic model for understanding the effects and outcomes of cancer-related financial
toxicity (objective burden and subjective distress). See Figure 3.3 (presented earlier)
which illustrates how the initial stress events (cancer and cost of care) enacts the primary
and secondary appraisal processes. Financial toxicity (the objective burden and subjective
distress) is appraised and coping resources are assessed which leads to the coping
response which in turn leads to patient outcomes and/or reassessment through the
feedback loop.
Stress-Buffering Hypothesis. The stress-buffering hypothesis can be used to
suggest that social support buffers the individual from adverse effects of a particular
stress event. It builds upon the conceptualized framework of Stress and Coping Theory.
(See Figure 3.4 for the addition of social support as a stress buffer to the Stress and
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Coping Theory in the context of financial toxicity). According to Cohn and Wills (1985),
social support may intervene with the stress and coping process during the appraisal
process and/or the coping response.

Social Support
-Emotional
-Instrumental
-Informational

Social Support

Primary
Appraisal

Stress
Event

-Emotional
-Instrumental
-Informational

-Financial
Toxicity
(Objective
Burden &
Subjective
Distress)

Coping Response
-Use Credit Cards
-Cut back on
expenditures
-Avoidance
-Medical noncompliance

-Costs of
Cancer Care

Patient
Outcome
- Quality of
Life
-Subjective
Distress

Secondary
Appraisal
-Assessment of
Coping
Resources

New Information Leads to Re-Appraisal
-Objective Burden Experiences
-Subjective Distress

Figure 3. 4 Social support on financial toxicity interpreted by Stress and Coping Theory
and Stress-buffering Hypothesis.
First, social supports may buffer the interaction between the stress event and the
appraisal process (Cohen & Wills, 1985). Due to perceiving or receiving adequate
support, individuals may not perceive the stress event to be as harmful or threatening as it
would without those supports. A second point of support intervention may occur during
the coping response process (Cohen & Wills, 1985). This may then cause the re-appraisal
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process to occur due to the acquisition of new information. This new information could
be in the form of problem-solving advice, information or resources that may ease or
eliminate the stress.
It is important to note that in order for the social support to be an effective buffer,
the support provided must match the demands of the stress event (Cohen & Wills, 1985).
Therefore, in the context of this proposed study, social support that helps to alleviate
financial toxicity would act as a buffering agent. Currently there is no empirical support
defining what this type of social support would be; however, the benefits of social
support on health have long been established (see the literature review in Chapter 2 for
more details).
Conceptual Model
There are two different ways a third variable can act as a buffer, either as a
moderator or a mediator. A moderator variable will regulate the relationship between the
independent variable and the dependent variable. The moderator variable may change the
direction or the magnitude of the IV, maximizing or minimizing its effectiveness on the
dependent variable. For study 2, social support will be examined to determine if it is a
moderator variable regulating the relationship between financial toxicity and quality of
life. Figure 3.5(a) displays the conceptual interpretation of social support as a moderator
variable.
In addition to this framework, a moderated moderator model will further examine
the moderator effects by adding social constraint to the model. Social constraint has been
shown by the works of Lepore et al. (1999) to negatively impact the benefits of social
support. See Figure 3.5(b) for social support as the moderated moderator model (Hayes,

47

2017). In this model, social constraint is conceptualized to regulate the interaction
between financial toxicity and social support; therefore, the relationship between
financial toxicity and QoL is moderated by social support which in turn is moderated by
social constraint.

Social Support
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Financial Toxicity
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Emotional,
Informational,
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Social
Constraint
Quality of
Life

Financial Toxicity
-Objective Burden
-Subjective Distress

Moderated Moderator Pathway
Figure 3. 5 Social support as a moderator variable, adapted from the work of Hayes
(2017).

Alternatively, a mediator creates a mechanism through which the independent
variable is able to influence the dependent variable. According to Hayes (2017),
mediation offers a causal explanation for what is occurring in the phenomenon. It
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assumes the relationships in the analysis are causal. It therefore assumes financial toxicity
has a direct causal relationship with QoL and an indirect effect on QoL through the
mediator variable, social support. In this mediator relationship, financial toxicity leads to
an increase in social support which in turn effects QoL. In this study, I will not be able to
unequivocally establish causality due to the study design and the data available for this
analysis. That will be noted as a limitation of this study; however, the analysis for a
mediation variable will allow for some interpretation. (See figure 3.6 (a).)
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Figure 3. 6 Social Support as a Mediator Pathways.
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Furthermore, social constraint will be examined in the mediator analysis as well.
This analysis will use a moderated mediator model (Hayes, 2018). It examines the impact
of social constraint on the relationship between perceived social support and quality of
life. (See Figure 3.6 (b).)
Summary
Researchers are tasked with identifying the best method to use to answer their
research questions. For the purposes of answering the overarching question presented in
Chapter 1, I chose to conduct a Multiple Method approach. This approach allowed me to
draw conclusions from both qualitative and quantitative methods allowing for different
perspectives and procedures to inform the discussion. As noted, there is a gap in the
literature in regard to social support and cancer-related financial toxicity accordingly this
multiple method approach will help to provide a broader perspective.
In addition, this chapter has addressed the foundational components underling the
development of this project. The Multiple Method design requires that the individual
studies be whole and complete. This requires the use of the appropriate philosophical and
theoretical perspectives to answer the study questions. The assumptions, theoretical
perspectives and frameworks for each study were presented, each providing the
individualistic approach to each study component.
The next chapter provides detailed descriptions of the methods used. To remain
true to the Multiple Method design as described by Morse (2003), each component of the
project will be discussed as separate studies. The first part of Chapter 4 covers Study 1
(qualitative) followed by Study 1 results in Chapter 5. Chapter 6 and 7 presents the
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methods and results for Study 2. Then Chapter 8 presents a final discussion drawing on
the finding from both studies to answer the overarching questions. This will also include
concluding remarks and implications for social work practice.
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CHAPTER 4: STUDY 1 METHODS
The overarching question that drives this research project is: What role does
social support play in the experience of cancer-related financial toxicity? To answer this
question a multiple method approach was used. Two studies were developed each
answering an aspect of the overarching question. To stay true to the assumptions of the
multiple method approach as presented in Chapter 3, each study was conducted
separately and is considered to be solely complete by itself. Study 1 is presented first as it
was the first study to be completed and aspects of the findings were used in the
development of Study 2. The present chapter details the methods used for Study 1.
Study 1 - Qualitative
Study 1 was a secondary data analysis of a qualitative study that explored the
lived experiences of 26 cancer survivors who self-reported experiencing financial burden
and distress (financial toxicity) due to the costs of their care. Secondary data analysis of
qualitative data is not a common practice but has been acknowledged in the literature as
an acceptable method (Smith, Ayanian, Covinsky, Landon, McCarthy, Wee, and
Steinman, 2011). I was involved with the original study (LEFT study) from its inception
and participated in all aspects of the process. Social support emerged as a primary
category, so the research team granted me permission to use this data.
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Purpose
The specific aim of my analysis was to better understand the existence and use of
social support within the lived experience of cancer-related financial burden. It
specifically explored the research question: For individuals who have had cancer, what is
their experience with social support in the context of cancer-related financial toxicity?
Pragmatism. Pragmatic philosophical assumptions were relied on in order to
seek and understand this phenomenon. (Refer to Chapter 3 for in-depth details on the
pragmatic worldview). The pragmatic worldview is focused on answering the research
question through whatever tools or methods are most appropriate. This viewpoint allows
for the use of multiple theories which not only provide the foundational support for the
study but also informs the analysis and interpretation of the results.
From a pragmatic stance, I used a generic qualitative approach informed by Caelli
et al. (2003). Since the generic qualitative approach does not align with any specific
epistemology or methodology it is acceptable to use with pragmatism. Caelli et al. (2003)
states that the epistemology and methodology used should be congruent. This leaves the
researcher tasked with clearly identifying and substantiating their research according to
four key issues: 1) a well-defined analytic lens, 2) a clear theoretical position, 3)
congruence between epistemology, methodology and selected methods, and 4) establish
rigor and trustworthiness (Caelli et al., 2003).
The analytic lens used for this study was social support theories. (For in-depth
details on the conceptualization of these theories refer to Chapter 3.) This involved a
back and forth process between social support theories and the data analysis process.
Relying on a theoretical abductive drive, processes of deductive and inductive reasoning
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were incorporated (Graenheim et al., 2017). Through the analysis procedures, a primarily
deductive approach was used to categorize the data. This process was followed with an
inductive approach of developing in-depth definitions for each category. (Further
explanation of these steps will be provided later in this chapter.) It is through this
inductive process that a greater understanding can emerge (Charmaz, 2014). Calling on
pragmatic roots, multiple methods of iterative processes that can occur through the data
analysis phase. These iterative processes will highlight similarities and differences in the
data (Miles and Huberman, 2014). Furthermore, the generic qualitative methodology
allows for selecting methods which will inform and answer the study questions.
For this study, Qualitative Content Analysis (QCA) was the most appropriate
method and remained congruent with the methodology (generic qualitative approach).
Content analysis must be “systematic, methodologically based, and transparently
reported” (Drisko & Maschi, 2016, p. 4). It can be used for secondary data analysis and
can be driven by inductive and/or deductive coding approaches (Drisko & Maschi, 2016).
Furthermore, it QCA uses deductive methods to organize data into categories and
inductive methods to create definitions of those categories (Mayring, 2000).
Data in this study are organized into categories through a direct approach. The
purpose of the direct approach is to validate or expand on a given theoretical framework.
The direct approach uses a theory-based approach to coding where codes are informed or
developed through using theory or relevant research findings (Hsiu-Fang & Shannon,
2005). These codes can remain manifested, meaning that they are grounded in the data
staying true to the participants’ words. On the other hand, the codes can be latent in
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nature allowing the researcher to immerse in the data and identify hidden, underlying
meanings (Bengtsson, 2016).
Congruent with pragmatism, the generic qualitative approach and QCA,
trustworthiness can be established through multiple methods. Results for the QCA can be
displayed in a table format to give readers a quick glance at the material. In addition,
quantification of sub-categories and categories can occur through counting occurrences of
the identified unit of analysis (Bengtsson, 2016). Quantification can increase the
magnitude of the phenomena being studied. However, according to Mayring (2000),
QCA follows the rules of content analysis except it does not require the quantification of
the data. Further efforts to establish trustworthiness can be borrowed from other
qualitative methods such as those proposed by Lincoln and Guba (1985).
Study Sample. Sampling methods that were used to obtain participants include:
criterion, snowballing and purposive. Initially, patients were obtained from a recruitment
announcement posted in cancer centers, cancer support organizations, churches, and the
University of Louisville daily e-news. It became clear that there was not much
representation from the older adult population so purposive sampling was used to acquire
more older adults. A total of 26 participants met the criteria and participated in the
interviews.
Inclusion criteria. In order to participate, participants needed to be age 18 or
older, had a cancer diagnosis and received treatment in the past 5 years. They also needed
to perceive that they experienced financial hardship due to the cancer experience.
Data Saturation. Data collection was conducted until the research team
determined saturation of data was reached. The process of determining data saturation
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involved multiple discussions regarding the data that had already been collected. The
team of researchers conducted initial data analysis and identified common categories
among all the interviews. Then conducted an assessment of the age ranges of the
participants. It was determined that the sample was missing representation of older
adults; therefore, the researchers purposely requested participation of individuals who
were over 60 years old. Once an adequate representation of all age groups was achieved,
the research team determined that the study had reached saturation.
Data Management. In order to ensure study integrity and confidentially for
participants, data were carefully maintained. Audio files were transcribed and then
destroyed. All identifiable information was removed from transcripts and data were kept
in a password protected computer. The transcripts were also maintained in DedooseTM
which is an online qualitative analysis program. DedooseTM provides a secure online
platform for handling qualitative work.
Study Procedures. The following section begins by detailing the steps taken by
the research team in the Origins section. It details how the initial categories of the larger
qualitative study were determined using a theory-based approach and how Gaps in
Support emerged from the analysis. This is followed by a description of my analysis
process found in the Social Support Analysis section.
Origins. Financial burden associated with cancer treatment was identified as
being a topic that dramatically affects patients and their families. After conducting a
literature review, a research team was assembled to develop a study proposal. Once
developed, study procedures were reviewed and approved by the Institutional Review
Board. A call for study participation was sent out through various means: university
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system announcements, cancer related organization emails and area church
correspondence. Interested participants responded by email or telephone and went
through a screening process. Participants were asked a series of questions to determine if
they met the study criteria (presented below). Those who met criteria were scheduled for
an interview.
A team of researchers, consisting of three university professors, two doctoral
students and a research assistant, conducted 26 one-on-one interviews. Interviews were
conducted in a private setting convenient to the participant. Interviews took place over
Skype if the participant was located in a different city than the interviewer. Other
locations included participants’ homes or their workplace offices, as well as offices
located on the university campus.
Prior to each interview the participant was provided the consent preamble (see
Appendix A for details). For those meeting over an online format, the preamble was
emailed to them prior to the interview. Each interview began with a brief explanation of
the study then participants were asked a series of semi-structured interview questions
designed to elicit in-depth information regarding their related experience (see Appendix
B for the interview schedule). Participants were asked about their cancer experience and
when they first began to feel financial hardship. They were asked about their
understanding of their medical expenses and insurance as well as how they coped with
the financial stress. Interviews were recorded, professionally transcribed, and analyzed
using qualitative data analysis software, DedooseTM.
After the completion of the interview, participants were asked to complete a
questionnaire (see Appendix C). This questionnaire consisted of measures for
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sociodemographic information including age, gender, marital status, ethnicity/race,
marital status, number of dependent children, income, job status before and after cancer,
occupation, insurance status before and after cancer, and cancer disease characteristics.
Other standardized measures were used as well and included quality of life, health
literacy, and financial toxicity.
Using a constructivist grounded theory (CGT) approach as described by Charmaz
(2014) and Corbin and Strauss (2008), data collection and analysis were conducted. Once
a few interviews were conducted, data analysis began with line-by-line coding. Each
member of the team assisted in this process initially. Focus codes were developed by
grouping similar initial codes and then a codebook was established using the more
frequent codes. The first ten interview transcripts were coded in DedooseTM using the
codebook. After a discussion of the interview transcripts and coding process, a finalized
codebook was established by the research team.
After each interview and coding session, the research team met to debrief,
discussing the interviews and reflecting on the individuals’ experiences. During each
meeting, the research team would evaluate the questions and interview format to ensure
that the interviews were obtaining the richest information possible.
All members of the research team engaged in the coding process for all of the
interviews. Throughout this process, researchers engaged in inter-rater reliability checks
to ensure rating consistency. A feature of DedooseTM analysis software assists researchers
in building and maintaining inter-rater reliability (Sociocultural Research Consultants,
LLC, 2014). Through this feature an initial pooled Cohen’s kappa statistic of 92% was
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achieved. After differences were discussed and raters came to agreement on variances, a
Cohen’s kappa statistic of 100% was reached.
Moving beyond the coding process, themes were identified. The research team
decided to divide the themes among the members of the team for further analysis. Social
support was one of the themes identified and given my interest in social support as well
as my active participation in the study, the research team provided me with the task of
further exploring this component.
Social Support Analysis. The following section details the analysis of the data
that I conducted for Study 1.
Overview. This section will provide a brief overview of the steps I carried out
after receiving permission from the team to further analyze.
1.

IRB approval was current for the original study; therefore, I did not need

to request approval. The data were used in accordance with their oversight.
2.

Interview transcripts were read multiple times and then uploaded to a new

DedooseTM file for analysis.
3.

Categories were informed and developed from social support theories

using the theory-based direct approach of QCA (Hsiu-Fang & Shannon, 2005).
4.

Using the theory-based categories, transcripts were first analyzed in

DedooseTM and meaningful excerpts were identified (Mayring, 2000; Drisko & Maschi,
2016, Bengtsson, 2016).
5.

Excerpts were extracted from the data and transferred into an Excel

workbook. They were then analyzed using a Partially Ordered Meta-Matrix table for
cross-case analysis (Miles, Huberman & Saldana, 2014).
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6.

I engaged in several forms of memo writing throughout the data analysis

process (Charmaz, 2014; Corbin & Strauss, 2013; Miles et al., 2014).
7.

Data interpretation and drawing conclusions involved developing links

within and between subcategories based on social support theories (Creswell, 2013; Miles
et al., 2013).
8.

Subcategories were consolidated when appropriate and in-depth

descriptions and definitions of each category and subcategory were created (Bengtsson,
2016; Hsiu-Fang & Shannon, 2005; Mayring, 2000).
9.

Situational mapping (Clarke, 2005).

10.

Development of Trustworthiness through the use of multiple techniques

(Bengtsson, 2016; Creswell, 2013; Lincoln & Guba, 1985; Padgett, 1998).
Detailed analysis. I created a new project in DedooseTM and uploaded the 26
interview transcripts from the LEFT study. I decided to start with clean transcripts instead
of going back to the ones originally used with all the prior codes. This allowed me a
fresh, unhindered look at the data.
First, I started with reading and re-reading the transcripts. As I did, I began to
recognize patterns that resembled social support theories. Participants clearly spoke
about receiving information, emotional, and instrumental support as well as experiencing
social constraints. Simultaneously, I recognized a clear distinction within the excerpts of
who provided the support. In most situations, individuals spoke specifically about the
person who provided the support. These excerpts were further organized on a system
level by support provider: family, friends, medical professionals, work, and other
organizations. In social support theories, whether or not an action is considered
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supportive is in part dependent on who the person is that provides the support. Therefore,
it made sense to me to further delineate quotes into these network categories. In response
to observing these patterns, I selected to use a theory-based direct approach to coding
(Hsiu-Fang & Shannon, 2005). Therefore, the codebook was developed to reflect social
support theories. (See codebook in Table 4.1). In addition to these theoretical codes, other
codes were created to fully capture interviewees’ experience.
Table 4. 1 Theory-based Codebook Used in DedooseTM
Category
Helpful
Support

SubNetwork Member
category
Sub-category
Emotional Support
Family - Spouse
Family - Parent
Family - Sibling
Family - Child
Family Member

Friends
Medical
Professional Nurses
Work/Employment

Organizations

Informational Support
Family - Spouse
Family - Parent
Family - Sibling
Family - Child
Friends

Description

Emotional support from spouse that is helpful and
supportive.
Emotional support received from a Parent that is
considered to be helpful and supportive.
Emotional support received from a Sibling that is
considered to be helpful and supportive.
Emotional support provided from the Child that is
considered to be helpful and supportive.
Emotional social support from a Family Member Not
Otherwise Specified that is considered to be helpful
and supportive.
Emotional support from Friends is considered to be
helpful and supportive.
Emotional support provided by Nurses that is helpful
and supportive.
Emotional support provided by an employer, boss,
work agency that is considered to be helpful and
supportive.
Emotional support provided by a Professional
Organization that is considered to be helpful and
supportive.
Information received from Spouse.
Information received from a Parent that is helpful and
supportive.
Information received from a Sibling that is considered
to be helpful and supportive.
Information provided by the Child that is helpful and
supportive.
Information received from Friends considered to be
helpful and supportive.
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Medical
Professional Doctors
Medical
Professional Social Worker
Medical
Professional Hospitals/Cancer
Centers
Organization
Instrumental Support
Family - Spouse
Family - Parent
Family - Sibling
Family - Child
Family Member

Friends
Medical
Professional Doctors
Medical
Professional Financial
Counselor
Medical
Professional Nurses
Medical
Professional Social Workers
Medical
Professional Hospitals/Cancer
Centers
Work/Employment

Organization

Nonhelpful
Supports

Social Constraint
Family - Spouse

Information received from Doctors that is considered
to be helpful and supportive.
Information received from a Social Worker that is
considered to be helpful and supportive.
Information received from Hospital/Cancer Center is
considered to be helpful and supportive.

Information provided by a Professional Organization
that is considered to be helpful and supportive.
Instrumental support from a Spouse that is helpful and
supportive.
Instrumental support from a parent that is considered
to be helpful and supportive.
Instrumental support from a Sibling that is considered
to be helpful and supportive.
Child provides an instrumental support that is helpful
and supportive.
Instrumental support received from a family member
that is not otherwise specified and is considered to be
helpful and supportive.
Instrumental support provided by Friends that is
helpful and supportive.
Instrumental support provided by Doctors that is
considered to be helpful and supportive.
Instrumental support provided by a financial
counselor that is considered to be helpful and
supportive.
Instrumental support provided by Nurses that is
considered to be helpful and supportive.
Instrumental support provided by Social Workers
considered to be helpful and supportive.
Instrumental support provided by the Hospital/Cancer
Center that is considered to be helpful and supportive.

Instrumental support that is provided by an employer,
boss, work agency that is considered to be helpful and
supportive.
Instrumental support provided by a Professional
Organization that is considered to be helpful and
supportive.
Emotional support from a spouse that is not helpful or
supportive.
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Family - Spouse
Family - Parent
Family - Parent
Family - Sibling
Family - Sibling
Family - Child
Family - Child
Family Member
Friends
Medical
Professional Doctors
Medical
Professional Nurse
Medical
Professional Social Workers
Medical
Professional Financial
Counselor
Medical
Professional Hospital/Cancer
Center
Work/Employment
Organizations
Gaps in
Support

Missing Support
Family
Friend
Medical
Professional Doctor
Medical
Professional -Nurse

Instrumental support from a spouse that is not helpful
or supportive.
Emotional support from a Parent that is not helpful or
supportive.
Instrumental support from a Parent that is not helpful
or supportive.
Emotional support from a Sibling (brother/sister/inlaws) that is not helpful or supportive.
Instrumental support from a sibling that is not helpful
or supportive.
Instrumental support from a child that is not helpful or
supportive.
Emotional social support from a Child that is not
helpful or supportive.
Social support from family members that is not
helpful or supportive.
Social Support from Friends that is not helpful or
supportive.
Social support from Doctors that was not helpful or
supportive.
Social support from a Nurse is not helpful or
supportive.
Social support from a Social Work is not helpful or
supportive.
Social support from Financial Counselor/Navigator
that is not helpful or supportive.

Social support from the Hospital or Cancer Center
that is not helpful or supportive.

Social support from coworkers or employers that is
not helpful or supportive.
Comments on social support from organizations that
are not helpful or supportive.

Expected social support from a family member is not
available.
Expected social support from a friend is not available.
Social support that could have been provided by
Doctors.
Expected social support from a Nurse is not available.
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Medical
Professional Social Worker
Medical
Professional Financial
Counselor
Medical
Professional Hospital/Cancer
Center
Work/Employment
Professional
Organizations
Miscellaneous Categories
Desire for Help
Difficulty Asking
for Help
Embarrassing
People don't want
to talk about it
Supports Needed

Expected social support from a Social Worker is not
available.
Expected social support from a Financial Counselor is
not available.

Expected social support from a Hospital/Cancer
Center is not available.

Social support that could have been provided by
employers.
Expected social support from Professional
Organizations is not available.
Statement about wanting help, services, resources
from any level of support.
Expressed difficulty talking to others and asking for
help.
Stated financial situation caused embarrassment.
Expressed feelings that others did not want to talk
about financial concerns.
The expressed desire for social support. Provided
advice to improve services: Instrumental &
Informational.

To ensure all excerpts of social support were captured by the analysis, I re-read all
the transcripts once excerpts were selected. In addition, in order to maintain integrity with
the original analysis, all excerpts of social support initially identified were compared to
those identified in my analysis. There were only a few differences which were discussed
with another research team member then included in the analysis.
The next analysis step was to create a partially ordered meta-matrix in Excel
described by Miles and Huberman (2014). This heuristics technique, used for exploring
qualitative data, assists the researcher by condensing large overwhelming amounts of data
into a visual “at-a-glance” format. The process provided another method to use to reflect
on the data and draw conclusions from them.
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A partially ordered meta-matrix displays the participants case-by-case and in
joining cells condenses relevant data. In order to do this, I downloaded excerpts from
DedooseTM and compiled them into four different Excel workbooks organized by the type
of person who provided the support (support provider). The four excel workbooks were
each labeled: 1) Family, 2) Friends, 3) Medical Professionals, and 4) Organizations &
Work. The first spreadsheet in each Excel workbooks provided an at-a-glance overview
of the analysis using the sensitizing lens of social support. The first column contained a
box for each participant code with demographic information. Then additional columns
were created for each category of social support: instrumental, emotional, information,
perceived, and negative support (social constraint). As I engaged in this analysis process
a sixth column was created to include when social support was missing. For example,
participant #1 indicated that she did not have anyone to talk to about her financial
concerns. This was indicated in the sixth column. At this point, I systematically marked
who provided that type of support by putting the person’s role in the column of the type
of support that was provided. (See Appendix D for visual examples of the partially
ordered meta-matrix.)
To further help with the organization of the analysis, I created individual
spreadsheets for the Family, Medical Professional, and Organization Excel workbooks
breaking down each category further by support provider role. For example, spreadsheets
in the Family Excel workbook included spouses, parents, children, siblings and other
members. On these excel sheets, the participant and their specific quote about social
support was inserted. I also used this form to provide additional thoughts on the quotes
and shorten notation of what the quote was about. These processes and at-a-glance charts
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allowed for a deeper understanding of the what, who, and most importantly the gaps
found within the experiences of these participants.
Through further reflection, I began to recognize commonalities between each of
the support provider groups. The additional thoughts and shorten notations that I had
made on each quote became concepts of which to collapse the data cohesively together.
Using an inductive process, descriptions of each category and subcategory were created
with the assistance of memo writing activities (Bengtsson, 2016; Hsiu-Fang & Shannon,
2005; Mayring, 2000). The outcomes that evolved through this process are discussed in
the result section found in Chapter 5.
Memo writing. Charmaz (2014) emphasizes the importance of memo writing as it
helps the researcher to remain active and stay engaged in the data. Memo writing serves
several functions such as forcing the researcher to work conceptually and enabling them
to work creatively giving insight into the data. Memos offer clarity, magnify important
ideas and generate meaning (Corbin & Strauss, 2015). Memos can be done in different
ways and serve numerous purposes. First and foremost, the memo writing that I engaged
in throughout the data analysis and interpretive process was a methodological journal.
This allowed me to keep an ongoing record of the analytical steps I was engaging in. It
provided me with a safe space to explore fleeting thoughts and engage in reflexivity to
maintain data integrity. Other memos took on a more structured purpose. For these types
of memos, I followed direction and prompts provided by Charmaz (2014, p.183) and
Corbin & Strauss (2015). See Appendix E for the outline used for memo writing
activities and an example of one of my memos. The exercise of memo writing helped to
provide connection and tease out distinctions within the data. Many of my memo writing
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excerpts were elaborated on and used in the results and interpretation section of this
manuscript.
Data interpretation. Interpreting the findings of the data is an active process of
making sense of the phenomenon. According to Creswell (2013), several forms of
interpretation can evolve from the researcher’s engagement and understanding of the
data. Personal perspective as well as social constructs emerge from the data analysis and
memo writing processes. Here the researcher is tasked with deciphering links within and
between subcategories (Creswell, 2013; Miles et al., 2013). These links, according to
Glaser (1978), are based on a deductive theoretical process. Charmaz (2014) takes this
process deeper to state that it needs to emerge from the data; therefore, the focus is on the
emerging theory or knowledge not on the imposing framework.
During the interpretation process of this study, I actively used social support
theories as frameworks to understand the context and experiences of the study
participants. This required building and constructing an understanding of the data
informed by the categories and subcategories. This was accomplished through the memo
writing processes as well as using situational mapping technique described by Clarke
(2005). See Appendix F for examples. The process of using deductive and inductive
reasoning to interpret the data was a useful way to show that social support theories exists
in this context and allowed for other findings to emerge (see findings in Chapter 5).
Trustworthiness. In order to ensure the findings are valid and genuine I used
several forms of trustworthiness. The development of trustworthiness for this study has
been guided by criteria established by Lincoln and Guba (1985). Careful consideration
was given to establishing these key concepts of trustworthiness: credibility,
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transferability, dependability, and confirmability, where possible (Cohen & Crabtree,
2006).
The concept of credibility is to have confidence in the outcomes of the analysis
and to believe that these finds are indeed correct and true (Lincoln et al., 1985). Lincoln
and Guba (1985) offer several ways to accomplish credibility in qualitative processes. Of
these options, I engaged in peer debriefing and negative case analysis. The peer
debriefing process requires the researcher to discuss research analysis procedures and
findings with a peer. The peer listens and asks questions of the researcher, the findings,
and the processes in an attempt to keep the researcher honest and true to the data
(Creswell, 2013). Throughout the analysis process I met weekly with a colleague who
was not involved in the original study. This was a mutually supportive process where we
both provided feedback and guidance to each other in our analysis processes. This
process assisted me in remaining true to the participants voices and gaining a clearer,
deeper understanding of the data.
Another technique for credibility that was used is negative case analysis. I
identified several cases that did not have excerpts of social support from specific people
such as a spouse, family, and medical professional category. In addition, I documented
instances of negative social support. These negative cases were pinnacle in the
examination of social support in this context. These cases were reviewed for insight into
why supports were deemed to either be missing or negative.
In addition to peer debriefing and negative case analysis, I compared the social
support excerpts from the original analysis with the excerpts derived from my analysis.

68

Any discrepancies were reviewed and re-evaluated. They were then discussed with
another member from the reach team and either included or excluded from the analysis.
Although the purpose of qualitative work is not to generalize the findings, Lincoln
and Guba (1985) suggest that it is still possible to show that the outcomes of the study
can be applicable in other contexts. Thick descriptions are a technique used by
qualitative researchers to establish transferability (Lincoln, et al., 1985; Cohen &
Crabtree, 2006). This allows for the researcher to understand the multiple dimensions of
the phenomenon; therefore, lending itself to be transferable to other times, people, and
setting (Cohen, et al., 2006). This was attempted through the multiple stages of the memo
writing (Corbin, et al., 2015) where each additional memo on the specific topic was
further thought about and elaborated on. Then a concise definition of each theme was
created attempting to provide a thick and rich definition.
Another concept to establish trustworthiness is dependability. The purpose for this
is to show that the findings of the study are consistent and repeatable. Lincoln and Guba
(1985) suggest using what is called an external or inquiry audit. This process can be very
time and labor intensive as it calls for an outside researcher not involved with the study to
evaluate your work. I chose instead to take other steps to establish dependability. As
noted earlier in the detailed analysis section, I re-analyzed the transcripts to ensure that
all excerpts on social support were captured. When inconsistencies were found, I
discussed these with a colleague to ensure what I was capturing was correct. In addition,
all analysis work was provided as an audit trail.
The final concept of trustworthiness addressed by Lincoln and Guba (1985) and
presented here is confirmability. This is the degree to which the findings arise from the
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interviewee and not a result of researcher bias. Three methods were used to establish
confirmability: triangulation, audit trail and reflexivity. Triangulation can be used to
establish a study’s credibility and confirmability. It is the process of using multiple
methods, theories, data, and analysis (Creswell, 2013). Triangulation occurred in this
study at the theory level, forms of data analysis and methods used. Several theories led to
the development and underlying understanding of financial toxicity and social support. In
addition, I engaged in several techniques of data analysis as described earlier in the data
analysis section. The second method used to establish confirmability is an audit trail. An
audit trail allows for others to repeat and/or confirm the study findings (Lincoln & Guba,
1985; Padgett, 1998). To fulfill this technique, the steps and procedures used were closely
documented and recorded. The final confirmability method, reflexivity, is an exercise a
researcher engages in to identify any pre-conceptions, judgments or biases they may have
prior to engaging in the analysis process. I engaged in this process by reflecting on me as
a researcher, and my own personal experience with family members who have had cancer
and their experiences with related financial concerns. I also reflected on my own
perception on financial struggles. The product of this activity is presented in Appendix G.
Ethical Considerations. The University of Louisville Institutional Review Board
(IRB) approved the larger qualitative study from which this study stemmed. I continued
to work within the guidelines of that approval. Although I did not directly come in
contact with human subjects during my analysis of the social support category, I was
working with data that originated from human subjects. This required attention to
confidentiality and sensitivity in the handling of this information. Steps were taken to
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insure confidentiality, as names and identifiers were removed or changed prior to my
analysis. There were no risks for emotional distress or harm done.
Summary
Chapter 4 entailed an in-depth description of the qualitative methods, including a
step-by-step description of the analysis procedures and memo writing exercises. It also
covered issues of trustworthiness and a personal reflective exercise to establish study
rigor. The results for study 1 can be found in Chapter 5 with examples of analysis
materials located in the appendices referenced. Study 2 methods and results can be found
in chapters 6 and 7. The final chapter 8, summarizes the overarching question, study
implications and future research ideas.
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CHAPTER 5: STUDY 1 RESULTS
“We had people go out and buy groceries and drop them off, making food and that kind
of thing. That helped alleviate some of the cost as well as trying to figure out throwing
together dinner when you're going through chemo and feeling awful and smells are
making you sick. That was very helpful. Support of family and friends has really helped.”
- Study 1 #23 (middle aged female, Multiple Myeloma)
"I didn't let anyone know I was sick, but it cost me mentally and emotionally."
-Study 1 #2 (65-year-old female, Breast Cancer)
Study 1 was used to gain perspective on what patients’ experiences were in regard
to social support and cancer-related financial toxicity (objective burden and subjective
distress). It sought to answer the question: For individuals who have had cancer, what is
their experience with social support in the context of cancer-related financial toxicity?
Using data analysis techniques outlined in chapter 4, I took an in-depth look at social
support expressed through the stories of 26 cancer survivors who experienced financial
hardship due to their costs of care. Several categories, subcategories and dimensions were
identified through the analysis. It revealed supportive issues that participants faced such
as barriers to accessing and missing support. This chapter first presents the sample
characteristic which is followed by the identified categories and subcategories. The
chapter will end with a brief interpretation of the results.
Characteristics of Participants
A qualitative approach was used to explore the lived experiences of cancer survivors
(N=26) who perceived financial hardship as a result of their cancer treatment. Tables for
the demographic characteristics have been published in a prior article by Head, Harris,
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Kayser, Martin and Smith, (2018). These can be found in Tables 5.1 and 5.2 as well.
Interviewees ranged from 30 to 67 years of age with a mean average of 50.6 years.
Twenty were female (77%) and 6 were male (23%). The sample was primarily white
(73%) and married (61%).
Table 5. 1 Demographics (Head et. al., 2018).
Characteristic
Gender
Male
Female
Race
Black
White
Hispanic
Marital Status
Single/Never Married
Single with Significant Other
Married
Separated/Divorced
Widowed
No Response
Income
Less than $25,000
$25,001 – $40,000
$40,001 - $60,000
$60,001 - $80,000
Over $80,000
No Response

N (26)

%

6
20

23
77

5
19
2

19
73
8

1
1
16
6
1
1

4
4
61
23
4
4

7
5
2
4
7
1

27
19
8
15
27
4

© LEFT Study
Many interviewees experienced a job change from before and after their cancer
experience. Prior to their cancer diagnosis 23 were employed full-time (88%), 2 were
employed part-time (8%) and only 1 was unemployed (4%). After their cancer experience
only 5 were employed full-time (19%), 6 worked part-time (23%), 8 were on disability
assistance (31%), 2 retired (8%), and 2 were unemployed (8%). See Table 5.2 for more
details on occupation and insurance status.
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Table 5. 2 Job Status, Occupation, Insurance Status (Head et. al., 2018).
Characteristic
Job Status Before Cancer
Employed Full-Time
Employed Part-Time
Unemployed
Job Status After Cancer
Employed Full-Time
Employed Part-Time
Unemployed
Homemaker
Disabled
Retired
No Response
Occupation
Homemaker
Manager
Professional/Technical
Sales/Services
Manufacturing/Trade
No Response
Insurance Status at the Time of Diagnosis
Through Employer
Self-Purchased
No Insurance
No Response
Insurance Status During Cancer
No Changes - Same Insurance
No Changes – No Insurance
Lost Insurance Due to Job Loss
Eligible to Medicaid
Eligible for Medicare
Lost Insurance Due to Job Loss – Now Self-purchased
No Response

N (26)

%

23
2
1

88
8
4

5
6
2
1
8
2
2

19
23
8
4
31
8
8

4
2
11
6
2
1

15
8
43
23
8
4

19
3
3
1

73
11
11
4

13
1
6
1
2
1
1

50
4
23
4
8
4
4

© LEFT Study

Interviewees presented with several different types of cancer diagnosis. Two types of
cancers were more prominent than the others: breast cancer n=8 (31%), and blood
cancers n=6 (23%). Other cancer types that were represented include: Colorectal n=2
(8%), Head and Neck n= 2 (8%), and 1 each (4%) of appendiceal, brain, lung, ovarian,
pancreatic, prostate/bladder, and synovial sarcoma. (Profiles on each participant can be
viewed in Table 5.3.)
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Table 5. 3 Characteristics by Participant Number (Head et. al., 2018).
Pt
#
1
2

Age

Sex

58
65

F
F

3

54

4

White
Black

Marital
Status
Married
Widow

Bachelor’s
Postgraduate

M

White

Married

Bachelor’s

52

F

Black

Sep/div

Postgraduate

5
6

35
60

F
F

White
White

Married
Sep/div

Postgraduate
Postgraduate

7
8

50
67

F
F

White
White

Married
Married

Some College
Postgraduate

9
10

30
35

F
F

Married
Single

Some College
Postgraduate

11

55

M

White
No
response
White

Married

12

51

F

Black

Married

High
School/GED
Some College

13

58

M

White

Married

Bachelor’s

14
15

64
56

F
M

White
White

Sep/div
Married

16

55

F

Sep/div

17

41

F

Hispanic/
White
White

Some College
High
School/GED
Some College

18
19

*
37

F
F

Black
White

Single
Sign.
other

20

53

F

Married

21
22
23

36
62
*

M
F
F

Hispanic/
Black
White
White
White

24
25

49
32

F
F

26 66
M
*Not Reported

Race

Education

Income @
diagnosis
<$25,000
>$80,000
$25,000$40,000
$25,000$40,000
>$80,000
$60,000$80,000
>$80,000
$40,001$60,000
>$80,000
<$25,000

Cancer
Type
Breast
Breast
Reoccurrence
Oropharynx
Hodgkin’s
Lymphoma
Breast
NSCL
Breast
Parotid Adenocytes
Ovarian
Leukemia

$60,001$80,000
$25,001$40,000
$40,001$60,000
<$25,000
<$25,000

Glioblastoma Brain

>$80,000

Colorectal

High
School/GED
*
Some College

<$25,000

Rectal

*
$25,001$40,000

*
Breast

White
White

Sep/div
Married

Some college
Bachelor’s

White

Married

Bachelor’s

$40,001$60,000
<$25,000
>$80,000
$60,001$80,000
<$25,000
$25,001$40,000
>$80,000

Pancreatic

Married
Married
Married

High
School/GED
Some College
Postgraduate
HS

Sep/div

Breast
AML
Breast
Synovial Sarcoma

Lymphoma
Breast
Multiple Myeloma
Lymphoma
Appendiceal
Prostate & Bladder

Qualitative Findings
All 26 interviewees commented on social support to some extent and the data
reflected social support theories. Interviewees commented on received emotional,
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informational, and instrumental support. They also provided examples of social constraint
and suggested missing supports. These findings fell into three major categories: Helpful
Supports, Non-helpful Supports, and Gaps in Support. These categories contain
subcategories which are further delineated into dimensions (see each section below for
details).
Quantification occurred at the subcategory level. All excerpts were tabulated to
display the magnitude of the social support discussed by interviewees. Refer to Table 5.4
to see a breakdown of the number of interviewees who commented on each type of
support and how many comments were made throughout the interviews.
Table 5. 4 Social Support Comments by Social Network

Helpful Supports
Received
Emotional
Social Network
Family
Friends
Med Prof
Organizations/W
ork
Total

Informational

Instrumental

Instrumental

Interview
ees

Excerp
ts

Interview
ees

Excerp
ts

Interview
ees

Excerp
ts

Interview
ees

Excerp
ts

7
7
2

18
8
2

4
10
10

4
10
11

26
8
13

65
26
23

1
0
0

1
0
0

5

8

9

16

21

34

0

0

21

36

33

41

68

148

1

1

Non-Helpful
Supports

Family
Friends
Med Prof
Organizations
/Work
Total

Perceived

Gaps in Support

Social Constraint

Missing Support

Interview
ees

Excerp
ts

Interview
ees

Excerp
ts

Interview
ees

Excerp
ts

10
4
2

11
4
2

3
5
14

3
5
20

0
0
11

0
0
14

0
16

0
17

3
25

4
32

4
15

4
18
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Barriers

The individuals who provided the support were categorized into five different
social network categories: family, friends, medical professionals, work, and
organizations. Refer to Table 5.5 for delineation of each social network category and the
individual roles included in each network group.
Table 5. 5 Social Network Categories.
Social Network Category

Network Member

Family

Spouses
Parents
Siblings
Adult Children
Other Family
Church Members
Co-workers
Neighbors
Doctors
Nurses
Social Workers
Financial Counselors
Hospital System Staff Members
Employer
Agency/Company

Friends

Medical Professionals

Work
Organizations

Non-profit Organizations
Social Programs

Before presenting the themes of this analysis, it is important to note that when
interviewees talked about social supports, they did not always make a clear distinction
between financially-related social supports and those that were generally provided during
their cancer experience. For example, in the below excerpt interviewee #9 (a 30-year-old
female with ovarian cancer), discusses how her family members advocated for her.
“My husband and sister were wonderful advocates for me, because I was totally
unable to advocate for myself. And really pushing him to check why I was so sick
in the hospital.” #9 (30-year-old female, Ovarian Cancer)
The family members action was geared toward finding medical answers or solutions not
specifically toward assisting her with the financial aspect. Although the interview script
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did not specifically ask about financial social support, these broad responses lead me to
question the extent to which patients compartmentalize their experiences. Perhaps
financial toxicity and social support overlap into all aspects of their lives.
Helpful Support
Helpful Support was the largest theme consisting of the three major categories
found in the data. These included subcategories of received support (emotional,
informational, and instrumental) and perceived (instrumental) support. Each subcategory
is discussed providing thick descriptions of dimensions within each subcategory.
Meaningful excerpts supporting these dimensions can be found in corresponding tables.
Received Emotional Support. As discussed in Chapter 3, emotional supports are
supports that make a person feel or believe they are cared for and appreciated (Cohen et
al., 1985). Some of the subcategories of emotional support intertwined with received
informational and instrumental supports. Subcategories revolved around the concept of
someone else taking control over part of the situation while others show emotional
support being communicated through being presence during difficult events such as
attending surgeries or treatments. By providing these other supports, the support provider
reinforces the person’s feelings of being loved, understood, and cared about. See Table
5.6 for a list of emotional support subcategories and example excerpts.
Table 5. 6 Received Emotional Support.
Dimensions
Acts of
Service

Excerpt
“It was emotional support more so than financial. I didn't have to worry about him
taking off work to take me to treatment, because my church members they were all
there to do that, but I didn't let it be known that other things were going on.” #12 (51year-old female, Breast Cancer)

Reassurance

My husband said, "Give that bill to me. I will call them. I will take care of them. You
don't worry about it. We can manage this… He just kept saying, "I'll handle this. This
I can do something about.". #22 (62-year-old female, Breast Cancer)
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“My husband actually took over and he just told me to calm down and not worry.” #25
(32-year-old female, Appendiceal)
“I didn’t realize how expensive, but I knew it was expensive because I would ask
questions about how much a specific my chemo was or whatever. They would be like,
‘It’s not too bad.’ They try not to worry people. They really try to work with cancer
patients. They don’t want people to be fretting.” #17 (41-year-old female, Rectal
Cancer)
Someone to
Talk To

“I feel like the women in the support group are like my new best friends because they
get it, and they understand what is going on. Some of them have had money
problems but some of them haven’t so they don’t, I don’t know if they quite
understand that, but they understand the cancer stuff.” #1(58-year-old female, Breast
Cancer)
“My only source of socialization right after my diagnosis became [support group].” #6
(60-year-old female, Lung Cancer)
“We would joke about it, especially like a [support group]. People would be like, ‘Oh,
how do you handle all the bills?’ I'm like, ‘I have two filing systems, the kitchen
garbage and the living room garbage.’ That's pretty much where the bills go when
they come in. They're too overwhelming. There's no way I can pay them. I can't even
feed my kids. I'm not going to pile them up somewhere and look at them every day, so
I chucked them.” #21 (36-year-old male, Lymphoma)

Supportive
Presence

“Then my other daughter, she doesn't have the money but she's the one that moved right
in with me. Came home from Arizona, moved in with me. I told her and her fiancé
could move in too and they were my caretakers.” #14 (64-year-old female, Breast
Cancer)
“My husband, he has also attempted to go to appointments with me and support me and
be there when I needed him.” #22 (62-year-old female, Breast Cancer)
“[My son] went to every doctor’s appointment with me b/c he was afraid for his mom
and he took notes to make sure that if I didn’t get it, he got it.” #2 (65-year-old
female, Breast Cancer)
“My sister lives out of town in upstate New York. She came into town for my initial
surgery and was here for two weeks, she’s flown back and forth several times.” #9
(30-year-old female, Ovarian Cancer)
“She's been there every [time]. She went to the surgeon here with me.” #8 (67-year-old
female, Parotid Adenoid Cystic)

Acts of Service. Acts of service are received instrumental or informational
supports that when provided in turn have an emotional impact on the individual. The act
of support can alleviate additional worry or concern relieving the patient from having to
do one more thing. In providing this assistance, patients may feel supported and confident
that someone else can take care of something for them while they focus on their treatment
and survival. For example, one interviewee (#12) discussed how receiving transportation
to and from her medical treatments alleviated the need for her husband to take time away
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from work to do so. She commented that the act of providing transportation was an
emotion support.
Feeling understood. A few interviewees spoke about feeling understood by
others. Having someone available who you can relate to and who understands what you
are going through can be emotionally supportive. Most comments were associated with
organizational social network members such as employment (employer, colleagues) and
support groups. One interviewee (#19) spoke about her employer understanding her
experience because she had had the same type of cancer. Another interviewee (22) shared
how her colleagues did not make her feel bad and expressed sympathy for her situation.
Additionally, support groups can provide a safe environment free from judgment where
participants can share their experiences leading to feelings of acceptance and being
understood. One interviewee (#1) commented that she did not talk to her friends about
her financial concerns because she felt they would not understand; however, she could
share them in a support group with others who were going through similar situations. The
idea that other people do not understand or get the financial hardship experience because
they have not experienced it is not a new concept in the context cancer. The loss or
distancing of friends due to cancer has been well-known. In addition to this idea we see
cancer-related financial toxicity as another component that may play a part in distancing
cancer patients from others. (This idea is further discussed in Gaps in Support.)
Reassurance. In this subtheme, we see the support provider reinforcing the idea
that things will be okay and that they (support provider) will take care of an additional
stressor such as the medical bills or getting additional services. This in turn relieves the
support receiver from concern or worry related to something other than their treatment.
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Several interviewees spoke about family members reassuring them. This was often a
behavior expressed by a spouse; however, for those who were single or lacked a
supportive spouse/significant other, a family member would sometimes provide this
support. One interviewee (#10) spoke about her mother assuming legal control to manage
her financial responsibilities while she was in the hospital. Medical Professionals were
also noted for attempting to provide assurance to patients to not worry about their costs of
care. Although this final example was an attempt to reassure patients that things would be
okay, it overlaps with the Non-helpful Support category: having good intentions that
were ultimately not helpful. This may in turn lead to Gaps in Support as missing
information or create barriers to patients seeking financial assistance.
Someone to talk to. Talking to other people about your concerns has long been
known to provide a sense of support and well-being. It helps one to feel closer to other
people and fosters relationship bonds. It can relieve stress and allow others to offer
solutions or help. This can provide the support receiver with feelings of comfort and
reassurance that things will be okay or that they are not alone in this situation.
Few participants commented on having someone to talk to about their financial concerns.
One interviewee (#7) stated she talked to her sister, but it was followed by an expression
of concern and desire to not want to burden her sister about her financial concerns.
Alternatively, several interviewees found a safe place to talk about their financial
concerns through organizations offering support opportunities. In these spaces, patients
can talk about what they are going through without the fear of being stigmatized or
judged. They can relate to the stories and experiences of others which allows them to feel
part or a group and not isolated. Patients feel heard, understood and encouraged to keep
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going. Support groups, through organizations such as Gilda’s Club and Cancer Support
Community, provide opportunities for patients and caregivers to share these difficult
experiences in a controlled and safe environment.
Supportive presence. Under this subcategory, interviewees explain ways in which
family and friends were there for them. One interviewee (#14) directly commented that
her daughter could not help her out financially, but she moved home and provided
comfort in being present through the experience. Family and friends provided a
supportive presence by attending medical appointments and taking notes. Some even
traveled from out of town to be there for important surgeries and to help with caretaking
during the healing process. Although these supports are not directly financially related,
their presence within the data and the discussions offered by participants lends support to
their importance within the total experience. In the context of experiencing cancer-related
financial toxicity, receiving emotional support is not solely financially connected. Here
participants received encouragement, assistance, and care from family and friends in
other ways that brought comfort to their experience assuring patients that they were not
alone in this experience.
Received Informational Support. Informational support occurs in response to a need for
knowledge, advice or guidance. Throughout the analysis there were a few examples of
informational support; although, not many. See table 5.7 for dimensions and excerpts.
The missingness noted in this subcategory led to the development of one of the
subcategories under the theme Gaps in Support which is explored later.
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Table 5. 7 Received Informational Support
Dimensions
Financial
Advice &
Information

Excerpts
“My brother is a financial or wealth manager, so he told me that he wasn’t going to let
me touch your 401K if it came to that, so it didn’t come to that. I was fortunate
enough to not have to explore any of the other options.” #3 (54-year-old male,
Throat Cancer)
“One of the ladies, when her husband had throat cancer, she said ‘well what I did was
once I got all of my EOBs, separated them all, I put them all, like, in an order and
then when the bill came, I would line it up with that. Then she said don't pay
anything until you make sure it's been through the insurance. They guide me on
don't pay this, don't pay that. Kind of leading me and helping me along.” #13 (58year-old male, Leukemia)
“They had a social worker come in and laid out everything that was available through
them, through Medicaid, and through the Lymphoma/Leukemia Foundation.” #24
(49-year-old female, Lymphoma)
“They also connected me with the Leukemia/Lymphoma Society because they
apparently have some programs for financial aid, too. We started the process for
that, but we felt like we were in a position at that point that we didn't need to take
that money away from somebody else that might need it.” #23 (middle aged
female, Multiple Myeloma)
“Then when I went to the clinic in [location], they recommended doing the Livestrong
prices for the clinic treatments, but they recommended the Walgreens grant for the
medicine.” #5 (35-year-old female, Breast Cancer)
“I went to a doctor at [location], and one of his residents said, ‘I think there might be a
grant that helps pay for some of this,’ but didn't know the details…so then I started
researching.” #5 (35-year-old female, Breast Cancer)

Navigating
Systems

“I was talking to the social worker I said, ‘I don't even know how much we have to
pay.’ So, she looked into it for me… [Someone at the cancer center] said I should
probably know all that, but she [the social worker] looked into it.” #15 (56-yearold male, Synovial Sarcoma)
“It was really the oncology office who you know, calls you in and kind of explains to
you this is what's covered, this is what's not covered, insurance will pay for this.
They're the ones that kind of schooled me on what was going to be covered, and
I'm thankful for that because at least I knew my chemotherapy was covered at a
hundred percent.” #15 (56-year-old male, Synovial Sarcoma)
“My doctor, my orthopedic oncologist said to go ahead and put application in for
disability.” #15 (56-year-old male, Synovial Sarcoma)
“The social worker is very helpful. She asks us to begin with if financially [we wanted
assistance]. Did I want to consider going on disability for social security? I didn't
want to do that unless I had to.” #8 (67-year-old female, Parotid Adenoid Cystic)

Financial advice and information. Advice is defined as information that is
provided for the purpose of providing guidance or recommendations. A few interviewees
commented on receiving advice. Those that did received it from family, friends, and
medical professionals. Having family members or friends with financial knowledge or
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insider information on navigating the healthcare system is a great resource that few may
have access to. One interviewee (#3) had a brother who worked in finance. He was able
to get guidance on how to manage his finances through this challenging experience.
Another interviewee (#13) shared her confusion over managing her insurance and
medical bills. She was not aware that she should wait for the insurance to cover their
portion and needed help in understanding how to ensure that process had been properly
completed. Fortunately, a friend told her when to make payments and when not.
Receiving advice on navigating the insurance and medical billing process is basic
information that patients may need. This sharing of ideas and providing guidance on how
to navigate the system or just interpret the forms can be helpful as long as the advice is
good, sound advice.
Medical professionals are positioned to provide accurate and timely information
on medical billing and insurance processes as well as resource information. Some
interviewees were fortunate and were provided a wealth of information at the time of
their diagnosis. Although medical professionals do not have all the resources and
information needed for every patient, they can offer direction on what might be available.
For example, one interviewee (#5) shared how a doctor/resident was aware of a grant to
assist with fertility treatment expenses. This information led her to seek out more
information and find needed resources to assist with the high costs of fertility treatments.
Navigating systems. Medical professionals have a complex understanding of
medical diagnosis and treatment, and a familiarity with the healthcare systems. One
interviewee (#15) shared how she did not know what her deductible and was told by
someone at the hospital that she should know that information. She asked a social worker
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who was able to quickly look into it and provided her the information. Finding this
information may be fairly simple for people who know where to look or ask questions;
however, to the average person, medical systems and insurance programs can be
complicated and arduous.
Interviewees also shared stories about how medical professionals provide
assistance regarding when to apply for government assistance programs like Medicare
and Social Security Disability. One interviewee (#15) discussed receiving guidance and
information from his doctor about applying for Medicaid. Another interviewee (#8)
shared how a social worker offered assistance and information about social security
disability. The participant was given the information needed to decide to apply or not.
The average individual is likely unaware of government assistance program
qualifications; therefore, patients could benefit from having some guidance on when and
how to apply for assistance. Medical Professionals may be able to provide that
information. If a patient is advised to apply for disability when their diagnosis and
treatment meet program requirements could potentially prevent undue financial hardship.
Received Instrumental Support. Instrumental support was the most abundantly
discussed type of support. Supports in this category were tangible items and services. All
types of support providers were commented on as providing instrumental supports. See
Table 5.8 to view the dimensions of support and who provided those supports. Further
detailed discussion on each of these themes are provided below.
Table 5. 8 Received Instrumental Support
Dimensions

Excerpts

Advocate

“She [mother] got it from calling around and asking, because she had to do the
same thing for my father who is disabled. So, she kind of knew the avenues.
For me she went in there.” #10 (35-year-old, female, Leukemia)

85

“She's really good at helping me advocate and encouraging me to use my voice
because when you're in the middle of it's a whole different story. #6 (60-yearold female, Lung Cancer)
“I felt like my healthcare system was an advocate.” #22 (62-year-old female, Breast
Cancer)
“Yes, she has become more of a friend and an advocate because she got on the
phone and was talking to them and they paid attention to her. I can barely
walk—but I can’t use a walker or a cane—but she got on the phone and made
them pay attention about it like the wheelchair back in December. So that I can
get around without being stuck in the house.” #2 (65-year-old female, Breast
Cancer)
Childcare
Assistance

“My dad's very supportive, he helps take care of our daughter when we're not
having good days. He's very supportive.” #25 (32-year-old female,
Appendiceal)
“And my sister moved in with me to help take care of my daughter when I was in
and out of the hospital. So, she’s okay.” #10 (35-year-old female, Leukemia)

Monetary
Assistance

“I still have one in college, but my parents started [paying for grandchild’s tuition]
just a couple of years ago, now that they have money. You know. Telling me
now ‘we never paid for your college so let us pay tuition for the last one so.” #3
(54-year-old male, Throat Cancer)
“She was feeding me, buying me food, paying [utilities] for me to be here.” #18
(middle-aged female, type of cancer not provided)
“My daughter sings. She did a little singing one night, sang twice at night one night
twice and the tips she gave to us, uh, one night it was $91.00 and, uh, one night
it was, uh, like $107, so anyway she gave us her tips.” #13 (58-year-old male,
Leukemia)
“Then of course family would bring me food and give me 20 or 30 dollars here or
$100 to help me out when they could. That was a help.” #4 (52-year-old female,
Lymphoma)
“We had had a couple of friends give us like, you know, $50 here or $50.” #20 (53year-old female, Pancreatic Cancer)
“We had a friend start a fundraiser for us that raised $19,000 that will cover my out
of pocket max for last year and this year. My brother in law is one of the people
who helped set up the fundraiser.” #9, (30-year-old female, married)
“[A non-profit agency] did have a piece where you could fill out an application and
on a monthly basis and get some reimbursement. I did utilize that for a while
especially those times when I only got paid for two days.” #6 (60-year-old
female, Lung Cancer)
“I applied for their financial assistance regarding some of the out of pocket. I
would say that they pretty much covered at least my hotel expenses when I was
there. They paid for mine and they paid for our meals while we were there. That
was nice.” #6 (60-year-old female, Lung Cancer)
“One of the pharmaceuticals helped with the one shot--$500 a pop—something that
I had to have for two weeks. I didn’t have $500 to shell out daily for 2 weeks.”
#4 (52-year-old female, Lymphoma)
“I was off work until July and I was able to tap into the shared leave program” #4
(52-year-old female, Lymphoma)
“In fact, my office has been fabulous. When I ran out of sick days, they have
donation sharing for sick days, so employees donated sick days, so that covered
me, so I was able to maintain a full paycheck each time.” #5 (35-year-old
female, Breast Cancer)
“My husband said, ‘Give that bill to me. I will call them. I will take care of them.
You don't worry about it. We can manage this." #22 (62-year-old female,
Breast, Cancer)

Managed Finances
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“'My husband actually took over and he just told me to calm down and not worry.
We have very supportive family members that helped, too.” #25 (32-year-old
female, Appendiceal)
“I guess the second week when I was in the hospital … my mom really kind took
over as a power of attorney so that she could go into my bank account and pay
all my bills and get everything set up.” #10 (35-year-old female, Leukemia)
Resolving System
Issues

“The insurance company put me in a panic. It was the social workers and the nurses
at the cancer center that kept me from going over the edge. They were helpful.
‘Tell us what they said. OK, we will take care of it. Breathe and relax. We will
take care of it.” #4 (52-year-old female, Lymphoma)
“I got my first disability check. I was approved the first time. My doctors all helped
push it, get it through.” #15 (56-year-old male, Synovial Sarcoma)

Small Stuff

“My husband had to do all the cooking, all the cleaning with the assistance of my
parents, so for the first six weeks and then when I was going through chemo...”
#5 (35-year-old female, Breast Cancer)
“They gave the number to my daughter, the guy’s number, and my daughter helped
me take care- she said, ‘mom don't worry about it, you take care of dad, I'll take
care of the ramp.’" #13 (58-year-old male, Leukemia)
“Then my other daughter, she doesn't have the money but she's the one that moved
right in with me. Came home from Arizona, moved in with me. I told her and
her fiancé could move in too and they were my caretakers” #14 (64-year-old
female, Breast Cancer)
“My friend, I called my friend who was a nurse and said, ‘Could you stay with
me?’ She works 7 PM to 7 AM, so I said, ‘Could you stay with me for 3 days
because I'm going to be.’ I didn't know how bad I was going to be. I really
couldn't open my eyes. I couldn't do anything, and so she did.” #8 (67-year-old
female, Parotid Adenoid Cystic)
“We had people go out and buy groceries and drop them off, making food and that
kind of thing. That helped alleviate some of the cost as well as trying to figure
out throwing together dinner when you're going through chemo and feeling
awful and smells are making you sick. That was very helpful. Support of family
and friends has really helped.” #23 (middle-aged female, Multiple Myeloma)
'"Oh, can we get you some groceries? Oh, let's cook dinner. Oh, can we help with
the kids? Here's a little gas money." #21 (36-year-old male, Lymphoma)
“My kids became my primary caregivers. At 17, it was hard with that. At 15, 17
years old, she’s buying groceries and paying bills and helping me get in and out
of the shower. It changed her in that way. She had to grow up faster than she
probably should have as a grown up.” #17 (41-year-old female, Rectal Cancer)

Transportation

“They would take me places where I couldn’t drive. For instance, we went to the
‘Look Good, Feel Better’.” #2 (65-year-old female, Breast Cancer)
“I have two neighbors that are retired and another friend that's retired so they can
give me rides and another neighbor doesn't go to work until two o'clock in the
afternoon so if I needed something, she can help me out. Another neighbor
offered to come you know, water my plants.” #16 (55-year-old female,
Colorectal Cancer)
“I had a period of time where I wasn't able to do any work due to my condition, and
then when I was able to start gradually working from home on my laptop, my
work allowed me to do that until I could come back to the office.” #5 (35-yearold, female Breast Cancer)
“For the most part, when I was going through my treatments, I happened to have a
great immediate manager. The president of our company had prostate cancer
and was going through exactly the same treatments as I was. I was able, for 6
weeks, to have every afternoon off. I was going through radiation at that time,

Work Allowances
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and working half days for 6 weeks, in a period which I don't know if most
companies would ever have been patient enough to go through that process.”
#26 (66-year-old male, Prostate & Bladder)
“My husband’s work let him take an unlimited number of days off without charging
him vacation time without docking his pay for it or anything like that…if I was
in the hospital he was there. So, if I was in the hospital for 40 days, he missed
40 days of work.” #9 (30-year-old female, Ovarian Cancer)
“They've been very generous with him here at work in that they have allowed him
to work from home when he needed to the first couple of days of my recovery.”
#22 (62-year-old female, Breast Cancer)

Advocate. Advocating is an act of service provided by the support provider to
ensure the well-being and needs of the support receiver are met. A life threatening or
severe disease, such as cancer, can cause a patient to feel vulnerable and physically
exhausted due to the effects of the illness and treatment; therefore, patients could benefit
from having someone to advocate for them. It allows them to take a step back and let
another person have control over part of the situation. The patient can then focus on their
health and well-being without having to spend time and energy on getting needed
services. By advocating for the patient, support providers are a voice for the patient
speaking up for their overall wellbeing, medical care, and needed health service.
In this instrumental support subcategory, we see that family members (spouses,
parents, adult children, siblings) and medical professionals (nurses or other providers)
served as advocates. Having another person available to attend appointments and assist in
treatment decisions can alleviate some responsibility and burden from the patient. Several
interviewees spoke about their spouse fulfilling this role. Other family members provided
this support as well. One interviewee (#10) commented on how her mother’s past life
experiences with the medical system proved to be useful in getting her the services she
needed. Knowing the avenues to take when seeking medical treatment or navigating the
insurance world can provide valuable assistance and guidance. Another interviewee (#6)
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discussed how her adult child encouraged her to have a voice in her medical care and
decision-making processes. From the perspective of social support theory, Medical
Professionals are in the formal support provider categories and expected to provide
information and instrumental supports. A few interviewees commented on their medical
professionals advocating for them and helping them to get the services they needed.
Childcare assistance. For families of young children, childcare assistance is an
important service. Parents care for the well-being of their child(ren) and want to make
sure they are in good hands when they are unable to care for them. Paying for childcare is
also noted in the literature as an often-unexpected expense that adds to the objective
experience of financial toxicity. For some interviewees, childcare was provided as a
support yet for others, it became a social constraint as seen in Good Intentions with
Financial Consequences.
Monetary assistance. Several participants commented on receiving tangible
financial assistance in the form of money or provided assistance that could lead to
obtaining money. These instrumental supports were provided by family members
(parents, adult child, siblings), friends, medical professionals and organizations. For some
interviewees, their parents were in a financial position that allowed them to help
financially. It is generally accepted that as you get older you have more financial means
due to working longer and having more equity or investments. Other interviewees
received assistance from their adult child(ren). One interviewee (#13) shared how his
daughter gave what she could. Adult children are often still trying to financially establish
themselves and often do not have access to the financial resources that older adults would
have. No matter how small or big the monetary assistance was, interviewees commented
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on how helpful and supportive these acts were. Some family members and friends
assisted in helping to organize fundraisers or benefit events to generate funds to help
cover medical expenses. Interestingly, interviewees who talked about this type of support
were typically younger adults and as discussed in Non-helpful Support, receiving
supports of this nature were not always supported by others.
Applying for grants from organizations or financial assistance/forgiveness
programs through the medical system appeared to be more widely commented on than
other network categories. Several interviewees commented on organizations and
programs offering assistance with food, paying small monthly bills and daily living
expenses. A few received funding to pay for the cost of out-of-state travel for medical
purposes. Yet another interviewee commented on receiving assistance with fertility
treatment costs. Some interviewees found assistance through their medical centers which
offered financial assistance program to help cover medical expenses. These provided a
huge relief from the hefty medical expenditure. Medications assistance from
pharmaceutical companies provided some financial relief as well. A few interviewees
were also able to tap into programs provided through work. Some employers offered
programs that provided financial assistance to their employees such as shared leave
programs or donated sick time.
In this subcategory there are several examples of participants receiving financial
assistance from all social network groups. Consequently, patients need to know about
these programs in order to apply for assistance. This informed the development of the
category Missing Information. Furthermore, seeking these resources can be time
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consuming and physically taxing on patients as noted in the Run Around subcategory of
Barriers to Support.
Managed finances. This subcategory points to the importance of having a
primary support person who can help manage the financial piece. Only a few participants
commented on having someone who would take on the responsibility of managing the
bills and household finances. This support was provided by spouses and parents. Taking
on the responsibility of managing the finances appeared to be an attempt by the support
provider to alleviate the worry or concern a support receiver had over their financial wellbeing. In this case, the instrumental support provided overlapped with the emotional
support received. Ultimately, having this support can relieve a big burden from patients,
allowing them to focus more on themselves and surviving cancer.
Resolving System Issues. Medical professionals are ideally positioned where they
can provide needed assistance to patients when dealing with complicated systems such as
insurance and disability. In this subcategory, support providers engage in action-oriented
instrumental support in an attempt to resolve barriers. For example, one interviewee (#4)
shared how a social worker and nurse were instrumental in resolving complications with
the interviewee’s insurance company. Another interviewee (#15) talked about how his
doctor assisted him with applying for medically-related disability. Insurance companies
and the social security disability system are notorious for having complicated and tedious
systems often causing most people to struggle when dealing with them. Medical
professionals can be instrumental in helping patients resolve complicated issues within
each of these systems.
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Small stuff. When facing a life-threatening disease, like cancer, patients can be
overwhelmed with simple life tasks. In this subcategory, family and friends were noted
for taking over the general organization and running of daily life activities. These
activities can include cleaning, cooking, general caretaking activities, and managing
medical care at home. Friends also provided assistance in caregiving and household
management for short periods of time. One interviewee (#8) shared a story about her
friend, who was a nurse, came and stayed with her for 3 days after her treatment. Tasks as
simple as preparing meals, buying groceries or gas, and mowing the lawn or taking the
garbage out, helped patients financially, physically and emotionally.
Sometimes these tasks and responsibilities are more time consuming and can have
a negative effect on the family member providing the assistance. In the case of one
interviewee (#17), her two teenaged children took on the primary caregiver roles in place
of a significant other or other family member. She shared the negative impact her cancer
had on her children.
Transportation. Research has shown that transportation causes a barrier to care
for many patients due to the cost of paying for gas, taxi service or compounding travel
expenses. Interviewees commented on family members and friends assisting them with
getting to and from appointments or to other cancer-related events.
Work allowances. It is noted in the literature that many cancer patients
experience a reduction in monthly income prior to diagnosis and during their cancer
experience. This is likely due to the need for patients to take time off to address negative
physical effects of their illness or treatment. Some interviewees commented on their
employers being flexible with their work schedules and allowing them to work from
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home or maintain their positions at a part-time status. In additions, the employers of
caregivers were also noted for being flexible with working hours. A few interviewees
shared how their spouses’ employers were lenient allowing the caregiver to take off time
when needed so they could be present during treatment or recovery periods. Having an
employer who understands (crossing over to emotional support) and is flexible to work
with alternative schedules or work from home options (instrumental support) can make
an impact on not only patients’ financial outcomes but the overall experience as well.
Perceived Instrumental Support. The perception that emotional, informational
or instrumental supports were available (which is considered different from the support
received being told the resources were available), did not have a strong presence in the
data. I came across one excerpt that eluded to perceived instrumental support. This was
in response to a probing question about whether an interviewee’s spouse or anyone else
helped her manage the medical bills and other finances. The interviewee responded:
“I'm sure he would have if I had needed his help, but I was able to keep track of
all the finances myself.” #5 (35-year-old female, Breast Cancer)
The absence of perceived support may have been due to the lack of a direct question or
perhaps due to the post-experience design of the study.
Non-helpful Support
Non-helpful support is made up from the social constraint. Social support can be
interpreted as a negative experience or as non-supportive action depending on the
outcome or how that support is interpreted by the support receiver.
Social Constraint. Social constraint occurs when a support provider does
something that they may believe is helpful, but the recipient does not interpret the action
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as supportive. See Table 5.9 to view the three dimensions of social constraint that and
excerpts.
Table 5. 9 Social Constraint
Dimensions
Good Intentions
with Financial
Consequences

Excerpts
“She lives with me. When she first moved here, she didn’t have anything. She just
started the job that she’s at now. This is the first time she has had a
permanent job—it goes back about 3 years. Before she had temporary jobs,
this was a permanent job, but she felt that she couldn’t take a lot of time off to
help me, but she was able to contribute more to help me out with the rent and
the phone, food and that sort of thing.” #4 (52-year-old female, Lymphoma)
“It's been a big stress. Big stress. You know, I was having to feed him and for
helping you know. I felt like it was my duty to feed him and not charge him
anything to live here. He was helping me, but when the help stopped, that's
when it was, became very, very, very stressful for me and then I just said you
know, you know how I feel about drugs, you've got to go.” #16 (55-year-old
female, Colorectal Cancer)
“Even my own sister charged me to watch my kids … I would have to pay her to
come pick the kids up or $20 in gas money to come 10 miles down the road
and get the kids for me while I had him in the emergency room. It was always
something. There were times when I just sat in the car and just cried.
Overdraft fees, that was a big one. I was constantly over-drafting the bank
account.” #21 (36-year-old male, Lymphoma)

Good Intentions
Not Helpful

“My oldest daughter who's an LPN … I saw her interact with my doctor and I told
her, ‘That's why you're not my medical power of attorney.’ It's that nurse
thing that thinks the doctor is God or something. It's like no, you have to
argue with the doctor sometimes.” #6 (60-year-old female, Lung Cancer)
“I got a package from my sister in the mail and I opened it and there were pictures
on top of when I was growing up and pictures of my mom, grandmother and
family and then after all that there was a ribbon that I had given my mom and
some of my mom’s belongings that were intimate belongings. So, I put that
aside and I pulled out my mom’s cosmetic bag. For crying out loud, why did
she send this to me? My mom’s make-up when she was in her end days. I
opened it and in the top was her hairbrush and it still had her hair in it. I took a
deep breath – it’s my mom. I lifted that out and mom’s prosthetic boobs were
in the bottom. I thought oh my god what did she send these to me for.” #7 (50year-old female, Breast Cancer)
“We were all sitting around talking about it. My mom was very cynical and just
not helpful. She's like, ‘Well nobody's going to donate to that. You're just
wasting your time. You're just going to embarrass yourself.’ I was like, ‘You
know what? It's my kids. It's his health. If it doesn't work, it doesn't work.’
What's the worst that can happen? It doesn't work." Really, the Go Fund Me is
basically what got us through.” #21 (36-year-old male, Lymphoma)
“It came back in September, and they started talking transplant, and I mentioned
to his oncologist ‘well, maybe they can do it this year because we have
already met our deductible.’ He was like ‘oh honey, it’s not going to matter
what your deductible is because you’re going too far exceed it next year too.’
So, I was like oh, ok. Here we go again… I was like thanks.” #11 (55-year-old
male, Glioblastoma)
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“I didn’t realize how expensive, but I knew it was expensive because I would ask
questions about how much a specific my chemo was or whatever. They would
be like, ‘It’s not too bad.’ They try not to worry people. They really try to
work with cancer patients. They don’t want people to be fretting. You know
what I mean? On top of trying to care of you. I would say how much is this
costing or whatever and they would be like, ‘It’s not too bad. It’s not bad.’ I
didn’t have any real clue what’s the real cost of some of this stuff was.” #17
(41-year-old female, Rectal Cancer)
Ineffective Support

“My husband at the time was theoretically also doing that, but I think that he was
also like, ‘Oh, crap. My wife has cancer.” #19 (37-year-old female, Breast
Cancer)
“I moved out and I had to take a really - Like everyone who gets divorced, I think,
I had to take a really hard look at finances.” #19 (37-year-old female, Breast
Cancer)

Good intentions with financial consequences. This subcategory is characterized
by a support provider engaging in an instrumental support such as childcare or attending
treatment, but the supportive attempt was a financial expense for the patient. For
example, one interviewee (#4) had her sibling move in with her under the expectation
that she would provide caretaking and household assistance. Initially when the sibling
moved in, she did not have any money and was financially dependent on the interviewee.
This was a financial burden until the sibling was able to secure a permanent job.
However, once the sibling secured a position, she was no longer available to assist around
the house. In a second example, an interviewee’s (#16) son moved in with her when she
was diagnosed with cancer. This was initially helpful but then he got involved with drugs.
Ultimately, this caused more stress, both emotionally and financially. Eventually the
interviewee had to send him out of town. Similarly, two other interviewees spoke about
the financial consequences when family or friends helped them out during their cancer
treatment by being present during or after treatment, or by providing childcare.
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By providing acts of social supports, friends and family may feel they are being helpful;
however, in these examples the helpful act came at a financial cost which further
exacerbated the financial hardship.
Good intentions that are not helpful. There were several examples throughout
the interviews of family, friends and medical professionals attempting to do something
helpful, but those acts were not interpreted as helpful. For example, one interviewee (#7)
shared that she had received a package from their sibling. The content of the package was
disturbing for the interviewee as it contained items from when her mother had cancer.
The sibling may have thought the recipient could use the items left after their mother had
passed away; however, the receiver was baffled by the gesture. In another example, the
interviewee (#21) was considering creating a Go-Fund-Me account to raise money to help
pay for her treatment. The interviewee’s parent made negative remarks about doing so.
These comments were interpreted as negative and critical putting the patient on the
defense; however, it is possible that the parent had intended to protect them from
engaging in something she felt was socially taboo. This behavior may have been an
attempt to prevented them from the embarrassment of asking others for financial help and
crossing socially acceptable norms. Another interviewee (#6) had her daughter, with a
medical background, attend her medical appointments. The interviewee, however, felt
like the daughter was just agreeing with the doctor and not being an advocate for her.
This is also an example of how the support that is provided needs to match the support
that is needed. If the support provided does not match the needs of the support receiver,
then the support receiver will not interpret the support provided as supportive. In this case

96

the daughter is providing support by being present at the appointments; however, the
interviewee wanted her daughter to advocate for her.
Interviewees shared experiences of social constraint from Medical Professionals
as well. For example, one interviewee (#11) shared his story about getting a second
diagnosis and treatment information from his doctor. The interviewee had already
experienced tremendous financial hardship during the first cancer experience and had
suggested they do the transplant before the year ended because he had already met their
deductible. The doctor responded that it was not going to matter because they would
most like meet the deductible the following year as well. The way in which this
information was presented was interpreted by the interviewee as insensitive; however,
that was likely not the doctor’s intent. Furthermore, the medical industry is often
criticized for being focused on curing the disease while neglecting to look beyond the
recovery phase. Several interviewees commented on receiving reassurance from medical
professionals, encouraging them to not worry about the costs even when they asked for
the information. In the end these patients were left with a stack of medical bills and
overwhelming feelings of financial hardship due to the costs they were encouraged to not
worry about.
In these excerpts it is apparent that the topic of finances and financial struggles
can evoke different reactions from patients and those around them. Acts meant to buffer
the patient from stress or benign comments attempting to illicit humor are not meant to
cause harm but can be interpreted as hurtful, insensitive and non-supportive.
Ineffective support. The act of receiving support is beneficial when the support
is reliable and helpful; however, there were a few instances that interviewees shared
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where the support provided ended up putting the interviewee in a worse situation or
provided them with unhelpful information or ideas. For one interviewee (#19), her
husband was supposed to take care of the finances during her cancer experience;
however, in her opinion, he did not do a very good job. The interviewee’s statements
appeared to be resentful toward how those finances were managed. This could be due to
the fact that her marriage dissolved after her cancer experience, but before her medical
debt was paid. The divorce further complicated her financial well-being. Another
interviewee shared how she was advised to only take half the medication prescribed.
Receiving inaccurate and unhelpful support can further complicate a person’s situation.
Gaps in Support
The final theme is Gaps in Support. This theme is made from two categories:
barriers to support or missing support. These categories evolved from direct comments,
and interpretations of what was not said.
Barriers to Support. Several barriers to accessing supports were identified. See
Table 5.10 for an overview of dimensions and interview excerpts.
Table 5. 10 Barriers to Support
Dimensions

Excerpts

Missing Timely Information

“I think I was in my second or third month before it clicked that there
was financial assistance available. If they could bring that to the
table right away that would be wonderful.” #24 (49-year-old
female, Lymphoma)
“No one came out and said ‘hey, you qualify for this’. I stumbled on
that.” #13 (58-year-old male, Leukemia)

Personal Barriers

“I can't say, ‘Well, I don't have any lights today,’ or ‘Refrigerator's
empty.’ I can't do that. It's different for everybody.” #12 (51-yearold female, Breast Cancer)
“There's some places that can help you with assistance like food or
electricity and things like that. You know, do I ever want to take
advantage of that? I don't know, it's kind of like I don't know.” #16
(55-year-old female, Colorectal Cancer)
“Then I don’t tell anyone about the money thing because to me it’s
like embarrassing.” #1 (58-year-old female, Breast Cancer)
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“If you don’t have money or know how to navigate the system or
know how to get the most of it paid. The ones who are supposed to
be the advocates at the hospital, the ones who want to get most of
it paid, they don’t care. It’s like you get flipped off. I had a
question for someone, and they said, ‘I don’t have to deal with you
anymore, you have Medicare.’ She said this in the hallway. I asked
her to meet her in her office. She says this in the hallway in front
of all of these people and she said, “I don’t have to see you
anymore.” #2 (65- year-old female, Breast Cancer)
Support That is Not Needed

“When I ask about something, it's like, ‘Well, you can just go to the
resource center.’ When I would say something, of course the nurse
navigator just kind of disappears after the first visit or so. They
told me that I could get a wig and they told me there were books
and I could get all that at the resource center." #6 (60-year-old
female, Lung Cancer)
“The cancer centers, they always are like, ‘You can have free art
therapy because you're a cancer survivor,’ and ‘You can have free
massage and acupuncture.’ I'm like, ‘give me some free financial
advice. Give me a free session with somebody that can tell me how
to pick up these pieces and pay for all this stuff.’ That would be so
much more useful, nothing against art therapy.” #19 (37-year-old
female, Breast Cancer)
“Here's the Resource Center. Go talk to them. Oh yeah, here you can
get a massage every other month for free. Yeah, that was great, but
at the end of the day it wasn't what was needed most. They didn't
come out and tell you about the other stuff.” #21 (36-year-old
male, Lymphoma)
“I was told I could call a counselor and I did speak to [person’s name]
on the phone and she said that she would send me forms, I could
fill them out, and they probably would just write it all off, which
would be wonderful. I'm telling you the truth, between filling out
all these disability forms for ten hours while I was going through
all this sickness and trying to move in the middle of chemotherapy,
all I could do was sit in the floor and try to pack boxes. I was so no
help. You're not allowed to lift, that's so awful. You're so sick with
all those forms and then I filed my own divorce. That's fun forms
about this thick. By the time I did all that I was wore out and I
thought, you know when her forms came, I'm sorry, I apologize. I
started filling them out, I never finished them.” #14 (64-year-old
female, Breast Cancer)

The Run Around

“But I was paying them and when I inquired to see if I could get help,
they said we are not funding breast cancer right now – we’re
funding colorectal cancer or this cancer but not breast cancer right
now. So, I did check with two resources given to me and it didn’t
help.” #7 (50-year-old, female Breast Cancer)
“I don't know who it was, but somebody gave me some pamphlet
about this organization. They said, ‘Here, call them. They always
help pay for prescriptions.’ I called them to try to get help. They
were like, ‘Well, you don't qualify because you didn't have the
right kind of cancer. After a while you burn out of resources
because it doesn’t take very long to go through the few places that
does offer the scholarships for people with this." #17 (41-year-old
female, Rectal Cancer)
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“I’ve caught buses in the snow to get to [appointments] for these
people from the United Way to the people for financial help in the
hospitals. And I’ve waited and waited until they were finished
with their lunches and chit chat to help me fill out forms that were
foreign to me. One reason they were foreign to me was I expected
one thing, they expected one thing and we never met in the middle.
All because of a zip code. I expected you to talk to me like a
person and you expected me to know the game and I don’t know
the game so consequently you didn’t talk to me like a person. I
would sit there and have a meltdown before anybody would look
at me like a person.” #2 (65-year-old female, Breast Cancer)
“I've applied for grants. Nobody has any grants or anything for that
drug. I called literally 20 different places to find assistance.” #16
(55-year-old female, Colorectal Cancer)

Missing timely information. Receiving information when the information is
needed and will benefit the patient is the premise of the next subcategory. Receiving
information in a timely manner may make a difference in how patients manage their
resources. One interviewee (#24) shared how she came upon information about financial
resources that could have benefited her months earlier. It was not until the second or third
month into her treatment that she realized financial assistance was available. Similarly,
another interviewee (#13) several months into his treatment said that the day he was
diagnosed he automatically qualified for Medicare and Social Security Benefits. He could
have applied immediately for assistance. In both of these examples, these individuals had
no idea they qualified for disability benefits. Instead they continued to tap the minimal
resources they had and struggled financially. To complicate the matter further, it can take
several months before a patient actually receives financial payments after they have been
approved. This can further lead to more financial distress. Receiving information about
financial resources and government assistance programs could benefit patients more if
they made aware of these programs at the beginning of their diagnosis.
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Personal barriers. Barriers to accessing financial resources and assistance can be
due to personal barriers as well. A few interviewees expressed a sense of pride that
prevented them from asking others for financial help and resources. Another interviewee
(#1) expressed embarrassment about her financial struggles. These personal barriers can
get in the way of patients talking with others and sharing their concerns. Patients may
fear being judged by others. Our society is based on individualism and we pride ourselves
on “picking ourselves up by our own bootstraps”. It is not common place to openly talk
about your financial situation. Talking about finances is considered to be one of the top
socially inappropriate subjects to discuss in public. Due to this social stigma, patients
may not feel comfortable admitting to others that they are struggling financially and need
help.
Further complicating the situation, is that some individuals feel stigmatized when
they ask for financial assistance. One interviewee (#2) shared how she attempted to get
help but was treated poorly. Ultimately, she was unable to access the resources she
needed and felt stigmatized because she was black and lived in the wrong neighborhood.
Receiving messages such as these could negatively impact how patients proceed through
the medical system and whether or not they seek further assistance. This could further
lead to a state of learned helplessness.
Struggling with fears of stigma, embarrassment or pride can prevent patients from
accessing and receiving needed financial assistance. These barriers can be further
reinforced by issues of social constraint. Encouraging patients by normalizing their
financial condition and providing a safe non-judgmental environment for them to express
their financial concerns will help them to overcome these personal barriers.
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Support that is not needed. According to social support theory, in order for a
support to be interpreted as helpful it needs to reflect the support requested. That was true
for participants in this study. Some interviewees who sought out resources and
information received resources that were not what they needed or wanted. Not receiving
the information and resources needed can further complicate their situation and frustrate
patients as they are trying to seek help. As a result, the supports provided can be
perceived as not supportive. Several interviewees commented on requesting financial
assistance and guidance but were instead told about free monthly massages or art therapy,
a wig, books or other services that were not what was needed. For one interviewee (#14),
she shared how she needed assistance with completing the paperwork associated with
getting financial assistance. She was overwhelmed with her cancer experience which was
complicated by a divorce and having to move. She did not have the energy or capacity to
complete the paperwork. Instead of applying for financial assistances she found it easier
to file for bankruptcy. When patients are so overwhelmed with their financial situation,
trying to survive cancer, and whatever else life has thrown at them, they may need help
completing simple tasks such as filling out paperwork. This theme brings attention to the
importance of providing resources and services that meet the requests of the patients. Not
all patients need or want the same services. So those in the Medical Professional network
should attempt to identify what those needs are and assist patients in locating requested
resources or services.
The run around. Some participants who received assistance and information on
resources reported to hit dead-ends. They spoke about receiving information and leads on
where to find resources. However, for some, when they followed up with these resources,
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they were denied access. Some were told they did not have a specific type of cancer or
did not live in the right zip code. Finding and accessing resources can be an exhausting
and defeating process for patients further complicated when those resources are not
accessible. The initial hope that aid and relief is available is quickly dashed by rejection
after rejection becoming a defeating experience.
Missing Support. Dimensions in this section refer to lacking emotional,
informational, and instrumental supports. Missing support was largely informed by
participants stories, but these subcategories were also informed from the silences within
the data. See Table 5.11 for a brief overview of subcategories and excerpts.
Table 5. 11 Missing Support
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Dimensions
Diminishing
Help

Excerpt
“Things settle off. Everybody else goes on and lives their life, yet this is our life. The
help and the concern drift off, and then you're left with still all of these stressors
and financial issues. You had so much help from people, you don't want to just say,
‘I need more help,’ or, ‘Can you do this?” #21 (36-year-old male, Lymphoma)

Lacking a
Confidant.

“It was emotional support more so than financial. I didn't have to worry about him
taking off work to take me to treatment, because my church members they were all
there to do that, but I didn't let it be known that other things were going on.” #12
(51-year-old female, Breast Cancer)
“I have a best friend that I have known her for over forty years and she’s wonderful,
but she has never had cancer and she just, she doesn’t quite understand it. I don’t
want to scare her or burden her so there are things I hold back you know and the
same way with my family, there are things that I hold back. I don’t tell them all
everything. Then I don’t tell anyone about the money thing because to me it’s like
embarrassing.” #1 (58-year-old female, Breast Cancer)

Missing
Information

“I cut back some hours when I was in chemo. I took like three weeks off when I had
surgery. If I had taken one more week off, I would have been able to qualify for
short-term disability, but my HR person didn't know that. They didn't tell me that,
so I just came back after three weeks, like, ‘I'm just going to do my best.’ People
don't really know.” #19 (37-year-old female, Breast Cancer)
“I was kind of in a catch 22, because when I started the whole process, I had like
fourteen weeks of sick time and vacation time banked up in my account. I thought,
Oh, that's great because then it will cover any kind of short-term disability but
didn't realize that people couldn't donate to me because I already had too much
PTO. Once I got through those twelve weeks, I didn't have any PTO but then they
couldn't donate to me because I wasn't on FMLA anymore. We were just in a bad
spot I guess, timing wise.” #23 (middle-aged female, Multiple Myeloma)
“The last time when I had to take 6 weeks off during my school year time, I became
aware of the program whereby school district employees can volunteer their sick
days. I got like 23 sick days given to me and it covered everything I needed to
make it through the last phase. But the first ones I didn’t have anything. Nobody
said anything.” #7 (50-year-old female, Breast Cancer)
“No and in fact I have made a few phone calls to see if there is anybody in their office
to talk to me about it because I get online, and they say talk to the social worker at
the hospital. There is no social worker at the hospital that will talk about that. At
least not that I’ve heard.” #1 (58-year-old female, Breast Cancer)
“No, but that would have been helpful” [to have someone sit down and talk about
costs… It would be really nice if there was some kind of counselor to help you
figure it out.” #1 (58-year-old female, Breast Cancer)
“No, we are lucky they gave us side-effects of the drugs… So, there wasn’t a lot of
education, especially the financial part. No one ever even asked.” #11 (55-year-old
male, Glioblastoma)
“I feel like nobody tells you that. I really can’t remember talking to anybody in my
cancer center about insurance filing or financial help or anything like that.” #19
(37-year-old female, Breast Cancer)
“I don’t know that anyone ever sat down and went through the financial part of it with
me and even being a financial professional it is not the first thing on your mind
once you, you know. You think well you know I have insurance and you worry
about the other stuff.” #3 (54-year-old male, Throat Cancer)
“They didn’t go over pretty much anything with the cost of that.” #23 (middle-aged
female, Multiple Myeloma)
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“Finances have never been mentioned by any of my providers or social workers with
the hospital or nurse navigators or anything… no one at any of the doctors or
hospitals ever talked to me about finances or insurance.” #5 (35-year-old woman,
Breast Cancer)
“We wanted to talk to someone…and all the social worker said was ‘oh we have art
therapy.” #9 (30-year-old female, Ovarian Cancer)
“when you go in and ask for information it wasn’t specific. It’s like, ‘Well, here’s a
website.’” #6 (60-year-old female, Lung Cancer)
“I didn’t realize how expensive, but I knew it was expensive because I would ask
questions about how much a specific, like, say, my chemo was or whatever. They
would be like, “It’s not too bad.” They try not to worry people…They don’t want
people to be fretting. On top of trying to take care of you. I would say how much is
this costing or whatever and they would be like, “It’s not too bad. It’s not bad.” I
didn’t have any real clue what’s the real cost of some of this stuff was.” #17 (41year-old female, Rectal Cancer)
“Didn't understand the prognosis so didn't feel she needed the services. Then I was
going through home care they suggested I apply for disability or contact a Social
Worker. I opted not to because I figured I'd just go back to work by the time that
any paperwork could be filed.” #25 (32-year-old female, Appendiceal)
“I was in my second or third month before it clicked that there was financial assistance
available. If they could bring that to the table right away that would be wonderful.”
#24 (49-year-old woman, Lymphoma)
“He was two years in before we even found out that they had a gas card program that
could help us just with gas and getting back and forth to treatment.” #21 (36-yearold male, Lymphoma)
“When the bills started coming in, to be able to have that contact person to say, ‘Okay,
what can I do with this,’ would have been really nice.” #6 (60-year-old female,
Lung Cancer)
Missed
Opportunities

“I try not to say a whole lot about finances to people. In some ways, you have to
because you don't have a normal life anymore. Other friends and people, even
when he's feeling good, they're going out to dinner, going out to do things and we
can't go simply because we can't afford to go like everybody else can.” #21 (36year-old male, Lymphoma)
“Then I don’t tell anyone about the money thing because to me it’s like embarrassing.”
#1 (58-year-old female, Breast Cancer)

Diminishing Help. During the diagnosis and treatment phase patients may
experience a lot of support from those around them; however, as time passes the help and
assistance from others declines. Others may have been made aware of an initial need for
support and are motivated to help where they can. For those who have cancers that
require a lengthier treatment schedule or additional complications, help may decline and
fade over time. This may be due to others being unaware of a need still existing. One
interviewee (#21) commented on experiencing guilty over repeatedly asking for
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continued support and help. When a need for support is not expressed support diminishes
potentially leaving needs unmet.
Lacking a confidant. Few interviewees made comments about sharing their
financial concerns with others. For most of the interviewees there was silence regarding
having someone to confide in about their financial struggles. One interviewee (#12)
shared that she had other forms of support such as transportation to treatments, but she
kept her financial concerns secret. A few participants provided insight into why they did
not share their financial concerns with others. One interviewee (#7) explained that she did
not share her financial concerns with her sister because she didn’t want to worry her.
Another interviewee (#1) stated she felt embarrassment over her situation and that is why
she did not confide in others. This subcategory of missing a supportive confidant overlaps
into the Barriers of Support as well. The embarrassment and desire to not worry others
becomes a personal barrier for some people.
Missing information. A commonality among several of the interviews was that
many lacked information that could have assisted in preparing them for the costs of their
care or possibly taking steps to alleviate that impact. Several of the examples provided
by interviewees were directly work related. Human Resource (HR) departments are key
to explaining how policies and employee benefits work. Knowing what is available and
timing the implementation of when to use these programs can possibly be tricky but
could work in favor of the employee. One interviewee (#19) shared how she could have
benefited from guidance from her HR on when to return to work. If she had stayed away
from work another week, she could have tapped into her short-term disability benefits.
Instead she returned to work even though she was not physically ready to do so. Another
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interviewee (#23) could have benefited from advice on how to navigate the use of her
paid time off (PTO), Family Medical Leave Assistance (FMLA), and the agencies PTO
donation program. Similarly, another interviewee (#7) was unaware of her employer’s
PTO donation program until her last treatment phase. Initially no one told her the
program existed. For each of these interviewees, having access to information about these
programs earlier and being given guidance on using them might have alleviated some of
the financial hardship they experienced.
Interviewees also lacked information from their Medical Professionals. In
response to a probing question about whether or not someone talked to them about their
medical costs, many responded negatively. Not all patients are interested in knowing how
much their medical treatment will cost, but some are. A few interviewees shared how
they requested the information from several of their medical providers but were not given
it. Some were told to not worry about it which, as discussed, overlaps into the Helpful
and Non-helpful Support categories.
Receiving timely and accurate information could be beneficial to patients. It is
important for patients to have an accurate understanding of their situation and what
resources are available so they can make financial decisions or take actions that could
soften the financial impact. For one interviewee (#6), the bills started to come in after
treatment was completed, and she did not know who to ask for help. Knowing who to ask
questions of when the bills are flooding in could perhaps help patients to cope with their
financial situation by developing a plan for repayment.
Missed opportunities. As noted in the literature, financial toxicity can lead to
changes in a person’s social life as they cut back on entertainment and discretionary
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spending. One interviewee (#21) talked about cutting back on going out to dinner with
friends because they could not afford it anymore. There friends still engaged in activities
but without them. By not engaging in these activities’ friendships are at risk of dissolving
missing the potential opportunity to let others know that help is still needed. As noted
earlier in this chapter, some patients do not disclose to others their financial concerns.
Similarly, not talking about financial struggles can compound a patient’s experience of
being isolated and cut off from others who can and would provide help. Ultimately, they
may miss out on social supports that could be available if others were aware of the need.
Brief Interpretation
In support of social support theories, cancer survivors in this study experienced
received social support (emotional, informational, and instrumental) and social constraint.
Emotional support was mostly provided by family members and friends; although, there
were examples of emotional support from the medical professionals and organizations
(mainly work). Emotional support is often seen intertwined or a result of a received
instrumental support. Benefiting from acts of service or being relieved of a stressful
responsibility can provide feelings of being cared about. Furthermore, having someone to
talk with and share your financial concerns can provide feeling of being understood and
can normalize the experience making cancer patients and survivors feel not so alone in
their experiences.
In addition, informational supports were provided by family members, friends,
and medical professionals. Cancer patients and survivors can benefit from advice on how
to organize and understand their medical bills and insurance. Understanding medical and
insurance forms and knowing when to pay medical bills or how to file appeals for
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insurance denials could give patients more control over their financial situation.
Likewise, receiving timely information on accessing financial assistance or advice on
when to apply for government assistance programs could ultimately have an impact on
the financial outcomes for patients.
More noticeably, received instrumental support had a strong presence in the data
and were provided by all social network members (family members, friends, medical
professionals, and organizations). Monetary support or support that could have an
economic value (childcare, transportation, food), no matter how small the assistance, can
indeed provide some relief from the objective and subjective perspectives of financial
toxicity.
As evident by the literature, cancer patients can be in a financially precarious
situation due to their cancer costs. This condition can be further augmented by the
presence and pressures of social constraint. Support providers may not take into
consideration the financial implications of the support they offer. As was evident in the
subcategory Good Intentions with Financial Implications where supportive efforts came
at a financial expense for the cancer patient or when support was just bad support further
complicated the patient’s financial well-being. Moreover, cancer patients are susceptible
to receiving supports that are not helpful or otherwise not wanted. Receiving advice that
is critical or not generally helpful, can put unwanted social pressure on patients and may
prevent them from seeking help or talking to others about their financial concerns.
The third category, Gaps in Support, gave insight into areas where support is
needed: missing support or barriers to accessing support. Cancer survivors in this study
lacked timely and accurate information that could have helped them steer through some
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of the financial healthcare maze. Receiving information on how to balance employment
related benefits to take the most advantage of those programs, or information on
accessing agency or government assistance programs could have major financial benefits.
Likewise, addressing personal barriers could alleviate patients’ feelings of stigma or
embarrassment about disclosing their financial concerns which in turn may improve their
help-seeking and receiving behaviors.
In essence, this study brings to light that there are social supports that can and do
benefit the financial well-being of cancer patients. Moreover, cancer patients and
survivors may experience unmet needs and barriers to accessing support. This study
opens up a discussion on ways to improve the system for future patients which will be
addressed in the final chapter.
Summary
This chapter presented the findings for Study 1. It provided insight into the types
of social support available and used by a sample of cancer survivors who self-reported
cancer-related financial burden and distress. The next two chapters (6 and 7) will present
the methods and findings for Study 2, respectively. This will allow further elaboration on
how social support impacts the experience of financial toxicity. Chapter 8 will intertwine
the interpretations from both studies for a final synopsis exploring implications for
practice, research, and policy.
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CHAPTER 6: STUDY 2 METHODS
This chapter presents the methods for the second study conducted to answer the
overarching question: What role does social support play in the experience of cancerrelated financial toxicity? Relying on quantitative methods, study 2 used a cross-sectional
survey design. Similar to study 1, study 2 relied on the understanding of financial toxicity
as presented in the Carrera et al. (2018) framework and social support theories as well as
the by the Transactional Model of Stress and Coping Theory (Stress and Coping Theory)
and the Stress Buffering hypothesis (see Chapter 3 for more details on these theories).
These theories provided guidance and direction to determine if social support played a
moderator or mediator role in the relationship between financial toxicity (objective
burden and subjective distress) and quality of life (QoL). The present chapter details the
methods used for study 2.
Purpose
Study 2 is the second study used in this multi-method project to gain a better
understanding of the impact social support has on the financial toxicity of cancer care.
The question that drives this study is: How does social support influence cancer-related
financial toxicity and patient’s quality of life? This question attempts to determine the
path by which social support impacts the relationship between cancer-related financial
toxicity and QoL, whether by mediating or moderating processes. The two specific aims
and corresponding hypotheses are listed below.
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Specific Aim 1: To determine if received and perceived social support moderates
the relationship between cancer-related financial toxicity, and quality of life controlling
for the effects of cancer treatment, education, employment, insurance status, marital
status, and social constraint. (Quality of life will be considered under two conditions: 1)
quality of life as determined by the FACT-G scale; and 2) quality of life with economic
well-being using the FACT-G scale plus the Economic Well-being scale. Scales will be
further explained in the Measures section below.)
Hypothesis 1.1: Received social support will moderate the relationship between
financial toxicity and QoL.
Hypothesis 1.2: Perceived social support will moderate the relationship between
financial toxicity and QoL.
Hypothesis 1.3: Received social support will moderate the relationship between
financial toxicity and QoL including socio-economic well-being scale (Plus
SEW).
Hypothesis 1.4: Perceived social support will moderate the relationship between
financial toxicity and QoL Plus SEW.
Specific Aim 2: To determine if received and perceived social support mediates
the relationship between cancer-related financial toxicity and QoL controlling for the
effects of cancer treatment, education, employment, insurance status, marital status, and
social constraint.
Hypothesis 2.1: Received social support mediates between financial toxicity and
QoL.
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Hypothesis 2.2: Perceived social support mediates between financial toxicity and
QoL.
Hypothesis 2.3: Received social support mediates between financial toxicity and
QoL Plus SEW.
Hypothesis 2.4: Perceived social support mediates between financial toxicity and
QoL Plus SEW.
Baron, et al., (1986) comments that it is acceptable to begin with a moderatororiented perspective that evolves into a mediator process; therefore, I first explored the
moderator-oriented perspective (specific aim 1) and then the possibility of a mediator
process as described in specific aim 2. The analysis procedure is outlined in the Data
Analysis section below and results can be found in Chapter 6.
Study Design
Study 2 was a cross-sectional survey design as data was gathered at one time
point for each participant. Cross-sectional study designs are appropriately used for
measuring outcomes and determining associations between variables.
Human Subjects Protection. Study 2 was approved by the University of
Louisville Institutional Review Board (IRB). The study required direct contact with
human subjects; therefore, it needed to meet ethical standards. All participants were
provided a consent preamble informing them of the purpose of the study and their rights
to not participant in the study at any time. See Appendix H for the consent preamble.
Study sample. Participants were recruited using a convenience-sampling method.
Multiple cancer-related agencies were asked and agreed to send out the call for
participants through social media platforms, websites, emails and online monthly
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newsletters. See Table 6.1 for a complete list of agencies used, method of dissemination
and number of participants obtained. If participants were interested in participating, they
could follow the weblink provided in the correspondence. See Appendix I for the IRB
approved call for participants.
Table 6. 1 Dissemination Methods and Responses by Agency.
Organizations
Adelphi
Atlanta Cancer
Foundation

Method of
Dissemination

Potential
Exposure

Number
Responses

Percent

~2000
Unknown
Unknown
Unknown

1
1
1
3

.9
.9
.9
2.8

~5000

56

52.8

~350
~2568
~6991
~8000
~20,000
1324 Contacted
74 Initial
Response

15
0
0
1
2
22

14.2
0
0
.9
1.8
20.8

ACS-Cancer Support
Network

Newsletter
Newsletter
Website
Announcement
Website

Breast Friends

Email/Newsletter

Friends for Life

Research Match

Email
Facebook
Twitter
Unknown
Facebook
Email

UofL Kent School

Website

Unknown

1

.9

Other: Referred by
friend or agency that
was not enlisted.

Unknown

Unknown

3

2.8

Komen Foundation
Kansas City

Inclusion criteria. Participation criteria required individuals to be 18 years and
older, who had a breast or blood cancer diagnosis and/or treatment in the past 5 years.
Power consideration. Since a moderating variable may interact directly and/or
indirectly with the outcome variable, it is difficult to detect an effect when statistical
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power is too low. The Sample Size application by Abu-bader (2014) was used to
calculate required sample size for a multiple regression analysis. This application
calculates the sample size necessary to achieve .80 statistical power for various statistical
analysis. For a three-factor logistical regression, a sample size of 77 is required for an
alpha level at .05 with a medium effect size. Three factors are consideration in a
moderator analysis because there are two independent variables that interact, The
interaction variable is considered to be the third factor. A sample size of at least 100
participants was sought to allow enough power to control variables that may have an
influence on the relationship during the analysis.
After the sample was collected a second power analysis was conducted using
G*Power (Faul, Erdfelder, Lang, & Buchner, 2007; Faul et al., 2009) to determine how
many control variables may be used in the analyses to maintain a medium effect size.
With the sample size obtained for this study at least 11 factors could be used (n=123).
Study Procedure
The survey was developed using initial data analysis from Study 1 as well as the
theoretical frameworks of Lazarus et al. (1984), and Cohen et al. (1985). Standardized
instruments were used to ensure validity and reliability of the measurement ofquality of
life, financial toxicity and social support. In addition, questions pertaining to the use and
type of social support, as well as demographic information, cancer type, and cancer
treatment received were collected.
After receiving IRB approval, the survey was created in the Blue survey
management system. The call for participants was sent out by participating cancer-related
agencies (see Table 6.1). Participation was voluntary. If participants were interested in
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participating, they could follow the link to the questionnaire where they would first be
presented with the consent preamble and then questions (see Appendix H for the consent
preamble and Appendix J the survey questions). Surveys were collected through the Blue
online survey platform between July 2017 to December 2018.
Data management. Data were initially collected in the Blue online survey system
which is a password protected program licensed with the University of Louisville. After
the data were collected, they were downloaded and transferred into an IBM SPSS v25
software file on a password protected and encrypted computer.
Measures. Variables were operationalized based on peer-reviewed literature and
published books (see Appendix K). Standardized instruments were selected based on
validity and reliability as well as their use in similar literature. Scales and questions were
selected to gain the most accurate information with the least respondent toxicity. In
addition, questions pertaining to the use and type of social support, as well as social
constraints, demographic information, and disease specific information were collected.
An overview of variables, measures, level of measurement and estimated time
requirement can be viewed in Appendix K.
Clinical Questions. Questions were created to first gather cancer specific
information about participants’ diagnoses and treatments since these variables may be
associated with other variables of interest.
Financial toxicity – independent variable (IV). Financial toxicity is the subjective
distress and objective burden due to cancer treatment costs and related expenses. The
COST-PROM was used to measure cancer-related financial toxicity. This is a
comprehensive instrument designed to consider the effects of direct and indirect costs
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caused by a cancer diagnosis and treatment. Examples of some of the items are: “I feel
financially stressed”, “I feel I have no choice about the amount of money I spend on
care”, and “I feel in control of my financial situation”. The COST-PROM is an 11-item
self-reporting inventory rated on a 5-point Likert scale (0 = not at all; 5 = very much).
The scale has been shown to have excellent internal consistency with Cronbach alpha =
0.9 in other studies (DeSouza et al., 2014). For this sample reliability was good (alpha =
.81). A high score on this scale indicates higher level of toxicity.
Social support – moderator or mediator variable. Social support is the emotional,
informational, and instrumental support perceived and/or received from formal and
informal support networks. The measures used to assess perceived social support are the
PROMIS Instrumental, Informational and Emotional Support instruments (PROMIS,
2015). Each instrument has 4 items that are rated using a 5-point Likert scale (1= never to
5 = always). Items are summed for a raw score and then converted to t-scores. Higher
scores reflect more support.
•

The NIH PROMIS Emotional Support SP4a instrument measures the perception
of being cared for and valued. Examples of items include: “I have someone who
will listen”, and “I have someone to confide in”. This scale had excellent internal
consistency (Cronbach alpha = 0.904).

•

The NIH PROMIS Informational Support SP4a instrument measures the
perception of available information and advice (PROMIS, 2015). Items include:
“I have someone to give me good advice”, and “I have someone to turn to for
suggestions”. The scale had excellent internal consistency (Cronbach alpha =
0.96).
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•

The NIH PROMIS Instrumental Support SP4a instrument measures the perception
of availability assistance with tasks, and material resources (PROMIS, 2015).
Questions include: “Do you have someone to run errands if you need it”, and “do
you have someone to help with your daily chores”. This scale had excellent
internal consistency (Cronbach alpha = 0.95).
Received social support – moderator or mediator variable. The short version of

the Inventory of Socially Supportive Behaviors (ISSB) assesses received social support
within the past month. This is a 19-item scale graded on a 5-point Likert scale ranging
from “not at all”, “once or twice”, “about once a week”, “several times a week” to “about
every day”. This scale assesses received Informational and Instrumental support for the
past month and included responses to a prompt asking how often someone provided
specific activities such as: “gave you information”, “helped you understand”, and
“suggested some action”. Internal consistency for reported studies is excellent (Cronbach
alpha between 90 – 94) and for this study was excellent (Cronbach alpha = 0.904)
(Barrera, Sandler, & Ramsay, 1981).
Quality of life – dependent variable (DV). Quality of life is a multidimensional
concept that encompasses a person’s perception of their overall well-being. Well-being is
defined as the personal perception of how well life is going and the degree to which it is
enjoyed. Quality of life was assessed using two version of the Functional Assessment of
Cancer Therapy (FACT-G) scale: 1) FACT-G and 2) FACT-G Plus which adds in the
socio-economic well-being subscale (Head & Faul, 2008). The quality of life domains of
the FACT-G includes physical, emotional, social, and functional. The FACT-G is a 28item scale rated on a Likert scale (0 = Not at all; 4= Very Much). Internal consistency is
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reported good with a total Cronbach alpha = 0.89 (Cella et al., 1993). For this sample, the
FACT-G showed excellent reliability (Cronbach alpha = 0.91). The Socioeconomic Wellbeing scale is 17-item scale rated on a 5-point Likert scale (0 = Not at all; 4= Very
Much). Respondents are asked to indicate how a statement applies to their situation and
include statements such as: “I believe that being sick will hurt me financially” and “I am
able to make enough money to pay for my healthcare.” In other studies, the subscale has
had excellent internal consistency (Cronbach alpha = 0.92) (Head, et al., 2008). For this
sample the reliability was excellent (Cronbach alpha = .94). These scales assess domains
of well-being for the past 7 days. Higher scores indicate increased quality of life.
Social Constraint – IV. Research has shown that social constraint may influence
feelings of support (Lepore, 2002) and therefore should be considered in the analysis.
The Social Constraint scale is a 15-item scale rated on a 5-point Likert scale (0 = Not at
all; 4= Very Much). Examples of questions include: “How often did it seem that other
people did not understand your situation” and “how often did other people avoid you”.
This scale has shown good internal consistence (Cronbach alpha = 0.89). For this sample
internal consistence was excellent (Cronbach alpha = .946).
Participant burden and time consideration. Scales and questions were selected to
gain the most accurate information with the least respondent burden. It is generally
accepted that an inventory instrument with 30 to 40 items should only take the respondent
a few minutes to complete (Wills & Shinar, 2000). To complete this questionnaire, it took
an estimated 20 minutes.
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Data analysis
Data cleaning. Once data were uploaded to SPSS the database was prepared for
analyses. See Appendix L for specific steps taken for database preparation and tests for
assumptions. Data were assessed for missing responses and outliers. Each standardized
instrument provided instructions for handling missing data. Scales for social support,
financial toxicity and QoL were calculated as instructed by specified guidelines. A
composite variable was created for perceived social support using the three PROMIS
scales. The PROMIS scales met expectations for a meaningful grouping and were not
highly correlation (Song, Lin, Ward, and Fine, 2013). Further justification and steps for
creating the composite perceived social support variable (emotional, informational, and
instrumental) can be viewed in Appendix L.
Descriptive statistics. Basic descriptive analysis provided general information
about the sample (mean, median, standard deviation, frequency and percentages of
ordinal measures, normal data distribution). Frequency distributions were run in SPSS for
sample characteristics included basic demographics, before/after job status, before/after
insurance status, and cancer-related characteristics.
Bivariate Analysis. Pearson’s bivariate analysis was conducted to determine the
relationships between continuous predictor variables (age, social constraint). Pearson’s
correlation will report if items are negatively or positively correlated. See Appendix M
for specific steps and Cohen conversion values.
For IVs that are nominal or ordinal level data, One-way Analysis of Variance
(ANOVA) tests were conducted with the DV being quality of life. See Appendix N for
steps. An ANOVA can be used as an independent sample t test for IVs that have 2 group

120

levels (Lawson et al., 2014). Dummy variables were created for ordinal level data See
Appendix L for steps.
Specific aim 1. The first aim was to determine if received and perceived social
support moderates the relationship between cancer-related financial toxicity and QoL
controlling for treatment, education, employment, insurance status, marital status, and
social constraint. As discussed, QoL is measured using the FACT-G and the FACT-G
plus.
If social support is a moderator, it will influence the relationship between the IV
and the DV. Introducing a moderating variable will change the direction or magnitude of
the relationship between the IV and DV. There must be a significant interaction effect
between social support and financial toxicity (Meyers et al., 2013). Refer to chapter 3 for
the conceptual model of a moderator effect based off Baron et al. (1986). Holmbeck
(1997) discusses two analytical methods used to determine moderator effects: multiple
regression and structural equation modeling (SEM). A sample size of at least 200 is
needed for SEM. Since the sample size is only 126, multiple regression methods were
used.
The equation for the multiple regression analysis is as follows:
Ypred=a+b1X1+b2X2+b3X1X2

(1)

This analysis will test if the interaction of X1X2 (i.e., financial toxicity, social support) is
related to the remainder of Y (QoL) after X1 (financial toxicity) and X2 (social support)
have been used to predict Y (McClelland & Judd, 1993). If the interaction variable is
significant then it can account for some of the variance in the outcome variable and
therefore moderates the relationship.
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Data Analysis. To conduct the analysis for a moderator effect the Introduction to
Mediation, Moderation, and Conditional Process Analysis (PROCESS) macro for SPSS
was used. PROCESS is a modeling tool for SPSS and SAS that enables the analysis of
moderator and mediator effects (Hayes, 2017). It is a robust tool and has been used in
several peer-reviewed journal articles since 2014. The PROCESS method was selected
because the Baron and Kenny (1986) method is no longer the preferred methodologically
approach (Hayes, 2017). PROCESS implements simultaneous multiple regression
analyses to determine if a moderation effect is present (Hayes, 2018). The PROCESS
macro automatically centers the predictor variable to avoid multicollinearity, computes
the interaction term, and runs simple slope analyses using ordinary least squares (Fields,
2013).
Assumptions that need to be considered for multiple regression analysis include
sample size, multicollinearity of predictor variables, outliers, excluded variables and
misspecification of variables. To avoid issues of multicollinearity created by the
interaction term between social support and financial toxicity, the variables were centered
before the interaction term was created centered (Meyers et al., 2013; McClelland &
Judd, 1993; Holmbeck, 1997; Hayes, 2018). As stated, PROCESS automatically centers
the variables to avoid issues with multicollinearity. Next, data should be homoscedastic
meaning the variance between the residual of each predictor variable should be fairly
consistent. Potential issues with heteroscedasticity (opposite of homoscedasticity) are
handled automatically through the PROCESS macro using bootstrapping techniques.
Bootstrapping is the process of generating a large number of replications from the data
(Tabachnick & Fidell, 2013); essentially random samples from the data set multiple
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times. This allows for the computation of confidence intervals and determination of
significance (Fields, 2013). Lastly, data for the predictor, moderator and outcome
variables should be continuous, interval or ratio form. Tabulated data from the scales are
in interval form. Any control variable should be in dichotomous form (entered in SPSS as
0, 1).
Hayes (2018) argues there is ultimately no difference between a hierarchical
stepwise regression and a simultaneous entry. Several scholars have commented further
on whether or not a stepwise or simultaneous method should be used. Holmbeck (1997),
states that if the variables are considered equal in the theoretical model then it is
appropriate to use a simultaneous process. Additionally, using a step-wise method relies
on chance which may lead to an unstable equation (Lawson et. al., 2014). Furthermore,
when there are less then 15 variables the simultaneous method will provide as good or
better model fit; however, if there are more then 15 variables then the stepwise methods
may be useful (NCSS & Hintze, 2007).
It is my understanding that the PROCESS macro simulates the simultaneous
multiple regression. The PROCESS macro provides the DR2 which is the variance in Y
due to the moderation of X by the moderator variable (M) and it uses ordinary least
squares (OLS) to evaluate model fit including R2 and overall F-test. In addition, it
provides bootstrap confidence levels and provides the Johnson-Neyman technique for
probing interactions.
The PROCESS macro was used to conduct the moderation analysis (using
simultaneous multiple regression analyses) for hypothesis 1.1 – 1.4 to determine if social
supports behaved as a moderator variable in the relationship between financial toxicity
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and QoL. For the analyses that showed significant moderator effects, control variables
(age, cancer treatment, education, employment, insurance status, and marital status) were
added to the model to determine if social support continued to moderate the relationship
between financial toxicity and QoL.
Final analysis was conducted to determine if social constraint had an influence in
the relationship. Social constraint was added using a moderated moderator model as
described by Hayes (2017). Specific steps in PROCESS for conducting these analyses
and an example of the SPSS output can be viewed in Appendix O. Results are presented
in chapter 7.
Specific aim 2: Aim 2 sought to determine if received and perceived social
support mediates the relationship between cancer-related financial toxicity and QoL
controlling for cancer treatment, education, employment, insurance status, marital status,
and social constraint. QoL is determined using two variations of the FACT-G scale: 1)
FACT-G and 2) FACT-G plus socio-economic well-being scale. The following equation
represents the statistical analysis for a simple mediation model.
M = iM + aX + eM
Y = iY + c’X + bM +eY (Hayes, 2017)

To test for mediator effect four conditions must be met through a series of
regression analyses. (See figure ___ for pathway notation.)
1) The IV must be significantly associated with the DV: financial toxicity to
quality of life (path C).
2) The IV must be significantly associated with the mediator: financial toxicity
to social support (path A).
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3) The mediator variable must be significantly associated with DV: social
support to quality of life (path B).
4) The impact of the IV on the criterion variable should be smaller when the
mediator is included: financial toxicity à QoL, control for social support
(Field, 2013; Hayes, 2017).

Stress Event
-Costs of Cancer
Care

Financial
Toxicity

Social Support
A

-Perceived
-Received
Emotional, Informational
Instrumental

-Subjective Stress
-Objective Burden

B

Patient
Outcome
- Quality of
Life
-Financial
Well-being

C

Figure 6. 1 Diagram of mediation model, adapted from Hayes (2017).

Data Analysis. In order to analyze the data for these conditions a series of
correlations and linear regression analyses can be used to determine the relationships
(Meyers, Gamst, & Guarino, 2013; Field, 2013); however, I again used the PROCESS
macro to determine if a mediator effect exists (Hayes, 2017). The PROCESS macro can
be used to conduct 92 different moderator and mediator analyses. For this analysis,
models 4 and 14 were used (see Hayes, 2017 and Chapter 3 for models). PROCESS
implements bootstrapping techniques to calculate standard errors and confidence
intervals. Confidence levels were used to determine at a 95% confidence that the true bvalue falls between the lower level and the upper level.
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The data assumptions to use this analysis are: interval or ratio level of
measurement, predictive relationship must be linear, and variable distribution must be
normal. Issues of multicollinearity should be considered (Meyer, et al., 2013); however,
social support and financial toxicity were not highly correlated. The assumption of
misspecification will occur when there are irrelevant variables included in the model.
Variables were added to the model when justified by theory and reason. (See steps for
analysis in Appendix P). Results are presented in chapter 6.
Dissemination
Preliminary results have been disseminated through conference presentations and
workshops to oncology providers including social workers, physicians, nurses, financial
counselors, and administrators. I presented a poster at CSWE in 2017 on the topic of
addressing financial toxicity in the educational process for oncology social workers. This
poster pointed out the importance of education professionals engaging in important
conversations about finances with cancer patients. Presentations were also made at the
American Cancer Society Doctoral workshop, 2017 and 2018, for fulfillment of grant
recipient responsibilities. Attendees for this workshop included other doctoral grant
recipients and professional oncology social work researchers. In addition, I was invited
to present on a cancer care access panel supported by a PCORI grant with the University
of Kansas Medical Center in January 2019. This webinar was attended by medical
professionals, patients and caregivers. I presented on the topic of financial toxicity
pulling in preliminary results from study 2.
Future dissemination of this material will include peer-reviewed journal
publications and the development of educational materials on addressing financial
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concerns for medical professionals. Creation of a program to highlight the importance of
engaging in financial conversations to ensure all available resources to assist patients are
accessed in a timely manner. I will address future research and development plans in
more detail in the discussion section.
Summary
This chapter provided the research methods that were used for Study 2. Study 2
was driven by quantitative methods and analysis. Specific aims and hypotheses were
presented along with sample collection procedures and detailed steps for cleaning data
and statistical analysis (located in corresponding Appendices). The results from Study 2
are presented in Chapters 7. An in-depth discussion on the interpretation and finding are
presented in Chapter 8.
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CHAPTER 7: STUDY 2 RESULTS
“I’m told I make too much money to qualify for financial assistance. I pay $50 a month.
They state it isn’t enough. I gross $770 a month. How am I to pay more? I’ve asked them
why they save patients if they are going to kill them with the stress they are creating.”
- Study 2 #88 (58-year-old female, Breast Cancer)
The primary purpose of this research was to determine if social support played a
role in the complex issue of cancer-related financial toxicity and if so, how does it impact
the situation. In Study 1, we see that social support is present and commented on by most
of the participants in that study. Many reported to benefit from received instrumental
support. However, there was a clear lack of the presence of received informational and
emotional support. There were also very few comments on perceived social support.
These results led to more questions about patients’ experiences and how that can be
improved.
This chapter will present the results from Study 2 which examined the
relationships between financial toxicity, social support, and quality of life (QoL). This
study used quantitative methods, described in Chapter 6, to answer the driving question:
How does social support influence cancer-related financial toxicity and patient’s QoL?
Specifically, I was interested in whether or not social support acted as a moderator or
mediator variable in the relationship between financial toxicity and QoL. This chapter
first presents a description of the sample characteristics followed by the results of each
hypotheses for the study aims.
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Sample Characteristics
There were 131 cases downloaded from the Blue survey system. One case was
deleted for missing excessive amounts of data. Four cases were deleted because they did
not meet study criteria for type of cancer. The remaining sample consisted of 126
participants who reported to have had breast cancer (n = 104) or blood cancer (n = 20)
diagnosis and treatment in the past 5 years. The age of participants ranged from 30-83
with a mean of 54.6 (SD 10.30). For those with breast cancer the mean age was 53.8 (SD
9.56) ranging from 32-83 years; those with blood cancer had a mean age of 59.1 (SD
12.81) and ranged from 30-80 years. Most of the participants were female n=117 (94%),
white n=103 (82%), and married or living with a significant other n=67 (53%). See Table
7.1 for a breakdown of each demographic characteristic.
Table 7. 1 Demographics of Participants.
Characteristic
Age
Gender
Female
Male
Missing
Race/Ethnicity
White
Black
Hispanic
American Indian
Missing
Marital Status
Married/Significant Other
Separated/Divorced
Single
Widowed
Missing
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Mean (SD)
54.6 (10.3)
Frequency

Range
30-83
Percent

117
8
1

93.6
6.4
0.8

103
9
6
3
4

81.7
7.1
4.8
2.8
3.2

67
34
13
4
1

53.2
27
10.3
3.8
0.8

Education
Graduate/Professional
Bachelor's
Some College/Technical
School
High School/GED
Missing
Occupation
Professional/Technical
Executive/Management
Clerical/Sales/Service
Agricultural
Craft/Manufacturing
Homemaker
Missing
Household Income
Over $80,000
60,001-80,000
40,001-60,000
25,001-40,000
Less Than $25,000
I don't know
Missing

39
33

31
26.2

36

28.6

16
2

15.1
1.9

62
15
23
2
5
15
4

49.2
11.9
18.3
1.6
4
11.9
3.2

33
19
34
21
13
3
2

26.2
15.1
27.5
19.8
10.3
2.4
1.6

Participants were asked if they experienced a job change due to their cancer
experience (see Table 7.2 to view reported employment status prior to diagnosis and after
treatment). A third of participants n=38 (30%) reported they experienced a change in
status due to their cancer experience. Over half of the participants n=66 (52%) reported
to leave their job temporarily during their cancer treatment or recovery phase. A fourth
n=27 (21%) reported to permanently leave their jobs due to their cancer experience.

130

Table 7. 2 Employment Status at Diagnosis and Current Status.
At Diagnosis
Full-time
Part-time
Retired
Disabled
Unemployed
Homemaker

N
87
11
16
6
1
5

%
69
8.7
12.7
4.8
0.8
4

Current Job Status
Full-time
Part-time
Retired
Disabled
Unemployed
Homemaker

N
56
15
24
17
9
5

%
44.4
11.9
19
13.5
7.1
4.

The majority of participants n=93 (73%) received insurance from an employerbased program prior to their cancer diagnosis. Just over a fourth of participants n=35
(28%) reported a change in their insurance due to their cancer experience. See Table 7.3
for participants’ current insurance status and insurance status when diagnosed.
Table 7. 3 Insurance Status at Diagnosis and Current.
Prior Insurance
Status
Employer Paid
Self-Paid
Veterans
Medicare
Medicaid
No Insurance

N
93
19
1
5
6
2

%
73.8
15.1
0.8
4
4.8
1.6

Current Insurance
Status
Employer Paid
Self-Paid
Veterans
Medicare
Medicaid
No Insurance

N
67
16
2
12
4
4

%
63.3
15.1
1.9
11.3
3.8
3.8

Cancer characteristics. The majority of participants reported to have had breast
cancer (n=106, 84%). Over half of participants n=78 (62%) reported to have received
treatment within the past year and “No Evidence” of cancer (n=67, 53%). (See Table 7.4
for more detailed cancer specific characteristics.)

131

Table 7. 4 Description of Clinical Characteristics.
Characteristic

Blood Cancer
(n=20)
Frequency

Cancer Type
Blood
Breast
Treatment
Surgery
1
Chemotherapy
16
Radiation
4
Stem Cell
7
Immunotherapy
5
Other
4
Time Since Last Treatment
Current – 1
12
year
1 year – 2 years
3
2 year – 3 years
3 year – 4 years
1
4 year – 5 years
2
Current Status
Active
4
Remission
9
No Evidence
7

Breast Cancer
(n=106)
%

Frequency

%

Total
(n = 126)
Frequency

%

20
106

15.9
84.1

5
80
20
35
25
20

101
79
71
1
7
23

95.3
74.5
67
0.9
6.6
21.7

102
95
75
8
12
27

81
75.4
59.5
6.3
9.5
21.4

60

66

62.2

78

61.9

15
5
10

15
9
8
5

14.2
8.5
7.5
4.7

18
9
9
7

14.3
7.1
7.1
5.6

20
45
35

23
23
60

21.7
21.7
56.6

27
32
67

21.4
25.4
53.2

Financial toxicity characteristics. Several One-way Analysis of Variance
(ANOVA) were conducted to determine if certain characteristics were associated with
financial burden and distress (financial toxicity). Financial toxicity and distress were
assessed using the Comprehensive Score for Financial Toxicity (COST). Those who had
undergone chemotherapy, had an active cancer status or were in remission, lower
education, single, minority and had an income below $80,000 were significantly more
likely to experience higher levels of financial toxicity. (See Table 7.5 for means, standard
deviations and significance levels.) Individuals who had a bachelor’s degree or higher,
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had a household income over $80,000, and were married reported lower financial
toxicity. Insurance status was not significantly related to financial toxicity. Individuals
who were unemployed had a lower mean score which tended toward significance. (See
Table 7.5 for means, standard deviations and significance levels.)
Table 7. 5 Level of Financial Toxicity by Demographics.

Variable
Treatment
Chemotherapy
No Chemotherapy
Cancer Status
Active
Remission
No Evidence
Education
Less than Bachelors
Bachelor or Higher
Employment Status
Unemployed
Other
Income
Under 80,000
Over 80,000
Marital Status
Single
Married/Other
Race
White
Other

Mean (SD)

df

F

Sig.

Partial Eta Power

20.01 (8.54) 1, 124 4.08 .046
16.42 (8.74)

0.032

0.518

20.41 (7.35) 2, 123 3.07
21.66 (10.01)
17.40 (8.24)

.05

0.048

0.584

20.21 (8.33) 1, 124 5.26 .041
16.69 (9.08)

0.034

0.535

24.22 (6.22) 1, 124 3.39 .068
18.73 (8.75)

0.027

0.448

20.42 (8.61) 2, 121
16.05 (8.33)

3.6

.03

0.056

0.657

21.09 (8.79) 1, 124
17.74 (8.40)

4.4 .032

0.035

0.575

18.38 (8.80) 1, 123 5.18 .025
22.95 (7.25)

0.04

0.617

Univariate analysis. All scales were calculated and assessed to determine if the
data met assumptions for analyses (see Appendix K for details on database preparation.)
A one-way Analysis of Variance (ANOVA) was conducted to determine if
differences existed between cancer types for all scales. See Table 7.6 for descriptive
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statistics. There were no differences between cancer types (blood or breast) for all scales
except for Received Social Support. Respondents with blood cancer reported more
received social supports than those who had breast cancer.
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Table 7. 6 Descriptive Statistics by Type of Cancer.

Total
Variable
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COST
Emotional Support
Informational Support
Instrumental Support
Composite Support
Received Support
Social Constraint
FACT-G
FACT-G Plus

Mean (SD)
20.5
51.82 (8.46)
52.14 (9.9)
51.04 (9.74)
51.67 (8.29)
45.74 (14.67)
21.75 (16.59)
67.05 (19.75)
111.38 (31.09)

Blood Cancer
Range
0-44
29.9-62
25.6-65.6
29.3-63.3
32.6-63.6
19-80
0-60
15-104
32-168

Mean (SD)
18.4 (11.9)
53.62 (7.61)
54.69 (6.85)
53.53 (11.03)
53.95 (7.34)
52.25 (16.66)
18.55 (19.03)
67.2 (18.66)
113.65 (30.3)

Range
2-44
40.5-62
39.8-65.6
29.3-63.3
41.8-63.6
26-80
0-58
36-102
59-162

Breast Cancer
Mean (SD)
19.26 (8)
51.48 (8.6)
51.67 (10.33)
50.57 (9.46)
51.24 (8.42)
44.52 (45.74)
22.35 (16.11)
67.02 (20.02)
110.95 (31.35)

Range
0-44
29.9-62
25.6-65.6
29.3-63.3
32.6-63.6
19-74
0-60
15-104
32-168

F (1, 124)
p
0.164
.686
1.077
.301
1.576
.212
1.565
.213
1.808
.181
4.811 .030*
0.882
.35
0.001
.097
0.136
.723

COST Comprehensive Score for Financial Toxicity, FACT-G Functional Assessment of Cancer Therapy scale for QoL, FACT-G Plus with Socioeconomic
Well-being scale.
* A one-way Analysis of Variance determined differences between groups p < 0.05.

Bivariate Analysis. Several analyses were conducted to determine which
variables could influence the outcome variable. A series of ANOVA analyses were
conducted to determine if nominal and interval variables had a mean difference in QoL.
Interval variables were transformed into dichotomous variables. See Table 7.7 for
variables that showed a significant difference between groups with the Functional
Assessment of Cancer Therapy scale (FACT-G), and Table 7.8 for Functional
Assessment of Cancer Therapy with Socioeconomic Wellbeing (FACT-G Plus).
Variables that showed a significant difference in mean QoL include: Chemotherapy,
Education, Employment Status, Insurance Status, Marital Status. All analyses for
homogeneity of variance (Levene’s Test) were non-significant. Time since last treatment,
income, and gender were assessed and were not significant.
Table 7. 7 Differences in Quality of Life (FACT-G) by Cancer Treatment and
Demographics.
Variable
Cancer Treatment
Other
Chemotherapy
Education
Less Than Bachelor
Bachelor or Higher
Employment Status
Not Working
Working
Insurance
No
Yes
Marital Status
Single
Married/Other

Mean (SD)

df

74.65(21.28) 1, 124
64.57(18.67)

F

Sig.

6.37 0.013

60.42(21.13) 1, 122 11.88 0.001
72.29(17.167)
62.22(20.01) 1, 124
70.79(19.75)

6.08 0.015

45.5(22.52) 1, 123 5.015 0.027
67.69(19.41)
62.12(20.86) 1, 123 5.772 0.018
70.61(18.38)

p = .05, FACT-G = Functional Assessment of Cancer Therapy scale
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Table 7. 8 Group Differences in Quality of Life Plus SEW (FACT-G Plus).
Variable
Cancer Treatment
Other
Chemotherapy
Education
Less Than Bachelors
Bachelor or Higher
Employment Status
Not Working
Working
Insurance
No
Yes
Marital Status
Single
Married/Other

Mean (SD)

df

122.12(30.70) 1, 124
107.87(30.55)

F

Sig.

5.067 0.026

99.00(31.59) 1, 122 17.364 0.001
121.12(31.05)
104.94(32.04) 1, 124
116.37(29.60)

4.3

0.04

71.00(41.18) 1, 123
112.70(30.14)

7.261 0.008

102.71(31.21) 1, 123
117.46(29.95)

7.072 0.009

p = .05

Further analyses were conducted to determine relationships between scales. In
order for a mediator variable to be present the variables must show correlation. Pearson’s
bivariate correlations were conducted (see Table 7.9 for correlation values and
significance.) Received Social Support was not significantly correlated with the FACT-G,
Comprehensive Score for Financial Toxicity (COST) or social constraint variables. This
violates the assumptions for the mediator analysis.
Pearson’s bivariate correlations were then used to determine the relationship
between age and all the scales used for the moderator and mediator analyses. Age
showed a moderate negative correlation with social constraint r (124) = -.22, p < 0.013.
Age was not correlated with the FACT-G, FACT-G Plus, COST or any of the social
support scales.
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Table 7. 9 Pearson's Bivariate Correlations (r) of Support, Quality of Life and Financial Toxicity Variables.
1
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1. FACT-G
2. FACT-G Plus
3. COST
4. Emotional Support
5.Informational
Support
6. Instrumental
Support
7. Composite Support
8. Received Support
9. Social Constraint

1

2
.944***
1

3
-.591***
-.696***
1

4
.528***
.5548***
-.385***
1

5

6

7

8

9

.510***
.556***
-.430***
.777***

.477***
.506***
-.402***
.622***

.570***
.606***
-.460***
.893***

0.174
.195*
-0.013
.377***

-.629***
-.647***
.524***
-.498***

1

.629***

.909***

.405***

-.534***

1

.854***

.337***

-.390***

1

.421***
1

-.535***
-0.162
1

*p < 0.05, **p < 0.01, ***p < 0.001; COST Comprehensive Score for Financial Toxicity, FACT-G Functional Assessment of Cancer Therapy scale for QoL,
FACT-G Plus Functional Assessment of Cancer Therapy with Socioeconomic Well-being scale.

Aim 1
The first aim of this study was to determine if received and perceived social
support moderates the relationship between cancer-related financial toxicity, and QoL. As
presented in Chapter 6, the equation for multiple regression analysis is:
Ypred=a+b1X1+b2X2+b3X1X2

(1)

The moderator models from Chapter 3 are presented in Figure 7.1. These models
represent social support as a moderator on the relations between financial toxicity and
QoL.

Stress Event
Cost of Cancer

Social Support
Emotional,
Informational,
Instrumental

Financial Burden

Quality of
Life

-Subjective Stress
-Objective Burden

Moderator Pathway

Social Support

Stress Event
Cost of Cancer

Emotional,
Informational,
Instrumental

Social
Constraint
Quality of
Life

Financial Burden
-Subjective Stress
-Objective Burden

Moderated Moderator Pathway
Figure 7. 1 Social Support Moderation Pathways (Hayes, 2018).
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The analyses were conducted using the Introduction to Mediation, Moderation,
and Conditional Process Analysis (PROCESS) macro for SPSS. (See Chapter 6 for
details on the PROCESS macro). Continuous variables included financial toxicity,
perceived social support, received social support and QoL. The variable financial toxicity
was assessed using the Comprehensive Score for Financial Toxicity (COST) scale. To
assess perceived social support, analyses were conducted using each perceived support
separately (emotion, informational, instrumental) and then with a composite variable
made from perceived emotional, informational and instrumental scales. The received
social support variable was created using the Inventory of Socially Supportive Behaviors
(ISSB) short form. The variable QoL was assessed in two ways: 1) four domains of
quality of life using the FACT-G (physical, emotional, social, and functional); 2) the
FACT-G Plus which is composed of the four domains previously stated and the socioeconomic well-being scale. (Details on each scale can be reviewed in Chapter 6).
Hypothesis 1.1: Received social support will moderate the relationship between
COST and QoL (FACT-G).
A simple moderation analysis was conducted in PROCESS using simultaneous
multiple regression analysis to determine if received social support moderated the
relationship between financial toxicity and QoL. Bootstrap (1,000 samples) technique
was used to avoid violations of normal distribution and produce confidence intervals
levels. The total model fit accounted for a significant amount of the variance in QoL, R2
= .38, F (3, 122) = 25.23, p = .001. Variables were centered on zero prior to creating the
interaction variable (interaction between financial toxicity and received social support) to
avoid the risk of multicollinearity which can occur between financial toxicity, received
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social support and the interaction variable. Nevertheless, the interaction variable was not
significant and did not account for variance in quality of life. Received social support did
not moderate the relationship. This finding did not support the hypothesis. (Data tables
reporting non-significant moderator analysis results can be viewed in Appendix Q Table
Q.1).
Analysis by cancer type. Since there was a difference in received social support
between cancer types, additional analyses were conducted on each cancer type. For
individuals with blood cancer, received social support did not moderate the relationship
between financial toxicity and QoL (FACT-G). However, received social support was a
moderator for participants with breast cancer. (The results of that analysis are presented
below.)
Breast Cancer Dataset. To test the hypothesis that received social support will
moderate the relationship between financial toxicity and FACT-G, a simple moderation
analysis was conducted in PROCESS (using simultaneous multiple regression analysis)
using the breast cancer dataset. Received social support, financial toxicity and the
interaction variable (toxicity*support) accounted for a significant amount of the variance
in QoL, R2 = .39, F (3, 102) = 18.18, p = .001. Received social support and financial
toxicity were centered prior to the creation of the interaction term to avoid
multicollinearity which can occur between the received social support, financial toxicity
the interaction variable. The interaction variable accounted for a significant proportion of
variance in quality of life, DR2 = .03, F (1, 102) = 5.65, p = .019. Quality of life increases
as financial toxicity decreased and received social supports increased. This moderation
model explains 39% of the variance in FACT-G; although, the interaction
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(toxicity*support) only accounts for 3% of the variance. Bootstrap technique at 1000
samples provided confidence intervals (CL). (See Table 7.10 and Figure 7.2 for
moderation analysis results.)
Table 7. 10 Received Social Support and Financial Toxicity as Predictors of Quality of
Life (FACT-G).
Variable
b
Predictor Variables
Constant
67.08**
Financial
Toxicity
-1.41**
(centered)
Received
Support
0.32*
(centered)
Interaction
Financial
Toxicity x
0.03*
Received
Support

SE

95% CL

1.51

[64.09, 70.09]

0.22

[-1.83, -0.98]

0.10

[0.11, 0.53]

F (df)
18.18 (3, 102)

5.65 (1, 102)
0.01

R2
.38

D R2

.03

[0.01, 0.06]

*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment
of Cancer Therapy scale .

Figure 7. 2 Moderation of Financial Toxicity and QoL (FACT-G).
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In this model, receive social support was significant at low, medium and high
levels of social support (see Table 7.11 for conditional effects). The Johnson- Neyman
technique was conducted to further probe the analysis using the parameters of one
standard deviation above and below the mean of received support. When social support
scores are equal to or below 69.28 units on the received support scale, financial toxicity
and QoL are significantly related t (102) = -1.98, p = .05, b = -.58. As financial toxicity
increases and received social support decreases, QoL also decreases.
Table 7. 11 Conditional Effects of Financial Toxicity at Levels of the Moderator.
Received Support b
Low
Average
High

SE

t

p

LLCI - ULCI

-1.88 0.36 -5.17 0.001 [-2.60, -1.16]
-1.41 0.22 -6.55 0.001 [-1.84, -.98]
-0.94 0.2 -4.8 0.001 [-1.33, -.55]

CL= confidence intervals at 95%. FACT-G = Functional Assessment of Cancer Therapy scale.

Moderation analysis with control variables. A second moderation analysis was
conducted adding control variables to the model. A simple moderation analysis was
conducted in PROCESS (using simultaneous multiple regression analyses) to determine
if received social supports moderated the relationship between financial toxicity and
FACT-G controlling for cancer treatment, education, employment, and marital status.
Dummy variables were created for all nominal variables. The total model fit accounted
for a significant amount of the variance in FACT-G, R2 = .49, F = (8, 96) = 17.16, p =
.001. All continuous scales were centered prior to analysis to avoid multicollinearity
which can occur between received social support, financial toxicity and the interaction
variable. The interaction variable accounted for a significant amount of the variance in
FACT-G with the addition of the control variables DR2 = .03, F = (1, 96) = 8.10, p = .005.
Received social support continues to moderate the relationship between financial toxicity
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and quality of life after taking into consideration the potential effects of the control
variables. As shown in Table 7.12 the entire model was significant, accounting for 49%
of the variance in FACT-G; although, the interaction (toxicity*support) only accounted
for 3% of the variance. A visual glance of the interaction is provided in Figure 7.3.
Table 7. 12 Predictors of Quality of Life (FACT-G) with Control Variables.
Variable
b
Predictor Variables
Constant
37.06***
Financial
Toxicity
-1.18***
(centered)
Received
Support
0.24**
(centered)
Interaction
Financial
Toxicity x
0.04**
Received
Support
Control Variables
Education
6.72*
Employment
8.43**
Insurance
14.43*
Marital Status
6.23*
Treatment
5.22

SE

95% CL

6.92

[23.32, 50.80]

0.20

[-1.58, -.78]

0.09

[0.06, 0.43]

F (df)
17.16*** (8, 96)

8.10** (1, 96)
0.01

[.01, 0.06]

3.14
3.2
7.2
3.07
3.5

[.4867, 12.96]
[2.07, 14.78]
[.14, 28.71]
[.14, 12.32]
[-1.71, 12.15]

R2
.49

D R2

.03

*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment
of Cancer Therapy scale.
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Figure 7. 3 Moderation of Financial Toxicity and Quality of Life (FACT-G) in presence
of control variables.
As displayed in Table 7.13, the conditional effects of financial toxicity decrease,
as received supports increases. The moderation interaction was further probed using a
Johnson-Neyman technique. When social support scores are equal to or below 64.5 units
on the received support scale, financial toxicity and QoL are significantly related, t (96) =
-1.98, p = .05, b = -.44. As Financial toxicity increases and received social support
decreases, QoL also decreases.
Table 7. 13 Conditional Effects of Financial Toxicity at Levels of the Moderator with
Control Variables.
Received Support b
Low
Average
High

SE

t

p

LLCI - ULCI

-1.70 0.34 -4.98 0.001 [-2.38, -1.02]
-1.18 0.20 -5.81 0.001 [-1.58, -.78]
-0.66 0.10 -3.64 0.001 [-1.02, -.30]

CL= confidence intervals at 95%. FACT-G = Functional Assessment of Cancer Therapy scale.
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Three-way moderation analysis. A final analysis was conducted to determine if
social constraint would have a moderation effect on the moderation between financial
toxicity and received support. Social constraint is a continuous variable and was added to
the model using a 3-way moderation or moderated moderation model (Hayes, 2018).
View the model of a 3-way moderation in Figure 7. 1(b).
A 3-way moderation analysis in PROCESS (using simultaneous multiple
regression analysis) was conducted to determine if received social support was associated
with the relationship between financial toxicity and FACT-G taking into consideration
social constraints. The total model fit accounted for a significant amount of variance in
QoL, F (7, 98) = 22.01, p = .001, R2 = .56. The interaction term between received social
supports, financial toxicity, and social constraint was significant and accounted for
variation in QoL, F (1, 98) = 10.03, p = 0.02, DR2 = .04. This means that there is evidence
of a three-way interaction between social supports, financial toxicity, and social
constraint. The magnitude of the moderation of financial toxicity by social support is
dependent on the effects of social constraint, though the moderation of the moderator
(Received Support) explains only 4% of the variance in QoL. (See Table 7.14 and Figure
7.4 for analysis details.)
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Table 7. 14 Financial Toxicity, Received Social Support, and Social Constraint as
Predictors of Quality of Life (FACT-G).
Variable
b
Predictor Variables
Constant
65.38***
Financial
Toxicity
-.89***
(centered)
Received
Support
0.40***
(centered)
Social
-0.58***
Constraint
Interaction
Financial
Toxicity x
Received
-0.003*
Support x
Social
Constraint

SE

95% CL

1.61

[62.18, 68.58]

0.20

[-1.28, -0.49]

0.10

[0.19, 0.60]

0.11

[-.79, -.37]

F (df)
22.01*** (7. 98)

10.03 (1, 98)

0.00

R2
.56

D R2

.04

[-0.005, -0.001]

*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment
of Cancer Therapy scale.

Figure 7. 4 Three-way moderation predicts Quality of Life (FACT-G).
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The conditional effects of financial toxicity decrease as received supports
increase; however, the effects with social constraint vary (see Table 7.15 For details). The
Johnson-Neyman technique was used to further probe the conditional toxicity*support
interaction according to the values of social constraint. When social constraint scores are
low (equal to or below 13.63) and high (equal to or above 46) units on the social
constraint scale, financial toxicity and received social support are significantly related,
low t (99) = 1.98, p = .05, b = .025 and high t (99) = -1.95, p = .05, b = -.065. As
financial toxicity increases and received social support decreases, social constraint
increases. These analyses support the hypothesis stating that received support moderates
the relationship between financial toxicity and quality of life. This moderation remained
true when control variables and social constraint were added to the model.
Table 7. 15 Three-way Moderation Conditional Effects of Financial Toxicity.

Received Support

Social
Constraint

Low
Low
Low
Average
Average
Average
High
High
High

Low
Average
High
Low
Average
High
Low
Average
High

b

SE

t

p

LLCI - ULCI

-1.77
-0.89
-0.01
-1.13
-0.89
-0.67
-0.48
-0.89
-1.3

0.35
0.35
0.56
0.21
0.2
0.33
0.19
0.24
0.45

-5.1
-2.52
-0.02
-5.3
-4.47
-2.02
-2.57
-3.73
-2.89

0.001
0.01
0.99
0.001
0.001
0.05
0.01
0.001
0.005

[-2.46, -1.08]
[-1.59, -.19]
[-1.12, 1.1]
[-1.55, -.71]
[-1.29, -.50]
[-1.30, -.01]
[-.85, -.11]
[-1.37, -.42]
[-2.20, -.41]

CL= confidence intervals at 95%. FACT-G = Functional Assessment of Cancer Therapy scale.

Hypothesis 1.2: Perceived social support will moderate the relationship between
financial toxicity and QoL (FACT-G).
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To determine if perceived social support moderates the relationship between
financial toxicity and QoL, a simple moderation analysis was conducted in PROCESS
(using simultaneous multiple regression analysis). The analysis was run individually with
each variable of perceived social support (emotional, informational, instrumental, and
composite perceived social support). Each variable of perceived social support and
financial toxicity accounted for a significant amount of the variance in QoL. The
interaction variable did not account for any variance in the perceived emotional,
informational or composite (emotional, informational, and instrumental) support models.
However, in the instrumental support model, the interaction variable reported
significance. The confidence levels crossed zero which is in violation of accepted
parameters; therefore, there is no significant interaction effect. The hypothesis that
perceived support moderates the relationship between financial toxicity and QoL was not
supported in this sample. (See Appendix Q Tables Q.2 -Q.5 for non-significant moderator
analysis results.)
Hypothesis 1.3: Received social support will moderate the relationship between
financial burden and QoL (FACT-G Plus).
To test this hypothesis a simple moderation analysis in PROCESS (using
simultaneous multiple regression). The total model accounted for a significant amount of
the variance in FACT-G Plus, F (3, 122) = 42.11, p = .001, R2 = .53. Although, the
interaction variable did not significantly account for the variance in FACT-G Plus.
Received social support did not moderate the relationship. See Appendix Q Table Q.6
for non-significant moderator analysis results for hypothesis 1.3.
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Analysis by cancer type. Due to the difference in received support by cancer type,
these same variables were then run by each type of cancer. For participants with blood
cancer, received support did not moderate the relationship between financial toxicity and
quality of life. On the other hand, received support did moderate the relationship for
participants with breast cancer.
Breast cancer dataset. To test the hypothesis that received social support will
moderate the relationship between financial toxicity and QoL (FACT-G Plus) a simple
moderation analysis in PROCESS (simultaneous multiple regression analysis) was
conducted. The total model accounted for a significant amount of the variance in QoL, R2
= .52, F (3, 102) = 26.84, p = .001. Scales were centered prior to the creation of the
interaction term to avoid multicollinearity. Next, the interaction term was added to the
model and accounted for a significant proportion of variance in quality of life, DR2 = .03,
F (1, 102) = 7.09, p = .009. Financial toxicity decreased as received social supports and
quality of life increased. This moderation model explains 52% of the variance in QoL
with 3% of that amount explained by the interaction (toxicity*support). Bootstrap
technique at 1000 samples provided confidence intervals (CL). (Table 7.16 and Figure
7.5 display analysis results.)
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Table 7. 16 Predictors of Quality of Life (FACT-G Plus).
Variable
Predictor Variables
Constant
Financial
Toxicity
(centered)
Received
Support
(centered)
Interaction
Financial
Toxicity x
Received
Support

b

SE

95% CL

F (df)

R2

D
R2

26.85** (2, 102) .52
111.06** 2.09 [106.02, 115.20]
-2.67**

0.31

[-3.29, -2.04]

0.46**

0.14

[0.18, 0.73]
7.09* (1, 102)

0.06*

0.02

.03

[.01, 0.10]

*p < .01, **p < .001, CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of
Cancer Therapy scale plus Socio-economic Well-being scale.

Figure 7. 5 Moderates of Financial Toxicity and QoL (FACT-G Plus).
In this model received social support was significant at low, medium and high
levels of social support. (See Table 7.17.) Then the Johnson- Neyman technique was
conducted to further probe the analysis using the parameters of one standard deviation
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above and below the mean of received support. When social support scores are equal to
or below 73.09 units on the received support scale, financial toxicity and QoL are
significantly related t (102) = -1.98, p = .05, b = -1.07. As financial toxicity increases and
received social support decreases, QoL also decreases.
Table 7. 17 Conditional Effects of Financial Toxicity at Levels of the Moderator.
Received Support b
Low
Average
High

SE

t

p

LLCI - ULCI

-3.44 0.52 -6.69 0.001 [-4.46, -2.43]
-2.66 0.31 -8.48 0.001 [-3.29, -2.04]
-1.88 0.32 -5.83 0.001 [-2.52, -1.24]

CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of Cancer Therapy scale plus
Socio-economic Well-being scale.

Moderation analysis with control variables. A second analysis was conducted to
test for moderation analysis controlling for the effects of cancer treatment, education,
employment, insurance status, and marital status. A simple moderation analysis in
PROCESS (using simultaneous multiple regression analysis) was conducted to determine
if received social supports moderated the relationship between financial toxicity and
QoL. The total model accounted for a significant amount of the variance in QoL, R2 =
.63, F (8, 96) = 25.04, p = .001. All continuous predictor variables were centered prior to
analysis to avoid multicollinearity. In the analysis, the interaction term accounted for a
significant amount of the variance in QoL even in the presence of the addition of the
control variables, DR2 = .04, F (1, 96) = 12.38, p = .0007. Received social support
continues to moderate the relationship between financial toxicity and QoL. This
moderation model accounts for 61% of the variance in QoL with the interaction variable
(toxicity*support) accounting for 4% of the variance. (Table 7.18 and Figure 7.6 provide
details of this analysis.)
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Table 7. 18 Predictors of Quality of Life (FACT-G Plus) with Control Variables.
Variable
b
Predictor Variables
Constant
63.9***
Financial
Toxicity
-2.4***
(centered)
Received
Support
0.27*
(centered)
Interaction
Financial
Toxicity x
0.07**
Received
Support
Control Variables
Education
13.02**
Employment
Insurance
Marital Status

Treatment

SE

95% CL

12.66

[38.77, 89.03]

0.29

[-2.96, -1.83]

0.12

[0.04, 0.51]

F (df)
25.04*** (8, 96)

R2
.63

12.38** (1, 96)
0.02

[.03, 0.10]

4.16

[4.77, 21.28]

5.41

5.24

[-4.99, 15.80]

30.57*
8.93*
3.00

13.4
41.2
4.32

[3.96, 57.18]
[.74, 17.12]
[-5.58, 11.57]

*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G Plus = Functional
Assessment of Cancer Therapy scale plus Socio-economic Well-being scale.

Figure 7. 6 Moderates of Financial Toxicity and QoL (FACT-G Plus) with Control
Variables.
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D R2

.007

Received social support was significant at low, medium and high levels of social
support. (See Table 7.19.) In order to probe the analysis for an understanding of what was
going on in the analysis, the Johnson- Neyman technique was conducted (using
parameters of one standard deviation above and below the mean of received support). For
social support scores that are equal to or below 68.78 units on the received support scale,
financial toxicity and QoL are significantly related t (96) = -1.99, p = .05, b = -.80. As
financial toxicity increases and received social support decreases; QoL also decreases.
Table 7. 19Conditional Effects of Financial Toxicity at Levels of the Moderator with
Control Variables.

Received Support b
Low
Average
High

SE

t

p

LLCI - ULCI

-3.32 0.52 -7.04 0.001 [-4.26, -2.39]
-2.40 0.31 -8.41 0.001 [-2.96, -1.83]
-1.47 0.32 -5.26 0.001 [-2.03, -.92]

CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of Cancer Therapy scale plus
Socio-economic Well-being scale.

Three-way moderation analysis. In the final step, social constraint was added
using a three-way moderation or moderated moderation model (Hayes, 2018). A
moderated moderation analysis in PROCESS (simultaneous multiple regression analysis)
was conducted to determine if received social support impacted the relationship between
financial toxicity and QoL taking into consideration social constraints. This model
accounted for a significant amount of variance in QoL, R2 = .80, F (7, 98) = 26.88, p =
.001. The interaction term between received social supports, financial toxicity, and social
constraint was significant, DR2 = .02, F (1, 98) = 4.82, p = .03). This suggests that the
three-way interaction between social supports, financial toxicity, and social constraint
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significantly explains 2% of the variance. (See Table 7.20 and Figure 7.7 for outcomes
of analysis.)
Table 7. 20 Three-way Moderation of Quality of Life (FACT-G).
Variable
b
Predictor Variables
Constant
109.20***
Financial
Toxicity
-1.94***
(centered)
Received
Support
0.52***
(centered)
Social
-0.72***
Constraint
Interaction
Financial
Toxicity x
Received
-0.003*
Support x
Social
Constraint

SE

95% CL

2.28

[104.68, 113.71]

0.32

[-2.58, -1.31]

0.14

[0.24, 0.81]

0.16

[-1.04, -.41]

F (df)
26.89*** (7. 98)

4.82* (1, 98)

0.00

R2
.80

D R2

.02

[-0.006, -0.003]

*p < .05, **p < .01, ***p < .001, CL= confidence intervals at 95%. FACT-G = Functional Assessment
of Cancer Therapy scale.
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Figure 7. 7 Three-way Moderation of QoL (FACT-G Plus).
The conditional effects of financial toxicity decrease as received supports
increase; however, the effects with social constraint vary (see Table 7.21 for details). The
Johnson-Neyman technique was used to further probe the conditional toxicity*support
interaction according to the values of social constraint. When social constraint scores are
low (equal to or below 12.01) financial toxicity and received social support are
significantly related, low t (98) = 1.98, p = .05, b = .04 and high t (99) = -1.95, p = .05, b
= -.065. As financial toxicity increases and received social support decreases, social
constraint increases.
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Table 7. 21 Three-way Moderation Conditional Effects of Financial Toxicity.

Received Support

Social
Constraint

Low
Low
Low
Average
Average
Average
High
High
High

Low
Average
High
Low
Average
High
Low
Average
High

b

SE

t

p

-3.09
-2.04
-0.99
-2.28
-1.94
-1.61
-1.85
-2.23
-2.23

0.52
0.55
0.89
0.32
0.32
0.49
0.44
0.74
0.74

-5.98
-3.71
-1.12
-7.08
-6.06
-3.28
-4.20
-3.01
-3.01

0.001
0.001
0.27
0.001
0.001
0.001
0.001
0.003
0.003

LLCI - ULCI
[-4.11, -2.06]
[-3.13, -.95]
[-2.75, 0.77]
[-2.92, -1.64]
[-2.58, -1.31]
[-2.58, -0.64]
[-2.08, -0.85]
[-2,73, -0.98]
[-3.70, -0.76]

CL= confidence intervals at 95%. FACT-G Plus = Functional Assessment of Cancer Therapy scale with
Socio-economic Well-being Scale.

Hypothesis 1.4: Perceived social support will moderate the relationship between
financial burden and QoL (FACT-G Plus).
Hierarchical multiple regression analyses were conducted using PROCESS macro
for SPSS to determine if perceived social support moderates the relationship between
financial toxicity and FACT-G Plus. Variables were added to the model in a stepwise
approach. Individual analyses were conducted with each variable of perceived social
support (emotional, informational, instrumental, and composite perceived support –
emotional, informational and instrumental combined). A significant amount of the
variance in FACT-G Plus was accounted for by perceived social support (each variation)
and financial toxicity directly; however, the interaction variable for perceived emotional,
informational and composite social support models did not account for any variance in
FACT-G Plus. See Appendix Tables Q.7 – Q. 9 for reported moderator analysis for each
variable of perceived social support and financial toxicity. The instrumental support
model showed a significant interaction effect, but the confidence intervals contained zero
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(CL-0.101, 0.003). This indicates non-significant interaction effect can be assumed.
Perceived social support did not moderate the relationship between financial toxicity and
FACT-G Plus. (See Appendix Tables Q.10 for perceived instrumental support and
financial toxicity interaction results.)
Specific Aim 2
Aim 2 sought to determine if received and perceived social support mediates the
relationship between financial toxicity and QoL. As previously stated, QoL is assessed
using two versions of the FACT-G scale: 1) the FACT-G and 2) FACT-G Plus (with
socio-economic well-being). Perceived social support was analyzed using the composite
(emotion, informational, and instrumental) variable. In order to test for a mediator
variable, a simple mediation model using ordinary least squares (OLS) regression-based
path analysis was conducted using the PROCESS tool in SPSS. This model uses the
statistical equation for a simple mediation model (Hayes, 2017):
M = iM + aX + eM

(2)

Y = iY + c’X + bM +eY
The mediations models informing these analyses can be viewed in Figure 7.8.
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Social Support

Stress Event
Cost of Cancer

Emotional,
Informational,
Instrumental

Quality of Life
Financial
Well-being

Financial Toxicity
-Subjective Stress
-Objective Burden

Mediator Pathway

Stress Event
Cost of Cancer

Social Support
Emotional,
Informational,
Instrumental

Financial Burden

Social
Constraint

Quality of Life
Financial
Well-being

-Subjective Stress
-Objective Burden

Moderated Mediator Pathway

Figure 7. 8 Social Support in Mediation Pathways

Hypothesis 2.1: Received social support mediates between financial toxicity and
QoL (FACT-G).
The data did not meet assumptions for mediation analyses. Received social
support was not correlated with the FACT-G, COST, or social constraint (see Table 7.8
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for correlation values.) The mediation analyses were not conducted. The hypothesis was
not supported.
Hypothesis 2.2: Perceived social support mediates between financial toxicity and
QoL (FACT-G).
To test whether perceived social support mediates between financial toxicity and
QoL (FACT-G) the PROCESS macro for SPSS was used. The PROCESS macro is a path
analysis-based tool using ordinary least squares linear regression analyses to determine a
mediator effect. Financial toxicity significantly predicted FACT-G when the mediator
variable is not in the model, b = -1.342, t (124) = -31.20, F (1, 124) = 72.29, p = .001, R2
= .35. The R2 value indicated that 35% of the variance in FACT-G can be explained by
financial toxicity. Beta (b) value is negative which means that the higher financial
toxicity the lower FACT-G. Next, financial toxicity significantly predicted perceived
social support, b = -0.44, t (124) = -5.85, F (1, 124) = 34.16, p = .001, R2 = .21 (see
Figure 7.8 for Path a). As financial burden increases perceived social support decreases.
The R2 value for Path a indicates that financial burden explains 21% of the variance in
the composite perceived social support variable. Then the outcome of FACT-G was
predicted by financial toxicity and perceived social support. Perceived social support
significantly predicts QoL in the model, b = 0.90, t (124) = 3.5, p = .001 (Path b);
financial burden also significantly predicts QoL, b = -0.95, t (124) = -5.69, p = .001 (Path
c). The total effect model is significant, F (2, 123) = 48.33, p = .001, R2 = .46 (Path c’).
The R2 value indicates the model accounts for 46% of the variance in FACT-G. The final
step indicates there is a significant indirect effect of financial toxicity on FACT-G
through perceived social support, b = -0.39. The true b-value for the indirect effect falls
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between the confidence intervals [-0.64, -0.20] which does not cross zero indicating
likelihood of significance indirect effect at a 95% confidence interval. (See Table 7.22 for
correlations among variables and Figure 7.9 for model with analysis results).
Table 7. 22 Correlations Among Mediation Variables.
Variables

1

2

3

1. Financial Toxicity

1

-0.5*

-0.55*

1

0.6*

2. Perceived Support
3. Quality of Life (FACT-G)
*p < .01

1

Financial
Toxicity

QoL
Path c
(Direct effect, b = -0.95, p =
.001

Path a
(b = -0.44, p =
.001)

Social Support
-Perceived

Financial
Toxicity

Path b
(b = 0.90, p = .001)

QoL
Path c’
Indirect effect, b = -0.39, 95% CI [-0.64, 0.20]

Figure 7. 9 Perceived Social Support Mediates Financial Burden as a Predictor of Quality
of Life (QoL).
Further analysis was conducted to determine if perceived social support mediates
between financial burden and QoL controlling for cancer treatment, education,
employment, and marital status. (Insurance status was removed due to creating an error in
the analysis.) There was a significant indirect effect of financial burden on QoL through
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perceived social support, b = -0.54 CI [-0.81, -0.31]. This model indicates a likely
indirect effect of financial burden through perceived social support at a 95% confidence
interval. (See Table 7.23 for summary of analysis results.)
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Table 7. 23 Summarized Mediation Regression Analysis for Financial Toxicity, Perceived Social Support and Quality of Life.
Path

Path a

Variable

b

t

Control Variables
Education
Employment
Marital Status
Treatment

5.73
7.29
5.53
6.35

2.82
4.55
3.01
1.71

COST -> Support

-0.41

-4.80
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Path b
Support -> QoL
COST -> QoL

0.92
-0.76

0.17
-4.35

Path c

COST -> QoL

-1.13

-7.06

Total Model

Direct Effect
Indirect Effect

-0.76
-0.54

-4.33

R2

F

df

p
.04*
.11
.068
.89

LLCL, ULCL
[0.14, 11.32]
[-1.72, 16.31]
[-0.43, 11.50]
[-0.99, 13.69]

.27

11.23

5, 120

.01**

[-0.57, -0.24]

.52

21.87

6, 119

.001**
.001*
.001*

[0.58, 1.26]
[-1.11, -0.41]

.001*

[-1.45, -0.82]

.001*

[-1.26, -0.42]
[-0.81, -0.31]

.41

17.58

5. 120

*p < 0.05 COST Comprehensive Score for Financial Toxicity, QOL Quality of Life FACT-G Scale. Bootstrap sample size = 5000

Social constraint may have an impact on social support and quality of life. A final
analysis was conducted to determine if social constraint impacted the relationship
between financial toxicity, social support and quality of life. To determine if social
constraint had an effect on the mediation model, a moderated mediator analysis (Hayes,
2018) was conducted (see Figure 7.8 b). In this model, social constraint is thought to
moderate between social support and quality of life. Social constraint did not moderate
the mediation [b = -0.01, CI [-.03, .01]; therefore, did not have an effect on the
relationship between financial toxicity, social support and quality of life. (See Table 7.24
for analysis findings.) The hypothesis stating that perceived support mediates the
relationship of financial toxicity and QoL was supported by these analyses and findings.
Table 7. 24 Perceived Support Mediation on Financial Toxicity and Quality of Life
without Moderation of Social Constraint.
Path Variable

b

SE

t

CL

Path a
a

Financial
Toxicity
Constant
Path b & c'

-0.44*

0.08

-5.85

[-0.59, -0.29]

8.38*

1.38

6.06

[5.64, 11.12]

b

0.62*

0.161 3.84

-0.61*

0.17

-0.46*
-0.01
77.92
*

0.09
0.01
3.56

c'
z

Perceived
Support
Financial
Toxicity
Social Constraint
Interaction 1
Constant

Path c
c
Financial
Toxicity

R2

F

0.21 34.16
*

1, 124

0.54 39.18
*

4, 121

[0.30, .94]

-3.6

[-.95, 0.28]
-4.88 [-.64, -.27]
-1.14 [-.03, .01]
0.01 1.3
21.87 [70.87, 84.97]
0.41 17.58

-0.61*

0.17

df

-3.6

1, 121

5. 120

[-9.5, 0.28]

*p < 0.001 QOL Quality of Life FACT-G Scale. Interaction 1 = Perceived Support *Social Constraint
does not Moderate the Relationship.
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Hypothesis 2.3: Received social support mediates between financial toxicity and
QoL with socio-economic well-being (FACT-G Plus).
The data did not meet the assumptions for mediator analyses. Received social
support was not correlated with financial toxicity or social constraint. The mediation
analysis was not conducted. Hypothesis 2.3 was not supported.
Hypothesis 2.4: Perceived social support mediates between financial toxicity and
QoL (FACT-G Plus).
Financial toxicity significantly predicted FACT-G Plus when the mediator
variable was not in the model, b = -2.49, t (124) = -10.47, F (1, 124) = 109.64, p = .001,
R2 = .49. The R2 value indicated that 49% of the variance in FACT-G Plus can be
explained by financial toxicity. The relationship is negative so as financial toxicity
increases, quality of life decreases. Next, financial toxicity significantly predicted
perceived social support, b = -0.43, t (124) = -5.85, F (1, 124) = 34.16, p = .001, R2 = .21
(path a); as financial toxicity increased, perceived social support decreased. Financial
toxicity accounted for 21% of the variance in social support. Then FACT-G Plus was
predicted by financial toxicity and perceived social support. This was a significant effect,
F (2, 123) = 78.73, p = .001, R2 = .59. Social support significantly predicted FACT-G
Plus, b = 1.36, t (123) = 5.47, p = .001 (path b); financial toxicity also significantly
predicted FACT-G Plus, b = -1.90, t (123) = -7.70, p = .001 (path c). This model accounts
for 59% of the variance in FACT-G Plus. Lastly, there is a significant indirect effect of
financial toxicity on FACT-G Plus through perceived social support, b = -0.60, CL [0.98, -0.32] (path c’). The confidence intervals do not cross zero indicating a likely
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significance indirect effect at a 95% confidence interval. (See Figure 7.10 for model
depiction.)
Financial
Toxicity

QoL
Path c
(Direct effect, b = -1.90, p =
.001

Path a
(b = -0.43, p = .001)

Social Support
-Perceived

Financial
Toxicity

Path b
(b = 1.36, p = .001)

QoL
Path c’
Indirect effect, b = -0.60 95% CI [-0.98, 0.32]

Figure 7. 10 Mediation of financial toxicity when quality of life (QoL) is assessed by
Functional Assessment of Cancer Therapy plus Socioeconomic Wellbeing.

Similar to Hypothesis 2.2, further analysis was conducted controlling for cancer
treatment, education, employment, and marital status. As stated before, insurance status
was removed due to creating an error in the analysis. Similar to the first analysis, this
model continued to show a likelihood of a significant indirect effect of financial toxicity
on FACT-G Plus through perceived social support. See Table 7.25 for a summary of
analysis results.
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Table 7. 25 Mediation by Perceived Social Support with Control Variables.
Path

Path a

Variable

b

t

Control Variables
Education
Employment
Marital Status
Treatment

14.28
10.13
3.02
3.88

4.23
1.71
0.85
3.7

COST -> Support

-0.41

-4.80
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Path b
Support -> QoL
COST -> QoL

1.41
-1.61

6.06
-6.5

Path c

COST -> QoL

-2.19

-9.34

Total Model

Direct Effect
Indirect Effect

-1.61
-0.57

-6.5

R2

F

df

p

LLCL, ULCL

.001*

[0.7.69, 20.97]
[-1.61, 21.88]
[-4.05, 10.10]
[-3.44, 11.21]

.09
.39
.29
.27

11.23

5, 120 .001*

[-0.57, -0.24]

.65

42.14

6, 119 .001*
.001*
.001*

[0.95, 1.87]
[-2.10, -1.12]

5, 120 .001*

[-2.65, -1.72]

.001*

[-2.10, -1.12]
[-0.94, -0.30]

.54

30.96

*p < 0.001 COST Comprehensive Score for Financial Toxicity, QOL= Quality of Life assessed by Functional Assessment of Cancer Therapy plus SocioEconomic Well-being Scale (FACT-G Plus). Bootstrap sample size = 1000.

A third analysis was conducted to see if social constraint impacted the
relationship between financial toxicity, social support and quality of life. Social
constraint was added to the mediator model as a moderator on the relationship between
perceived social support and quality of life. As shown in Table 7.26 social constraint did
not moderate the mediation [b = .03, CI [-.03, .02]. Hypothesis 2.4 is supported, and
perceived support mediates the relationship with financial toxicity and QoL.
Table 7. 26 Mediation without Moderation of Social Constraint
Path Variable
Path a
a
Financial
Toxicity
Constant
Path b & c'
b
Perceived
Support
c'
Financial
Toxicity
z
Social
Constraint
Interaction 1
Constant
Path c
c
Financial
Toxicity

b

SE

t

CL

R2

F

df

0.21 34.16* 1, 124
-0.44*

0.08

-5.85

[-0.59, -0.29]

8.38*

1.38

6.06

[5.64, 11.12]
0.64 54.25* 4, 121

0.97*

4.33

[0.52, 1.41]

-1.52*

0.22
3
0.23

-6.50

[-1.99, -1.06]

-0.54*

0.13

-4.05

[-.81, -.28]

-0.00
140.39
*

0.02
4.87

-.16
28.8
5

[-.03, .02]
0.00 .03
[130.76, 150.02]

-1.52*

0.23

-6.50

[-1.99, -1.06]

1, 121

*p < 0.001 QOL Quality of Life = Functional Assessment of Cancer Therapy plus Socioeconomic
Wellbeing (FACT-G Plus) scale. Interaction 1 = Perceived Support *Social Constraint does not Moderate
the Relationship between support and quality of life.

Summary of analyses. Several analyses were conducted to determine if social
support moderated or mediate the relationship between financial toxicity and quality of
life. Received support moderated and perceived support mediated the relationship
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between financial toxicity and quality of life. See Table 7.27 for the summary of
analyses.
Table 7. 27 Analyses Outcome by Hypothesis.
Hypothesis
1.1 Received social support will moderate
the relationship between financial
toxicity and QoL.

Analysis Outcome
Supported

1.2 Perceived social support will moderate
the relationship between financial
toxicity and QoL.

Not Supported

1.3 Received social support will moderate
the relationship between financial
toxicity and QoL including Plus SEW.

Supported

1.4 Perceived social support will moderate
the relationship between financial
toxicity and QoL Plus SEW.

Not Supported

2.1 Received social support mediates
between financial toxicity and QoL.

Not Supported

2.2 Perceived social support mediates
between financial toxicity and QoL.

Supported

2.3 Received social support mediates
between financial toxicity and QoL
Plus SEW

Not Supported

2.4 Perceived social support mediates
between financial toxicity and QoL
Plus SEW.

Supported

Summary
The purpose for the present study was to examine the experience of financial
toxicity (objective burden and subjective distress) with blood cancer and breast cancer
survivors. Specifically, I sought to examine the relations among financial toxicity, social
support and quality of life. Social support was conceptualized as perceived (emotional,
informational, and instrumental) social support and received (informational and
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instrumental) social support. Previous research has demonstrated that social supports can
have a positive impact on the cancer experience (see Chapter 2 literature review). The
current study extends this research by examining the role (moderator and mediator) of
social supports in the context of financial toxicity. These analyses indicate that both
received and perceived social supports play a significant role in the relationship between
financial toxicity and quality of life. However, these roles were very different.
Received social support for the total sample (blood and breast cancers) only had a
direct correlation with quality of life (FACT-G and FACT-G Plus). It did not have a
moderator or mediator effect on the relationship between financial toxicity and quality of
life. However, when the analyses were conducted on just the breast cancer respondents,
received social support moderated the relationship between financial toxicity and quality
of life.
In contrast, perceived social support was significantly related to quality of life and
financial toxicity in the expected directions, and functioned as a mediator of the
relationship between financial toxicity and quality of life. Indirectly, financial toxicity
still had a negative effect through perceived social support; however, as expected, this
effect was must smaller. These results show that having a perception of available support
may ease the negative impact of financial toxicity.
This chapter presented the results for study 2 which examined social support as
either a moderator or mediator variable. The next chapter, 8, includes a final discussion
and concluding thoughts on the findings from this multiple method design project as well
as present implications for practice and future ideas for research.
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CHAPTER 8: DISCUSSION & CONCLUSIONS

“It hit me like a train and I’m barely recovering. I lost insurance coverage several
months ago right when new lymph nodes became suspicious. They have since grown and
become so painful. The same side the previous cancer was. I know I need to get help and
get checked out, but the very thought of this financial burden has left me in a solitary
confinement of madness in my head and just being okay with letting cancer get me (if it
is) than put my family through the financial burden again. Absolute hopelessness.”
-Study 2 #37 (32-year-old female, Breast Cancer)
“I was forced out of my job, after many years with good reviews, during my cancer
treatment. I had no income for almost a year. Used savings up, maxed out credit cards,
took loan against life insurance, withdrew money from retirement savings. Was
DESPERATE and destitute. All recommended sources of help turned me down. Filed for
disability retirement – finally approved. Have not recovered financially, socially,
emotionally. Many “friends” dropped me after the cancer diagnosis…Need help with
housework but don’t know how to get this help with limited money. Still drive 1990
Toyota car, hope it holds up. Refinanced mortgage to lower interest rate. That helped. If
my cancer recurs, based on my initial experience: I would likely not seek treatment; can’t
afford it.”
- Study 2 #41 (62-year-old female, Breast Cancer)
There are no easy fixes to addressing cancer-related financial toxicity (objective
burden and subjective distress), and to date there are no evidence-based practices to help
patients resolve this problem. As is evident, financial toxicity is a complex issue that can
leave patients financially and emotionally devastated. The purpose of this project was to
gain a different perspective on cancer-related financial toxicity than what is already
identified in the current literature. Specifically, I examined the role of social support
within this context, determining if social support is associated with the relationships
between financial toxicity and quality of life (QoL) as well as determining what types of
supports were available, used or needed.
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Using a multiple methods approach, two studies were conducted to answer the
overarching question: What role does social support play in the experience of cancerrelated financial toxicity? The first study used qualitative data (see Chapter 4 methods
and Chapter 5 results), and the second study used quantitative data (see Chapter 6
methods and Chapter 7 results). This final chapter presents a discussion of this project
bringing together the results from both studies. It discusses at length the implications for
practice and further research ideas to improve patient-centered care.
Discussion
Study 1. Differing from much of the literature on financial toxicity, this study
takes a unique view of this complex issue. Using qualitative methods, Study 1 answered
the question: For individuals who have had cancer, what is their experience with social
support in the context of cancer-related financial toxicity? Social support theories were
used as a sensitizing lens to explore the supportive resources available and used by 26
cancer survivors who self-reported experiencing financial hardship due to their cancer.
The broad categories that were identified from this analysis were the following: Helpful
Support, Non-helpful Support, and Gaps in Support. First, this process allowed for the
distinction of received and perceived supports to be witnessed in the data and brought to
light that the data lacked the presence of perceived supports. More noticeably, it validated
the presence of received social support (emotional, informational, and instrumental). In
turn it gave insight into areas where support is needed (i.e., missing supports or barriers
to accessing it).
It is clear that aspects of social support theories can be supported by the Helpful
Support and Non-helpful Support categories. In support of Cohen and Wills (1985),
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participants spoke about receiving helpful supports such as emotional, informational, and
instrumental support. Received emotional and informational support had a weaker
presence in this data, and perceived support only had one excerpt; however, instrumental
support was discussed by all of the participants. This is understandable as the overall
topic was financial hardship, thus the logical solution is monetarily related. Participants
reported receiving supports such as food, money, childcare, and transportation assistance
from family and friends. Some received grants, medication and medical bill assistance
from more formal social networks (medical professionals and organizations).
Instrumental supports also included services such as advocacy efforts, managing
finances, and resolving issues with complex healthcare systems. In spite of the
participants’ comments on receiving some form of instrumental support, the support
received was not enough to offset their perception of financial burden.
It is well supported in the literature that emotional and informational supports also
play important roles (Cohen & Syme, 1985; and Sarason et al., 1990 and Cohen, 2013).
Emotional support is suggested to have the greatest effect on individuals who are
experiencing stressful events. This is likely due to help-seeking behaviors which can lead
to corresponding supportive responses from others (Cohen & Wills, 1985). Although
emotional support was depicted in these interviews, not all interviewees spoke about
receiving emotional support. Moreover, several stated they did not have anyone to talk to
about their financial struggles. One interviewee went as far as saying she did not talk to
others about her financial concerns because she was embarrassed. On a similar note,
informational supports can act as a buffer (Cohen & Wills, 1985). Having information
about what is expected can allow patients to prepare emotionally or find other ways to
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cope financially. Interviewees talked about receiving advice on finances, navigating
complex systems, and receiving direction on when to seek assistance from government
programs. Receiving information can allow patients to make educated decisions or
emotionally prepare for an expected outcome of their medical decisions.
As a further support to this theory, the present study provides an example of
social constraint in the experiences of cancer patents. Adding to the works of Lepore
(2002), social constraint is observed in the context of cancer-related financial toxicity.
Some participants shared experiences of receiving non-helpful supports (social
constraints). Participants gave examples about behaviors from others that were likely
meant to be helpful but were not interpreted as such or ended in outcomes that may have
further jeopardized the support receiver’s financial situation. As evidenced in the
literature, stressful life events may elicit avoidant or minimizing behaviors from others
(Veiel et al., 2013). This was true for some participants in this study. Here we saw
instances where social network members said or did things that were interpreted by the
participant as inappropriate, critical, or insensitive. Hypothetically, these aspects of social
constraint could play a role in preventing patients from engaging in help-seeking
behaviors.
As a result of using social support as a theoretical sensitizing lens and the iterative
processes of the analysis, Gaps in Support became apparent. This category was formed
by two subcategories: missing support and barriers to accessing support. Several
interviewees commented on not receiving information that consequently could have
directed them to take steps to overt financial catastrophes or emotionally prepare for the
financial outcomes. Receiving timely information about resources through the medical
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system, pharmaceutical assistance, government assistance, or employer-based benefits,
could potentially lead to alleviating some financial demands on patients. Unfortunately,
this was not the only missing information, as most of the participants talked about lacking
information on what the costs of their care would be. Some attempted to request this
information but were told to not worry about it or to not talk about it. One participant was
told by the hospital staff that she should know what her insurance deductible was and
proceeded to not provide the participant with that information. Additionally, participants
talked about receiving resources that were not helpful or did not meet their financial
needs. In order for support to be interpreted as helpful, it must address a patient’s need or
request (Cutrona & Russell, 1990). Participants shared examples of being offered support
that did not match their need for financial assistance. In these examples, participants were
seeking information on financial assistance; instead, they were provided information
about other services such as a free monthly massage or art therapy. “But at the end of the
day it wasn’t what was needed most” (#21, 36-year-old male, Lymphoma).
In addition, interviewees talked about diminishing help and missed opportunities
for getting support. When patients are unable to maintain social relationships due to
cutting back on entertainment, they may miss out on opportunities to connect with others
and receive or request support. Having close relationship bonds may instill in others a
strong desire to help and may also serve as a reminder that help is needed. These types of
relationships take time to develop, however, and need to be nurtured. Creating further
barriers to accessing support are feelings of embarrassment, pride and guilt - all issues
that may get in the way of people reaching out to others and sharing their financial
concerns. We live in a society with the ingrained idea that you should pick yourselves up
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by the bootstraps. Social messages falsely blame financial struggles on the person as a
result of not working hard enough or not spending money wisely. On the contrary,
financial struggles are a devastating consequence of the costs of cancer care. Not only are
the costs of care astronomical, but patients also struggle to find helpful resources and
acquire information.
In summary, we see the presence of social support in the context of financial
toxicity. This in turn brings our awareness to the gaps in support that patients may
experience. To an extent, these gaps may be targeted for solutions to addressing the
financial devastation caused by cancer. Implications from this study will be discussed in
culmination with the results from Study 2 at the end of this chapter.
Study 2. Deriving from the overarching question and aspects informed by Study
1, Study 2 sought to statistically verify the importance of social support in the context of
financial toxicity due to the costs of cancer care. It attempted to answer the question:
How does social support influence cancer-related financial burden and patients’ quality
of life? Specifically, Study 2 investigated the influence of social support on the
relationship between financial toxicity and QoL. Conceptualizing social support through
the use of theory, Study 2 investigated the moderating or mediating potential of received
(informational and instrumental) and perceived (emotional, informational, and
instrumental) support.
Received social support (informational and instrumental) acts as a moderator
between financial burden and quality of life. Moderation implies that received social
support changes the direction or magnitude of the relationship between financial burden
and quality of life. Received social support acts as a buffer where increasing received
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social supports may decrease the effect of financial burden on quality of life. This result
adds to the body of research demonstrating that received support acts as a moderator. In a
study with gynecologic cancer survivors, received social support was found to moderate
the relationship between physical functioning and traumatic stress (Carpenter et al.,
2010). Another study conducted on the general population found that received social
support buffered the relationship between financial stress and psychological well-being as
well as between financial stress and psychosomatic symptoms (Aslund et al., 2014).
Instrumental support was suggested to be greatest in the presence of higher financial
stress and decreased the likelihood of experiencing low psychosomatic symptoms.
Consistent with buffering hypotheses, the interactions between financial toxicity
and received instrumental support were significant. The interaction variable accounted
for only a small amount of the variance in QoL. These findings suggest that received
instrumental support does have a buffering effect on the relationship between financial
toxicity and QoL.
To further examine the relationship, social constraint was added to the model. In
essence, social constraint is negative support (i.e., when the support provided is
interpreted by the support receiver as negative or not helpful). This study is unique in that
it examines social constraint in a three-way moderation (moderated moderator) analysis.
Interestingly, social constraint was observed to moderate the relationship of received
social support and financial toxicity on their relationship with QoL. Prior research and
theory suggest social constraint is associated with cancer-specific distress and
psychological adjustment to stressful events (Adams, Winger, & Mosher, 2014). In terms
of psychological outcomes, negative interactions are thought to be more salient than
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positive ones (Baumeister et al., 2001). Cancer patients may be more vulnerable to the
effects of social constraint as they would generally be expecting to receive support and
empathy from others.
In contrast, perceived social support did not interact as a moderator variable.
Instead, perceived social support played the role of a mediator in the relationship between
financial toxicity and QoL. This implies that the potential effect of financial toxicity on
QoL can also be explained by way of perceived social support. In this interaction,
financial toxicity may lead to the perception of social support which in turn changes or
alters this association with QoL. While perceived social support mediates financial
toxicity indirectly, it also has a direct association with QoL. As a person’s awareness of
perceived social support increases, the indirect influence of financial toxicity and QoL
decreases. This study adds to the literature on perceived support as a mediator variable.
Hodges et. al. (2012) showed that perceived social supports mediated the relationship of
optimism and positive affect in cancer survivors. From a moderator perspective, Lewis et
al. (2001) revealed that perceived social support moderated the impact of intrusive
thoughts on QoL in long-term breast cancer survivors.
The results for Study 2 provide an interesting view of the influence of social
support on the relationship between financial toxicity and QoL. They add to the literature
supporting the importance of social support as a buffer to the long-term negative impact
of cancer. Moreover, these findings are distinctive in that few studies on financial toxicity
have examined variables that may influence (moderate or mediate) the impact financial
toxicity can have on cancer patients and survivors. They provide insight into the complex
variable of social support (received and perceived emotional, informational, and
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instrumental) and provide support to the idea that having access to support can play a
valuable role in easing the financial hardship faced by many patients with cancer.
Bringing it all together. Taking a pragmatic approach to investigate this
phenomenon, we are able to create an understanding of the reality faced by some cancer
patients. Using an overall inductive approach, the results of these two studies are brought
together to confirm the existence and significance of social support in the cancer-related
financial experience. Research has shown that social support is important in the cancer
experience. This research project broadens the existing literature further by exposing the
importance of support in addressing the financial component of cancer.
In Study 2, received support moderates the relationship between financial toxicity
and QoL. This is understandable since receiving supports such as those identified in
Study 1 (food, monetary assistance, groceries, gas, childcare, advice, etc.) can provide
some financial relief. Several participants in Study 1 commented on how helpful these
supports were. No matter how small or large the support (emotional, informational,
instrumental) was, it made a difference.
Further investigating this moderator model in Study 2, social constraint (nonhelpful support) was observed to moderate the relationship between financial toxicity and
received support. In this respect, as financial toxicity and social constraint increase,
received support and quality of life decrease. Participants in Study 1 talked about
receiving support that was not helpful or came at a cost, adding to their financial
hardship. In contrast, individuals with low social constraint and high received support
reported higher quality of life. These individuals were able to access the supports they
needed without the constraint or non-supportive behavior of others. The presence of
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social constraint adds to the complexity of the situation and points to the importance of
surrounding yourself with people who are supportive and understand that cancer has
financial implications as well. This claim is supported by responses from participants in
Study 1 who found the support and understanding they need through support groups such
as Gilda’s Club in Louisville, KY.
Equally important, in Study 2 perceived support mediated the relationship
between financial toxicity and quality of life instead of moderating it. Perceiving
something exists is a cognitive activity. The perception of support means to be conscious
of its existence and to have the belief that it is realistically available if needed. In essence,
this way of thinking is a means of coping with the financial experience. Believing the
support exists could ease feelings of anxiousness or hopelessness. In spite of its statistical
importance in Study 2, perceived support was only mentioned once in Study 1. One
reason for this absence could be that participants did not believe they had someone who
could help them with their financial hardship. Participants may have exhausted the
resources they had access to and felt they could not ask for more help as was stated by
one participant. With respect to this, it was unexpected that social constraint did not
moderate the mediation model in Study 2. It may be that social constraint plays into the
scenario in another capacity, which could be further explored.
If one revisits the theoretical models presented in Chapter 3, both Study 1 and
Study 2 can provide further understanding. Figure 8.1 presents social support in a model
adapted from the Stress-buffering Hypothesis (Cohn & Wills, 1985) and Transactional
Model of Stress and Coping Theory (Lazarus & Folkman, 1984). In Figure 8.1 we see
that social support is part of the appraisal process and coping responses. As stated in
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Chapter 3, social support is thought to buffer the experienced burden during the appraisal
process. An individual may not perceive the threat to be as much of a threat as it would
be if social support was not present. Similarly, during the coping response, social support
directly alters or eliminates the stress response (Cohn & Wills, 1985). Findings from
Study 1 and Study 2 provided empirical support for the Stress-buffering Hypothesis in
the appraisal and coping processes. As interpreted from the findings of Study 2, in
perceived social support interacts as a mediator and received social support as a
moderator (Figure 8.2). Both of these forms of support in turn influence the outcome
(quality of life). Furthermore, social constraint (Unhelpful Supports) interacts with
received social support (Helpful Support). Social Constraint regulates the buffering
abilities of received support to impact the outcome. Although not presented in the model,
the Gaps in Support (missing and barriers to support identified in Study 1) further detract
from the coping response. When emotional, informational, and instrumental supports are
unavailable or blocked due to barriers, social supports are unable to function to their
capacity.
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Figure 8. 1 Depiction of social support informed by the Stress and Copying Theory and
the Stress-buffering Hypothesis (Cohn & Wills, 1985).
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Figure 8. 2 Social support moderating and mediating the relationship between
financial toxicity and quality of life.
Similarly, the Financial Toxicity Framework proposed by Carrera & Zafar (2018)
allows an additional perspective in viewing the study findings. Received social support
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interacts along the pathway from financial toxicity to quality of life (see Figure 8.3). In
considering the forms of support, we can conceivably say that received support impacts
the objective burden experience. Receiving helpful information can lead to financial
assistance or smarter ways to organize and pay medical bills as well as lead to food,
monetary, or other tangible assistance. This, in turn, can relieve the objective financial
burden, which subsequently impacts the subjective financial distress. Furthermore,
perceived supports can influence the subjective distress component of financial toxicity.
Having the perception that financial assistance is available and accessible if needed can
alleviate the anxiety and fear of not being able to afford medical treatment or daily living
expenses.
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Figure 8. 3 Moderator and mediator interactions of social support using the Financial
Toxicity Framework (Caerrera & Zafar, 2018).
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Finally, the results from this multiple method approach aided the development of
a ‘Things to Do’ checklist for oncology social workers. Largely influenced by Study 1,
this checklist can guide oncology social workers or other healthcare professionals in
engaging in important financial conversations and identifying supports. (See Table 8.1 to
view the checklist). Oncology social workers are well trained to address these financial
concerns with patients. Not all patients want to know what their costs are, but someone in
the person’s support network should be aware. Furthermore, it is important to offer the
information and provide it. Several participants in Study 1 commented that they were
never told the costs of their care, and those who directly asked were not told. Purposely
engaging in financial discussions with patients opens up that line of communication
essentially giving them permission to ask for help. Furthermore, giving patients the
information, they need to make informed choices about their care and related financial
costs gives patients control over their situation. Moreover, it is important to recognize
that these questions should be asked again at other times throughout the cancer
experience as situations may change.
Table 8. 1 Checklist for Engaging Patients in Financial Toxicity Conversations
Things to do:
Communicate openly with patients about financial issues.
Normalize the experience of financial concerns and hardship.
Address the issue in a non-judgmental or non-shaming way.
Provide current and updated resources.
Questions to ask:
What is the patient’s diagnosis, treatment and prognosis?
Do they have insurance?
• What is their deductible?
• What will their costs be after insurance?
• Do they qualify for Medicaid/Medicare?
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Does the patient want to know what their healthcare costs will be?
• If not, do they have a support person who can assist?
Are they satisfied with their financial situation?
Do they need help understanding their medical bills and insurance forms?
Does the patient have an advocate or support person to help them organize their
medical bills and insurance forms?
• Someone to assist with appeals to the insurance agency if needed or apply for
other financial assistance programs?
Does the diagnosis and treatment meet Medicare and/or Social Security Benefit
qualifications?
Does the patient work? Do they have a spouse/partner who works?
• What benefits do they have through their employer? (Sick leave assistance
programs, part-time disability, Family Medical Leave, etc.)
• Do they feel comfortable disclosing their cancer diagnosis to their employer?
Do they have student loans that can be deferred for medical reasons?
What barriers to accessing treatment might the patient be facing?
• Does the patient need help completing paperwork?
• Do they need guidance on how to talk to others about their financial concerns?
• How to approach their employer?
• What specific support or information is it that they need?
• Does the service provided to patients match their needs?

Further considerations should be made to ensuring an environment is created that
will encourage patients to discuss their financial concerns with their medical provides. As
noted in Chapter 3, certain conditions of support need to meet for social support to be
requested or provided. First, the request for assistance cannot be a request that will
potentially harm the relationship (Cohen, 2013). This requires a certain amount of trust
and comfort within the relationship for requests to be made. Second, the stress-causing
issue must be socially acceptable (Cohen, 2013). Given the fact that financial discussions
are generally considered taboo in our society, requesting financial assistance from others
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or sharing financial concerns with others can be difficult for some people. Some
participants in Study 1 commented on not talking to others about their financial situation.
In order to breakdown these social barriers, financial concerns should be normalized for
cancer patients. There should be a level of trust, non-judgment and empathy conveyed
from the healthcare professionals (financial counselor, social work, physician, etc.) to the
patient. Third, overreacting to the request for assistance could lead the individual into
feeling ashamed or embarrassed (Cohen, 2013), which could have further help-seeking
implications. One participant in Study 1 shared her story of attempting to get information
and resources. The response and lack of help she received left her feeling as though it
was a racial issue, and she was angry for being treated so poorly. Fourth, the support
provider needs to be capable of providing the support needed (Cohen, 2013) and needs to
have access to available resources. This requires a skilled individual who is not only
aware of the impact of cancer on a patient’s life but is also familiar with working in
social systems (healthcare, insurance, disability). Lastly, the resources must match the
needs of the patient (Cutrona & Russell, 1990). Although many of the supports provided
to cancer patients (resource centers, art therapy, monthly massages) provide a sense of
well-being for patients, they do not directly impact the issue of financial toxicity. Several
participants in Study 1 sought information and were sent to the hospital’s resource center
but were unable to obtain helpful advice. Others were provided resources that did not
provide assistance. Consequently, there were multiple examples of those resources not
meeting the needs of the participant.
In summary, the present study contributes to the knowledge and understanding of
the financial experience of cancer survivors. This study highlights the importance of
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social support broadening its benefits within the cancer experience and highlighting its
role in financial toxicity. It has also examined the different pathways by which each form
of support (perceived and received) influences the situation. Cancer patients with fewer
social supports are at greater risk of experiencing financial toxicity. This can be further
complicated by issues of social constraint. From this investigation emerges the need for
better communication with patients about their costs, the needs for adequate resources
and information to help improve their circumstance, as well as the need to break down
barriers that prevent patients from accessing financial assistance. It therefore follows that
oncology social workers and healthcare professionals have an essential role to fulfill in
assisting patients in averting financial hardship.
Implications for Practice
Findings from the present study suggest the benefits associated with social
supports in the context of financial toxicity. The results from this research study should
be used to inform practice of the need to ensure information and guidance is provided to
patients. Social support (emotional, information, and instrumental) as it relates to
financial toxicity can have a significant impact on patient outcomes. Yet, as evident by
the findings of Study 1, participants lacked information that could have assisted them and
potentially improved their financial outcomes. To that end, it is imperative that social
workers and medical professionals address financial toxicity before it is a problem.
Proactive discussions with patients regarding the costs of cancer care should
occur at the beginning of the cancer experience before treatment starts. Waiting until a
patient is experiencing financial toxicity, which could be several months later, limits the
availability of receiving support and assistance. Instead, all patients should be approached
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immediately upon their diagnosis, provided financial assistance information and
encouraged to look into specific work-related benefits or other supports. As was seen in
Study 1, patients were taken off-guard by the costs of their care. Many of them were
unaware of the expenses until receiving an overwhelming amount of bills several months
later. By not engaging in these important conversations, patients are caught off-guard
and may have no idea who to approach for assistance. Oncology social workers are well
positioned for engaging in these proactive conversations. They are skilled and proficient
in quickly developing a trusting rapport with patients. They understand the importance of
engaging in active listening and taking time to fully understanding what patients are
experiencing. They are skilled in ways to put others at ease creating a comfortable safe
environment for patients to share their concerns.
Justifiably, discussing finances is said to be one of the most difficult
conversations for people to have. This was an issue for several participants in both
studies. Financial struggles can lead to feelings of inadequacy, guilt, and embarrassment
making it difficult for people to confide in others. Yet much of the information available
for patients, encourages them to bring up the conversation and tells them to talk to their
medical providers about their financial concerns. This could be very difficult for some
patients, especially those who are embarrassed about their financial situation. Therefore,
individuals who fulfill those roles should be well training and equipped to handle these
difficult conversations.
Oncology social workers have the clinical skills required to engage in difficult
conversation in a sensitive, empathetic and respectful manner. They seek to identify and
deal with the significant stressors created by burden. They are skilled at building trusting
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relationships which allows them to approach difficult conversations such as finances.
With respect to this, engaging in important and difficult, even taboo, conversations are a
common occurrence for oncology social workers.
To the contrary, the majority of people who provide financial counseling to
patients in the healthcare setting have a high school level education (Advisory Board,
2014). They lack the necessary medical understanding of diagnosis and treatment as well
as how those can impact a patient’s life and ability to continue working. Furthermore,
they lack the necessary training to engage in difficult, taboo conversations that require
sensitivity and empathy. In spite of this, there are no policies or regulations requiring
these positions receive training or certification. Consequently, many patients do not
receive the information, resources or help they need.
Furthermore, there is a lack of resource availability and what is available
(Medicare, financial and pharmaceutical assistance programs, charity) may not be enough
to help patients once they are experiencing financial toxicity. A study by Smith, Nicolla,
and Zafar (2014) and another by Spencer et. al. (2018), found that many oncology social
workers and financial navigators do not have the resources needed to help patients. This
can lead to avoidant behaviors or non-helpful responses from medical professionals as
was seen in Study 1. Arguably, this is because issues of financial toxicity are not dealt
with until it is a problem instead of addressing them from the initial diagnosis. With
respect to this, a program created by Dan Sherman and the NaVectis Group (2016)
addresses the needs of patients and their families early in the cancer experience. Through
optimizing health insurance coverage (Medicare, Medicare, and the insurance exchange),
they are able to ensure patients have the best and most affordable insurance to meet their
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needs. Further, they provide patients with all the available information on patient
assistance, programs. Although this program has not been proven in terms of evidencebased research, it is considered to be practice informed and best practices.
To date there are no evidence-based practices to address financial toxicity, but
there has been some progress. A pilot study by Shankaran et al. (2017) implemented a
patient navigation program offering counseling and case management assistance. The
program provided patients with access to counselors and case managers who assist with
budgeting, answering medical billing questions, and applying for assistance programs.
Although this study did not find a difference in financial burden, some patients did
experience a decrease in anxiety over their medical costs (Shankaran et al., 2017). A
second intervention, Care Payment program, provided patients with 0% APR lines of
credit up to $25,000. Patients were put on repayment plans of 4% or as little as $25 per
month. Patients were less likely to report barriers to care and bad credit issues as a result
of the medical costs (Lessard & Solomon, 2017). Although both of these programs
provided patients with assistance and some relief, patients still faced huge amounts of
debt accumulation due to their treatment. This could be were the NaVectis program may
be superior as it addresses financial issues through intervening by means of healthcare
insurance before financial toxicity becomes a problem.
Lastly, patients can take control over their cancer-related financial experiences by
seeking the support and help they need. They should be empowered to advocate for
themselves or seek the assistance of someone who can advocate for them. Staying
organized and on top of their medical bills and insurance forms could be a way to catch
billing errors which can lead to unnecessary insurance denials. If medical expenses are
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denied, patients should be encouraged and assisted in finding out why. Equally important,
patients should be encouraged to talk to others and openly communicate with their
medical professional about their financial concerns. This could open the door to financial
advice (what to pay, when to pay) or lead to other resources that may be beneficial.
Support groups through organizations such as Gilda’s Club offer supportive
programming in a safe and encouraging environment.
Implications for Policy
In order to truly enact change and improve conditions for patients, a larger
systemic change is needed. Healthcare was one of the top issues in the 2018 elections and
it will continue to remain a concern as costs of care continue to rise. Policy changes at
both the healthcare level and larger government level can improve conditions for patients
and possibly help patients avoid financial toxicity.
From a public policy perspective, it is of utmost importance that cancer patients
and survivors have “affordable, adequate, and accessible healthcare” (ACS-CAN, 2017).
The Patient Protection and Affordable Care Act (ACA) ensured patients would have
access to healthcare plans that covered a basic degree of cancer care, prevented denials
for pre-existing conditions, and were affordable. Yet, these efforts were not enough;
although, many American were able to purchase affordable insurance, patients still
experienced financial toxicity. Furthermore, the current Presidential Administration and
Republican-based Congress have made efforts to overturn parts and all of the ACA,
which could jeopardize the financial security of many cancer patients and survivors.
Accordingly, efforts should be made to craft legislation that covers all Americans
in the event of a cancer diagnosis. A universal healthcare program would provide equal
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health coverage to all Americans. According to Sen (2015), the United States could
effectively provide a high level of universal healthcare. There is a considerable amount of
evidence showing the benefits of such programing. It is well known that Canada and
several countries in Europe have versions of universal healthcare, and all show better
quality of health and quality of life than the United States. It is less known that poorer
countries, such as Thailand, Rwanda, and some states in India (Himachal Pradesh and
Tamil Nadu) are implementing universal healthcare policies and are seeing improvements
in premature and infant mortality rates (Sen, 2015).
With respect to the idea of universal healthcare, Medicare-for-All appears to be
promising. There are currently several proposed bills that provide versions of access to
insurance options that are Medicare or Medicaid based. One bill proposed by Senator
Sanders (S. 1804) and Representative Ellison (H.R. 676) is a single national health
insurance program that would cover all Americans. Alternatively, three other bills
provide versions of a new plan option that could be available through the ACA
marketplace: Choice Act (S. 194, H.R. 194), Medicare-S Choice Act (S. 1970, H.R.
4094), and Choose Medicare Act (S. 2708, H.R. 6117). These would offer programs
similar to Medicare to individuals and possibly employers. A fourth version provides a
Medicare buy-in option for individuals who are nearing the eligible age for Medicare
programs: Medicare at 55 Act (S. 1742), and Medicare Buy-in and Health Care
Stabilization Act (H.R. 3748). These would be greatly beneficial to those nearing the age
of retirement and also at a higher risk of receiving a cancer diagnosis. A final version of
Medicare-for-All provides states with the authority to allow individuals a Medicaid buyin option through the ACA marketplace: State Public Option Act (S. 2001) and (H.R.
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4129) (Kaiser Family Foundation, 2019). Through legislation such as these acts a greater
number of Americans will have affordable access to insurance coverage.
Unfortunately, achieving change at the governmental level can be an onerous task
that could take a long time to achieve and patients need help now. Financial health
literacy in the United States is considerably low (Lin, Lusardi, and Mottola, 2016). A
survey in 2015 found that 63% of adults (N = 25,000) could not answer 4 out of 5
financial literacy questions correctly. Likewise, many Americans lack the financial
capability to make ends meet and deal with everyday financial matters. In this same
survey, 34% felt they could not come up with $2000 in a month for an unexpected
emergency without borrowing and 50% did not have enough funds set aside to cover a 3
month laps in income (Lin, et. al., 2016). This is indicative of a substantial number of
Americans being at risk of financial devastation in the event of a cancer diagnosis or
economic downfall.
To that end, it is imperative that the health care industry assist patients. The
findings from this research suggest that patients need information and guidance in
understanding their medical bills and health insurance forms. This information should be
understandable at a basic-educational level. Agencies (medical and insurance companies)
could simplify their forms to make them easier for patients to interpret and understand.
One participant in Study 1 shared her confusion over her medical bills and consequently
paid bills that her insurance eventually paid as well. When she attempted to get the
money back from the medical provider, she was unsuccessful about doing so in a timely
manner. Had she understood her medical bills, she would not have paid them at that time
and possibly could have prevented some discord as a result.
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Moreover, several participants in Study 1 struggled with the overwhelming
amount of medical bills and insurance forms arriving through the mail. By providing a
centralized billing system where patients can access their medical bills and insurance
information all in one spot could help to eliminate redundancy in the system and could
relieve patients from having to manage these documents. This would make the process
more patient friendly relieving the burden of receiving excessive amounts of forms and
documents through the mail.
In addition, these agencies (medical and insurance) could provide trained and
skilled individuals to help patients in a sensitive and empathic way. This service could
assist patients in understanding what bills they need to pay and what their insurance will
cover. Furthermore, just having someone to help complete paperwork could make a
difference in whether or not patients complete paperwork requesting financial assistance.
Likewise, assistance should be offered to caregivers as they may be responsible for
managing the financial aspects of the experience.
In summary, there are several ways the American healthcare system can be
improved to ease the financial burden and distress experienced by patients. The
healthcare industry can take steps to improve the exchange of information and provide
services from trained, skilled workers who are aware of the circumstances resulting from
cancer.
Future Research
As evidence accumulates on the devastating effects of cancer-related financial
toxicity, there is an urgent need to develop and implement interventions to alleviate the
burden and distress experienced by patients and their families. Further research should be
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conducted on the NaVectis Group method of addressing financial toxicity to determine its
overall effectiveness. It is imperative that research identify interventions and best
practices to assure that patients can afford their cancer care and do not end up financially
devastated attempting to do so.
Further research could explore patients’ preferences for information and, equally
important, who they would like to receive this information from. It may be important for
every member of the medical team to be knowledgeable and sensitive about financial
concerns. Providing patients with some guidance or at least direction as to who to get
information from encourages them to continue to try to find relief. Future research could
develop and assess the effectiveness of a training program for medical professionals on
engaging in these difficult financial discussions in a caring and respectful way.
Another piece to the puzzle may be understanding help-seeking behaviors as they
relate to financial aspects. Socially taboo issues have long constrained people from
talking about such issue as politics, religion, sex, and money. This was supported in
Study 2, which showed that social constraint was indeed a factor. Research could further
explore ways to break down these barriers.
Limitations
The benefits of social support have long been established in the cancer
experience. This study extends this knowledge into the experience of cancer-related
financial toxicity. A strength of this project was the use of multiple studies. Using this
pragmatic approach allowed for this topic to be explored through qualitative and
quantitative measures providing different perspectives and information. Another
strengths was the variety of theoretical frameworks, which informed the development of
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the study procedures and data analyses. Furthermore, each study provided a different
perspective on the availability, use, and need for social support during the cancer
experience.
Despite the use of multiple methodologies, weaknesses were identified for each
study. Study 1 had an almost non-existent presence of perceived support. This lack of
perceived support as well as a weak existence of received information and emotional
supports could be due to the way the interview questions were designed. This was a
secondary analysis and the interview questions sought to understand the overall
experience of cancer-related financial hardship not specific to social support. To the
contrary, there was a strong presence of received instrumental support discussed by all
participants. To that end, Study 1 provided insight into the types of social support
(emotional, informational, and instrumental); nevertheless, it does not indicate which is
more important. The aim of this study was not to determine the level of importance but
rather to identify the existence of support, its use, and need for more. What we can
surmise is that received instrumental support was more talked about than any other type
of support.
A strength of Study 2 was that the models accounted for a portion of the variance
in QoL. However, the observed moderation variable (received social support) did not
account for a large amount of the variance in QoL. According to Cohn & Willis (1985),
the ability to detect a buffering effect could be dependent on the measures used. This
requires having measures that directly get at the type of social support which can best
respond to the stressor. In this respect, results may have shown more variance in QoL had
the larger version of the scale (Inventory of Socially Supportive Behaviors short version)
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or a different scale been used. Another weakness was that other variables could have
been included, such as are the length of treatment and number of other chronic illnesses.
These variables may have explained some of the variance in QoL. Furthermore, the study
design did not allow for the establishment of causality.
Study 1 and Study 2 cross-sectional designs were used, which does not allow for
causal or directional inferences. In addition, a cross-sectional design prevents the
evaluation of long-term financial impact. Furthermore, both studies were limited by a
lack of racial diversity; most participants were white and female. Individuals from
minority populations tend to have less access to financial reserves. According to the
American Cancer Society (2018), Hispanics (16%) and blacks (11%) are more likely to
be uninsured then Caucasians (6%). Minority populations are also more likely to be
diagnosed with cancer at a later stage. It is therefore conceivable to propose these
populations may experience higher toxicity and be in need of more intervention services.
Future research could focus on identifying the effects of financial toxicity on minority
populations and determining if racial differences exist in regard to the availability of
social support.
Conclusion
It is evident that a significant number of people are impacted by the costs of
cancer care and as costs continue to rise, more will experience financially toxic
situations. Although financial toxicity continues to be extensively studied, answers to
alleviating patients’ financial distress and burden are lacking. To my knowledge these are
the first studies conducted to focus on specifically how social support can impact the
cancer-related financial experience. These findings confirm the existence, use, and
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importance of social support in this context. Furthermore, they provide empirical
evidence for attending to the supportive financial needs of cancer patients.
From this investigation emerges the need for purposeful conversations
surrounding financial issues at the beginning of a cancer diagnosis. Patients should be
provided information about their costs of care and the amount they are responsible for
instead of being surprised by the bills several months later. Exactly who is at risk is
debatable; therefore, the assumption should be made that anyone with cancer is at risk of
experiencing financial toxicity. All patients should be provided financial assistance and
resources before they experience financial toxicity (i.e., at the beginning of their cancer
experience). Furthermore, all members of the healthcare team should receive training on
engaging patients in a sensitive and empathic way when handling financial discussions.
On a theoretical level, the study findings provided empirical evidence in support
of the Stress-buffering Hypothesis (Cohn & Wills, 1985) and conceptually adds to the
Financial Toxicity Framework proposed by Carrera & Zafar (2018). This has important
implications for practice. Practitioners should understand the complexity of financial
toxicity and how these supports can buffer patients’ experiences.
Furthermore, the costs of care should not weigh into the decision of whether or
not a person obtains cancer care. It is of the utmost importance that policies at the federal,
state, and agency level address the astronomical costs of health care. Whether by cost
regulation or universal health plans, systemic change needs to occur in order to
effectively prevent patients from the experience of financial toxicity.
Future studies should continue to investigate evidence-based interventions for
addressing financial toxicity. Equally important is examining patient preferences for
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information and with whom they prefer engaging in purposeful financial conversations.
Other studies should explore the development of training for medical professional in
engaging in sensitive financial conversations.
In considering the findings from this research, it appears that the answer to the
overarching question to what role does social support play, we can unequivocally answer:
an important one. Social support is a critical element in helping protect patients from
cancer-related financial toxicity.
“I wish there would have been somebody, just to say, this is going to start costing you
money, because all you’re thinking about is, ‘I want to save my life.’”
-Study 1 # (53-year-old woman, Pancreatic Cancer)
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APPENDIX A: STUDY 1 CONSENT PREAMBLE
Living with the Financial Consequences of Cancer: The Stories of Survivors Support Person
Consent
You are being invited to participate in a research study by participating in a one-time interview
conducted by a member of the research team. This interview can occur in your home or at our
research office. The interview will ask about your experiences related to the financial and
personal distress caused by a cancer diagnosis and related treatment. Completing the interview
will take approximately 1 hour. Your interview will be audiotaped and then transcribed (typed
out).
The purpose of the study is to learn how a cancer diagnosis impacts financial well-being, how
cancer patients manage financial hardship and how financial distress affects overall quality of
life. The ultimate goal is to develop sustainable and effective interventions to assist cancer
patients in preventing financial hardship.
There are no foreseeable risks associated with this study besides the discomfort you might
experience answering interview questions. There may be unforeseen risks. The study data
collected may not benefit you directly, but it will be used to identify and address financial barriers
to cancer care which could positively impact the future lives of survivors and their families.
Your completed interview will be stored in a locked file cabinet at the Kent School of Social
Work. Your responses to the questions will be maintained on a password protected computer.
Identifying information such as your name will not be connected to the database or your
transcribed interview, nor will any of your identifying data be published in articles written about
the study.
Individuals from the Department of University of Louisville Department of Medicine and the
Kent School of Social Work, the Institutional Review Board (IRB), the Human Subjects
Protection Program Office (HSPPO), and other regulatory agencies may inspect these records. In
all other respects, however, the data will be held in confidence to the extent permitted by law.
Should the data be published, your identity will not be disclosed.
Taking part in this study is voluntary. By completing the interview you agree to take part in this
research study. You do not have to answer any questions that make you uncomfortable. You may
choose not to take part at all. If you decide to be in this study you may stop taking part at any
time. If you decide not to be in this study or if you stop taking part at any time, you will not lose
any benefits for which you may qualify.
If you have any questions, concerns, or complaints about the research study, please contact the:
principal investigator at 502-852-1946.
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If you have any questions about your rights as a research subject, you may call the Human
Subjects Protection Program Office at (502) 852-5188. You can discuss any questions about your
rights as a research subject, in private, with a member of the Institutional Review Board (IRB).
You may also call this number if you have other questions about the research, and you cannot
reach the research staff, or want to talk to someone else. The IRB is an independent
UofL Institutional Review Boards
IRB NUMBER: 15.0407
IRB APPROVAL DATE: 06/04/2015 IRB EXPIRATION DATE: 05/13/2016

committee made up of people from the University community, staff of the institutions, as well as
people from the community not connected with these institutions. The IRB has reviewed this
research study.
If you have concerns or complaints about the research or research staff and you do not wish to
give your name, you may call 1-877-852-1167. This is a 24 hour hot line answered by people
who do not work at the University of Louisville.
Sincerely,
Karen Kayser PhD. Barbara Head PhD.
DATE: 06/02/2015
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APPENDIX B: STUDY 1 INTERVIEW GUIDE

The Experience of Financial Toxicity during the Cancer Trajectory
I would like to have a conversation with you about your experience with cancer.
Specifically, I would like you to tell me in your own words the story of how your illness
caused financial hardship in your life.
Point of Most Financial Distress
• When did you first start to experience financial stress related to your cancer?
(Probe: Can you tell me more about that?)
• When did you reach your highest point of financial stress and what was that like
for you?
Financial Situation & Health Insurance at the Time of Diagnosis
• Tell me about your financial situation during the time of your diagnosis.
• Were you employed at that time? Were you able to maintain your employment
throughout your treatment? If so, tell me about the work you were doing?
• Did you have health insurance coverage? If so, what type? (Probe: private,
employer, self-paid)
Understanding Assistance with Insurance, Medical Costs, and Coverage.
• What did you understand about the costs of cancer care and your insurance
coverage at the time of your diagnosis?
• What assistance was given to you from the Cancer Center or any of your medical
providers to guide you through the cost s and insurance coverage period during
your cancer experience? (Probe: Financial counselor.)
• Did you encounter any out of pocket expenses that you did not expect? If so, what
were they?
Managing the Financial Stress
• What strategies did you use to manage the financial burden during your cancer
experience?
• What, if any, methods did you use to offset costs of care and expenses such as
loans, credit cards, or second mortgages?
Effects of financial distress on treatment and outcomes.
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•
•

Did the worry about your financial situation affect any of your treatment
decisions?
Did you ever not receive, limit or stop treatment because of the inability to pay for
it? (E.g. not filling prescriptions or taking fewer medications) Probe: Tell me
more about that.

Current Quality of Life
• Looking back on your life before your cancer diagnosis, what has changed about
your life overall?
• How do you think it has affected your family/loved ones?
o How would you describe their quality of life before, during and after
treatment?
• What are your current healthcare needs and are they being met or addressed?
(Probe: include follow-up care, preventive screenings or other chronic conditions)
Ending interview
• If you could give another person who is diagnosed with cancer advice about
finances and stress, what would it be?
• What advice would you give to the healthcare system (hospitals, cancer centers,
insurance companies, government) to alleviate the financial consequences of a
cancer diagnosis and treatment?
• What else do you think it would be important for me to know about financial
stress and cancer that I did not ask you about today?
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APPENDIX C: STUDY 1 QUESTIONNAIRE

Introduction
This questionnaire is about your experience with cancer specifically your
experience with financial burden as a result of the cancer treatment, access to care, and
social support during your illness. All answers are completely confidential. Please do not
write your name of the questionnaire.
Section I Financial Toxicity Scale (Cost-Prom)
Below is a list of statements related to the financial impact of your illness. Please place
an X in the box which describes how you feel about that statement.

I feel financially stressed.
I am satisfied with my current
financial situation.
I worry about the financial problems I
will have in the future as a result of
my illness or treatment.
I am frustrated that I cannot work or
contribute as much as I usually do.
My cancer or treatment has reduced
my satisfaction with my present
financial situation.
I feel in control of my financial
situation.
I am able to meet my monthly
expenses.
I know that I have enough money in
savings, retirement or assets to cover
the costs of my treatment.
I am concerned about keeping my job
and income, including working at
home.
I feel I have no choice about the
amount of money I spend on care.

Not at
all

A little
bit

Sometimes

Quite a
bit

Very
Much

0
0

1
1

2
2

3
3

4
4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4
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My out of pocket medical expenses are
more than I thought they would be.

0

1

2

3

4

Section II Brief Health Literacy Screening Tool (BRIEF)
Please circle the answer that best represents your response.
How often do you have someone help you
read hospital materials?
How often do you have a problem
understanding the written materials about your
medical condition?
How often do you have a problem
understanding what is told to you about your
medical condition?

How confident are you filling out medical
forms by yourself?

Always

Often

Sometimes

Rarely

Never

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Not at
all

A little
bit

Somewhat

Quite a
bit

Extre
mely

1

2

3

4

5

Introduction
This questionnaire is about your experience with cancer specifically your
experience with insurance, being uninsured or receiving Medicaid coverage. It will help us
to assess the impact of medical insurance on the affordability and ability to receive health
care services. All answers are completely confidential.

Section III Well-Being (Fact-G Version 4)
Below is a list of statements that other people have said are important. Please circle or
mark one number per line to indicate your response as it applies to the past 7 days.
Physical Well-Being

I have a lack of energy.
I have nausea.
Because of my physical condition, I
have trouble meeting the needs of my
family.
I have pain.
I am bothered by side effects of
treatment.
I feel ill.
I am forced to spend time in bed.

Not at
all
0
0
0

A little
bit
1
1
1

Somew
hat
2
2
2

Quite a
bit
3
3
3

Very
much
4
4
4

0
0

1
1

2
2

3
3

4
4

0
0

1
1

2
2

3
3

4
4

Social/Family Well-Being
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I feel close to my friends.
I get emotional support from my
family.
I get support from my friends.
I am satisfied with family
communication about my illness.
I feel close to my partner (or the
person who is my main support).

Not at
all
0
0

A little
bit
1
1

Somew
hat
2
2

Quite a
bit
3
3

Very
much
4
4

0
0

1
1

2
2

3
3

4
4

0

1

2

3

4

Regardless of your current level of sexual activity, please answer the following question. If you prefer not
to answer it, please mark this box ☐ and go to the next section.

I am satisfied with my sex life.

0

1

2

3

4

Please circle or mark on number per line to indicate your response as it applies to
the past 7 days.
Emotional Well-Being

I feel sad.
I am satisfied with how I am coping
with my illness.
I am losing hope in the fight against
my illness.
I feel nervous.
I worry about dying.
I worry that my condition will get
worse.

Not at
all
0
0

A little
bit
1
1

Somew
hat
2
2

Quite a
bit
3
3

Very
much
4
4

0

1

2

3

4

0
0
0

1
1
1

2
2
2

3
3
3

4
4
4

Not at
all
0

A little
bit
1

Somew
hat
2

Quite a
bit
3

Very
much
4

0

1

2

3

4

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

0

1

2

3

4

Functional Well-Being

I am able to work (include work at
home).
My work (include work at home) is
fulfilling.
I am able to enjoy life.
I have accepted my illness.
I am sleeping well.
I am enjoying the things I usually do
for fun.
I am content with the quality of my
life right now.
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Section V Healthcare Access
Q1 How was your cancer found?
1- It was found during a screening test (such as a mammogram, colonoscopy)
2- It was found during a routine check-up or physical exam with my doctor.
3- It was found when I went to my doctor because I was sick and had physical
symptoms.
4- It was found after I went to the emergency room because I was sick.
Q2 What type of cancer did you have? _________________
Q3 Prior to your cancer diagnosis, where did you receive most of your healthcare?
1- At my doctor’s office
2- At a clinic
3- At an immediate or urgent care center
4- At the emergency room
5- I never needed healthcare
Q4 Did you get routine screening for cancer such as a mammogram or colonoscopy
before your cancer diagnosis?
____ Yes ____ No
Q5 Did you go to your doctor or a clinic for regular check-ups before your cancer
diagnosis?
____ Yes ____ No
Q6 At the time of your first cancer diagnosis did you have insurance?
____ Yes ____ No
If you had insurance which of the following types of insurance did you have
(check all that apply)?
1- Private Insurance through my employer
2- Private insurance I purchased myself
3- Veteran’s Administration coverage
4- Medicare disability insurance
5- Medicaid
Q7 Did you have medical insurance prior to your cancer diagnosis?
____ Yes ____ No
If you did not have medical insurance prior to your cancer diagnosis, what
was the reason (check all that apply)?
1- My employer did not offer insurance as a benefit

227

23456-

I could not afford the cost of health insurance
I did not think I needed insurance
I was not eligible for Medicaid when I applied
I wasn’t working and could not afford insurance
I didn’t know how to get insurance I could afford

Q8 Which of the following insurances changes have you experienced since your
cancer diagnosis?
1- None, I still have the same insurance
2- None, I still do not have any insurance
3- I lost my insurance because I can no longer work
4- I lost my insurance because I can no longer afford it
5- I became eligible for Medicaid
6- I became eligible for Medicare disability
7- I lost my insurance coverage through my employer and now pay for my own
Q9 If you have Medicaid, when did you get it?
Month ____ Year____
Q10 If you have Medicaid, did you (check all that apply)
1- Have it before you got sick with cancer
2- Apply for it when you got cancer
3- Apply for it after you got cancer because you lost your private insurance
4- Apply for it when a social worker or other person told you about it
5- Apply for it when you learned that Medicaid rules had changed making you
eligible
Q11 If you have Medicaid, how did you learn about it (check all that apply)?
1- I heard on the news that I might be eligible
2- I saw a sign or was given information at the doctor’s office, clinic or hospital
3- My doctor told me about it
4- A social worker or discharge planner at the doctor’s office, clinic or hospital
told me about it
5- A friend or family member told me about it
6- A family member has it and told me about it
Q12 Did you know that Medicaid became available to more people in Kentucky as
part of the Affordable Care Act (Obama care) in January 2014?
____ Yes ___ No
Q13 Did you apply for Medicaid because you heard it was more available?
____ Yes ____ No

Section VI Demographic Questions
Gender: ___ Male ___ Female
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Age:
What is your ethnicity?
1- Latina/Latino/Hispanic ancestry
2- Not Hispanic
What is your racial/ethnic group?
1- Caucasian/White
2- African-American/Black
3- Asian
4- American Indian/Alaskan Native
5- Native Hawaiian/Other Pacific Islander
6- Other __________________________
Have you ever been or are you currently married?
1- Single, never married
2- Currently married
3- Not married, but in a relationship with significant other
4- Separated or divorced
5- Widowed
How many children under the age of 18 are living in your home? _____
What is the highest level of formal education that you have completed?
1- Less than high school
2- Completed high school or GED
3- Some college (includes technical, vocational, or certificate program and
Associate’s degree)
4- Bachelor’s degree
5- Postgraduate or professional degree (includes Master’s, MD, PhD, and JD)
Do you currently work for pay? ____ Yes ____ No
What is your current job status?
1- Employed full-time
2- Employed part-time
3- Unemployed
4- Homemaker
5- Disabled
6- Retired
Before your cancer diagnosis, what was your job status?
1- Employed full-time
2- Employed part-time
3- Unemployed
4- Homemaker
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5- Disabled
6- Retired
If you currently work for pay, in the last month:
How many hours per week did you work on average for pay? _3___
How many days off did you take because of physical health problems? ____
How many days off did you take because of emotional health problems? ____
What is your occupation?
1- Homemaker
2- Executive of manager
3- Professional or technical
4- Clerical, sales or service work
5- Occupation in agriculture, forestry or fisheries
6- Occupation in crafts, repair, manufacturing, transportation or operation of
machinery
How important is your occupation or continuing to work to your well-being? If
disabled or unemployed, how important was your occupation or continuing to work
to your well-being?
1- Not at all important
2- Not very important
3- Somewhat important
4- Moderately important
5- Very important
What are/were your household (family) gross wages or income last year (before
taxes)?
1- Less than $25,000
2- $25,001-$40,000
3- $40,001-$60,000
4- $60,001-$80,000
5- Over $80,000
6- I don’t know

230

APPENDIX D: FAMILY PARTIALLY ORDERED META-MATRIX
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APPENDIX E: STUDY 1 TEMPLATE & EXAMPLE OF MEMOS

The below templates are informed by Corbin & Strauss (2015) chapters 6 & 10.
Memo 1: Open Data Exploration
Purpose – beginning to explore concept.
Memo 2: Develops the Properties and Dimensions Further
Purpose – is to sensitize to possible properties/dimensions.
Memo 3: Comparison and Question-Asking Memo.
Purpose – it to make more sensitive to data.
Memo 4: Summary Memo
Purpose – demonstrate the relationships between conditions, actions-interactions,
and consequences.
Conceptual Heading: What defines this theme?
Questions to ask throughout the process:
1. What seems to be going on here?
2. What theme keeps emerging over and over when I read these?
3. What thoughts/ideas come through in the data even though it may not be
said directly?
Example
Advocated Memo 1 Data Exploration
Provided by spouses.
• During a cancer experience patients are facing a life threatening disease. Having
someone to advocate for them allows them to take a step back and let someone
else have control of part of the situation. This allows the patient to focus on their
health and well-being.
•

'my wife is a medical professional. She also is a person who is very conscious of
what costs are and is not afraid to say, "We can't afford to have that type of
service, even though you might want to have a 2nd or 3rd opinion, which is fine,
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we can deal with that. Unless, you can have that as a part of our insurance
situation, I don't see ..." Your spouse can be skeptical of any 2nd or 3rd opinion
just because they're out of network.” #26
Spouses all for having someone to just give to all over to. They provide support,
advocacy.
Excerpts in this category revolve around the concept of someone else taking control of
part of the situation.
PARENT - she got it from calling around and asking, because she had to do the
same thing for my father who is disabled. So she kind of knew the avenues. For
me she went in there. - #10
Knowing the avenues to take when seeking disability such as in this case or navigating
the insurance world can provide a lot of assistance. In this case the patient’s mother was
able to advocate for her to get disability assistance when she could no longer work due to
her treatment.
Provided by Child
• Adult Children were also able to provide advocacy support. --60-year-old woman
with three adult children comments on how one of her children encouraged her to
have a voice.
'Yeah. She's real good at helping me advocate and encouraging me to use my
voice because when you're in the middle of it's a whole different story. #6
Provided by Medical Professionals
• Med Prof provided emotional support in the form of Advocacy – this stretches the
expectations of formal support providers to also include emotional supports opposed to what is explain in theory. This may be due to the deep level at which
health care can effect a patient – medical providers cross the divide between
formal and information – they become personal relationships – friends.
'I felt like my healthcare system was an advocate. - #22
“Yes, she has become more of a friend and an advocate b/c she got on the phone and was
talking to them and they paid attention to her. I can barely walk—but I can’t use a
walker or a cane—but she got on the phone and made them pay attention about it like the
wheelchair back in December. So that I can get around without being stuck in the
house.” - #2
Advocate Memo 2 Develops
Advocate. A life threatening or severe disease, such as cancer, can cause a patient to feel
vulnerable. They may feel week due to the effects of the illness itself or the physical
demand treatment has on their bodies. In this emotional support theme, we see that family
members (spouses, parents, adult children, siblings) and medical professionals (Nurses)
served as advocates. Having someone to advocate for you allows you to take a step back
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and let someone else have control of part of the situation. This allows the patient to focus
on their health and well-being.
Emotional supports are expected to be performed by Family and Friends. In this
study several different family member roles engaged in advocating for the needs of the
patient. In the below quote from #26, the participant appears to speak with confidence
about his spouse’s ability to handle the situation and ensure that whichever health
decision the select will make the most economical sense.
Parents can have past life experiences that prove to be useful as seen in the case of
a 35-year-old, single female. Knowing the avenues to take when seeking disability such
as in this case or navigating the insurance world can provide a lot of assistance. In this
case the patient’s mother was able to advocate for her to get disability assistance when
she could no longer work due to her treatment.
Adult Children were also able to provide advocacy support. In the below excerpt a
60-year-old woman with three adult children comments on how one of her offspring
encouraged her to have a voice in her medical care and decision-making processes.
From the perspective of social support theory, medical professionals are in the
formal support provider categories and expected to provide information and instrumental
supports. In this study they are also observed providing emotional support. Med Prof
provided emotional support in the form of Advocacy – this stretches the expectations of
formal support providers to also include emotional supports -opposed to what is explain
in theory. This may be due to the deep level at which health care can effect a patient –
medical providers cross the divide between formal and information – they become
personal relationships – friends.
During a cancer experience, patients are faced with a life-threatening disease. Having
someone to advocate for them allows them to take a step back and let someone else have
control of part of the situation. This allows the patient to focus on their health and wellbeing.
Advocacy Memo 3 Questioning Memo
Provider advocates for the patient’s wellbeing, medical care, and health service
needs. In providing this assistance, patients are comforted and may feel supported having
the confidence that someone else can take care of things. Provider supports the patient by
ensuring their well-being and needs are met. Acts as a voice for the patient. The patient
has confidence in the provider to make sure what is needed is done.
Advocacy Memo 4 Summary Memo
A life threatening or severe disease, such as cancer, can cause a patient to feel
vulnerable. They may feel weak due to the effects of the illness itself or the physical
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demand treatment has on their bodies. In this emotional support theme, we see that family
members (spouses, parents, adult children, siblings) and medical professionals (Nurses or
other providers) served as advocates. They take control of a situation and resolve the
issue so that the patient does not need to worry about it. In this act they are a voice for the
patient speaking up for their wellbeing, medical care, and needed health service. In
providing this assistance, patients may feel supported and confident that someone else
can take care of some thing for them while they focus on their treatment and survival.
According to theory, emotional support is expected to be performed by family and
friends. In this study several different family members (spouse, parent, adult child,
sibling) engaged in advocating for the needs of the patient. In the below quote from #26,
the participant appears to speak with confidence about his spouse’s ability to handle the
situation and ensure that whichever health decision was made would make the most
economic sense.
“My wife is a medical professional. She also is a person who is very conscious of
what costs are and is not afraid to say, ‘We can't afford to have that type of
service, even though you might want to have a 2nd or 3rd opinion, which is fine,
we can deal with that. Unless, you can have that as a part of our insurance
situation, I don't see.’ Your spouse can be skeptical of any 2nd or 3rd opinion just
because they're out of network.” #26 (66-year-old, male, Prostate & Bladder)
This example is in accordance with the role expectations of a spouse as they are expected
to be a primary support. Having a spouse available to attend appointments and assist in
treatment decisions can alleviate some of the responsibility and burden from the patient.
Other family members can step into this primary supportive role as well. Parents
may have past life experiences that prove to be useful as seen in the case of a 35-year-old,
single female.
“She [mother] got it from calling around and asking, because she had to do the
same thing for my father who is disabled. So, she kind of knew the avenues. For
me she went in there.” #10 (35-year-old, female, Leukemia)
Knowing the avenues to take when seeking medical treatment or navigating the insurance
world can provide valuable assistance and guidance. In this case the patient’s mother was
able to advocate for her to get disability assistance when she could no longer work due to
her treatment.
Similarly, adult children may be in the position to provide advocacy support as well. In
the below excerpt a 60-year-old woman with three adult children comments on how one
of her daughters encouraged her to have a voice in her medical care and decision-making
processes.
“She's really good at helping me advocate and encouraging me to use my voice
because when you're in the middle of it's a whole different story. #6 (60-year-old,
female, Lung Cancer)
From the perspective of social support theory, Medical Professionals are in the
formal support provider categories and expected to provide information and instrumental
supports. In this study they provide emotional support as well. In the next two excerpts
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participants comment on their medical professionals getting them the services they
needed.
“I felt like my healthcare system was an advocate.” #22 (62-year-old, female,
Breast Cancer)
“Yes, she has become more of a friend and an advocate b/c she got on the phone
and was talking to them and they paid attention to her. I can barely walk—but I
can’t use a walker or a cane—but she got on the phone and made them pay
attention about it like the wheelchair back in December. So that I can get around
without being stuck in the house.” #2 (65-year-old, female, Breast Cancer)
Having someone to advocate for you allows you to take a step back and let another
person have control of part of the situation. This allows the patient to focus on their
health and well-being.
Conceptual Heading – What defines this theme?
Provider supports the patient by ensuring their well-being and needs are met. Acts as a
voice for the patient.
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APPENDIX F: SITUATIONAL MAPPING
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Financial
Advice

APPENDIX G: STUDY 1 REFLEXIVITY
In order to further establish trustworthiness, this section will introduce me as the
researcher providing background information that has prepared me for completing this
research task.
This is my sixth year in the PhD program at the University of Louisville, Kent
School of Social Work. I am a PhD Candidate and have successfully completed all
required coursework and the comprehensive examination process. Coursework
requirements included research design and analysis for both qualitative and quantitative
studies. The in-depth course on qualitative analysis assisted in the development of the
focus for this proposed study. Other coursework that has assisted in preparing me for this
task includes theory and research ethics.
In addition to my coursework, I have had the opportunity to work on qualitative
and quantitative studies with several different professors at the university. I have
engaged in studies addressing the psychosocial needs of cancer patients as well as
community needs analysis, teaching practices, and theory development. Working under
the guidance of well-established professors has provided me with the skillset required to
tackle this project.
Some skills cannot be learned through the classroom or university environment;
instead, developed over life experiences. I am a non-traditional student obtaining my
higher degree at an older age. Prior to returning to obtain my Master’s and PhD, I worked
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in a variety of settings. The majority of my career was focused in mental health and child
welfare. These positions helped to develop skills of empathy and understanding for the
effects of oppression, life stressors, and varied life situations.
Other positions I have held over the years have prepared me as well. I spent
several years working in a laboratory processing materials for cancer screening. This
position provided me with insight into the breadth of those affected by cancer and the
importance of cancer screening awareness. The final position that I will discuss may be
most influential on my current studies. For several years I was a financial loan processor
working with individuals who had poor credit ratings and excessive amounts of debt. In
this position, I had the opportunity to meet with individuals who struggled financially.
The experience was humbling and provided me with insight into how difficult it was for
those individuals to seek financial assistance and to ask for help.
In addition to my work history experience, I have had three family members who
have experienced cancer: my grandmother, uncle and step-father. These family members
have all died from the effects of having lung cancer and I was unaware of their financial
concerns at the time of their cancer experiences. When speaking with my mother about
her and my stepfather’s experience, she elaborated on the stress of the associated costs.
Although they had adequate funds to afford him care, the expense was immense and the
loss that much greater after he lost his battle. Additionally, although I do not know for
certain, I suspect my uncle selected to not receive cancer treatment due to cost. He was
diagnosed at a late stage and the cost/benefit may not have been in his favor. As for my
grandmother, she would be considered lucky back then as they removed half of her lung
and with the assistance of oxygen, she survived several years after.
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All of my educational, career, and life experiences have led to the development of
who I am as a researcher on this project. As I engaged in the analysis process, I was
challenged to recognize who I am and how that may affect the interpretation of the
participant’s experience. It was my goal to allow the views of the participant to not be
overshadowed by any preconceptions that I had.
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APPENDIX H: CONSENT PREAMBLE

Hello
You are being invited to participate in a research study by answering the
following survey about understanding the financial demands cancer patients may
experience during and after treatment, as well as exploring their preferences for support
and information. There are no known risks for your participation in this research study.
The information collected may not benefit you directly. The information learned in this
study may be helpful to others. The information you provide will be used to inform
medical professionals about the information patients want and need regarding the costs of
cancer treatment and available resources to assist them. Your completed survey will be
collected in a protected survey collection system and then stored on a password protected
and secured computer. The survey will take approximately 20-30 minutes to complete.
Individuals from the University of Louisville Kent School of Social Work, the
Institutional Review Board (IRB), the Human Subjects Protection Program Office
(HSPPO), and other regulatory agencies may inspect these records. In all other respects,
however, the data will be held in confidence to the extent permitted by law. Should the
data be published, your identity will not be disclosed.
Taking part in this study is voluntary. By completing this survey you agree to
take part in this research study. You do not have to answer any questions that make you
uncomfortable. You may choose not to take part at all. If you decide to be in this study
you may stop taking part at any time.
If you have any questions, concerns, or complaints about the research study,
please contact: Dr. Kayser at [telephone number]
If you have any questions about your rights as a research subject, you may call the
Human Subjects Protection Program Office at [telephone number]. You can discuss any
questions about your rights as a research subject, in private, with a member of the
Institutional Review Board (IRB). You may also call this number if you have other
questions about the research, and you cannot reach the research staff, or want to talk to
someone else. The IRB is an independent committee made up of people from the
University community, staff of the institutions, as well as people from the community not
connected with these institutions. The IRB has reviewed this research study.
If you have concerns or complaints about the research or research staff and you do not
wish to give your name, you may call [telephone number]. This is a 24-hour hotline
answered by people who do not work at the University of Louisville.
This study is supported through a Doctoral Training Grant from the American
Cancer Society and approved by the University of Louisville IRB: 17.0187.
Sincerely,
Karen Kayser, PhD and Lisa Smith, MSSW
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APPENDIX I: STUDY 2 CALL FOR PARTICIPANTS
What was your experience with the financial costs of cancer treatment?
This study, conducted by researchers at the University of Louisville, is about the impact
of cancer treatment on the financial well-being and quality of life of cancer survivors.
We are inviting volunteers who have been diagnosed with breast cancer or blood
(Leukemia, Lymphoma, or Myeloma) cancer within the past five years to participate in
this study.
This study is open to men and women 18 years and older. It involves taking a 20-30
minute online survey and it is completely anonymous.
By better understanding your experiences we may be able to help others navigate the
financial terrain of cancer.
If interested in participating follow this link to the survey.
https://qmsweb.louisville.edu/blue/a.aspx?l=3325_1_AAAAAAAAaB8
Please let me know if you have any question.
Lisa Smith
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APPENDIX J: STUDY 2 QUESTIONNAIRE

Financial Impact of Cancer: Patient Preferences for Information and Support
Introduction
This questionnaire is about your experience with cancer and the impact this has had
on you financially. It attempts to explore your preferences to receiving information about
you medical costs as well as explore helpful resources and supports you may have relied
on. It will help us to assess the impact of the costs of cancer care and understand how to
financially guide future cancer patients. All answers are completely confidential. This
survey is expected to take about 30 minutes to complete.
Section I Contextual Questions
What type of cancer did you have?
1- Blood cancer
a. Leukemia
b. Lymphoma
c. Myeloma
2- Breast cancer
What type of cancer treatment did you receive? (Mark all that apply)
1- Surgery
2- Chemotherapy
3- Radiation
4- Stem Cell Transplant
5- Immunotherapy
6- Other _________________
What is the current status of your cancer?
1- Active
2- Remission
3- Cured
When were you first diagnosed with cancer? ___yr (fill-in)
When was your last cancer treatment? ___yr ___month (fill-in)
When you were diagnosed with cancer,
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How much did you understand your
health insurance coverage?
How much did you understand about
how much your treatment would cost?
How much did you understand how
much you would have to pay out of
pocket?
How much financial guidance did you
received from your cancer clinic?

Nothin
g at all
0

A little
bit
1

Some
2

Quite a
bit
3

Very
Much
4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

Which statement best describes your experience:
1. Someone at the cancer center/hospital offered to help me understand my
insurance, and medical costs.
2. I asked someone at the cancer center/hospital for help in understanding my
insurance and medical costs.
3. I needed help understanding my insurance and medical costs but was not
sure whom to ask.
4. I did not need help in understanding my insurance and medical costs.
5. Other_____
During your cancer experience: (Mark all that apply)
No
Doctor Financial Social Nurse Insura
One
advisor at worker
nce
cancer
compa
center
ny
0
1
2
3
4
5
Who talked to you about your
treatment costs?
Who talked to you about what
0
1
2
3
4
5
your insurance would cover?
Who provided you with
resources to get financial
help?
In your opinion, whom should
0
1
2
3
4
5
talk patients about treatment
costs, insurance coverage and
resources? (mark all that
apply)
Was there ever a time during your cancer experience that you felt stressed about your
financial situation (any time you were concerned about the cost of treatment,
managing every day expenses, what your insurance might cover, etc.)? 0-No, 1- Yes
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During your cancer experience:
Not at
all

A little
bit

Sometimes

Quite a
bit

Were you ever concerned about how
you would pay for your medical
expenses?

0

1

2

3

Very
Muc
h
4

Were you ever concerned about how
much your insurance would cover?
Were you ever concerned about how
you would pay for every day expenses
(food, rent, utilities, etc)?

0

1

2

3

4

0

1

2

4

5

Patients have reported to experience out-of-pocket expenses related to their cancer
treatment and follow-up. These include travel, over-the-counter medications,
supplies, childcare, increases in co-payments and insurance premiums. Over the
course of your cancer treatment, what was your estimated out-of-pocket expense?
1) $0 - $5000
2) $5001 - $10,000
3) $10,001 - $20,000
4) $21,001 - $40,000
5) More than $40,000
If over $40,000, how much? _________________
What is your estimated post-treatment expense per year? (I.e. medical costs for
follow-up visits, screening, medication, etc.).
1) N/A
2) $0 - $5000
3) $5001 - $10,000
4) Over $10,000
If over $10,000, how much? ______
How many times per year do you receive post-treatment services (cancer screening,
medical appointment, etc.)? _______
Due to your cancer experience:
• Did your insurance ever deny a cancer-related medical claim?
0 – No 1- Yes
If yes, how many times? ________
•

Did you file an appeal with your insurance provider for not covering cancerrelated medical claims? 0 – No 1- Yes
If yes, how many times? ________
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•

Did you contact your medical providers because of an error in their billing
process? 0 – No 1- Yes
If yes, how many times? ________

•

Did your receive collection calls due to your medical bills? 0-No, 1- Yes

•

Did you file for bankruptcy? 0-No, 1- Yes

Due to your cancer experience did you:
Not at
all
Delay receiving treatment
0
Stop receiving treatment
0
Alter medication choices due to
0
costs
Cut back on spending for food,
0
clothing, entertainment
Modify your mortgage or rent
0
payment
Negotiate bill payments
0
Defer student loan payment
0
Sell possessions
0
Use credit cards
0
Use retirement money
0
Use savings
0
Debt consolidation
0
Use vacation time/money
0
Eliminated expenses
0
Gave up career/job
0
Changed career/job
0
Apply for patient grants
0
Use employee sick-time
0
assistance
Open a Go Fund Me account
0

A little
bit
1
1
1

Sometimes
2
2
2

Quite
a bit
3
3
3

Very
Much
4
4
4

1

2

3

4

1

2

3

4

1
1
1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4
4
4
4

1

2

3

4

N/A

What helpful information or guidance did you receive regarding your treatment
costs, payments, insurance, etc.? (Mark all that apply)
[ ] Treatment options and costs.
[ ] Insurance coverage.
[ ] Estimate on how much I would have to pay for treatment.
[ ] Estimate on out-of-pocket expenses not covered by insurance would be.
[ ] Eligibility for disability.
[ ] Eligibility for FMLA.
[ ] Eligibility for Medicare/Medicaid.
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[ ] Student loan deferment.
[ ] Resources to help pay for treatment costs.
[ ] Resources to help pay for medications.
[ ] Resources to help pay for every-day living expenses.
[ ] other ___________________

Do you feel the following information would be helpful to receive when diagnosed
with cancer:
Not at
A little Some- Quite a Ver
all
bit
times
bit
y
Muc
h
Treatment options and their costs.
0
1
2
3
4
What your insurance will cover.
Estimated costs you will have to pay.
How to file an appeal with your
insurance company?
Estimated out-of-pocket expenses on
items that are not covered by
insurance.
Eligibility for disability
Eligibility for the Family and Medical
leave Act (FMLA).
Eligibility for Medicare/Medicaid
Financial resources to help pay for
medications?
Financial resources to help pay for
treatment costs?
Financial resources to help pay for
every-day living expenses (rent, food,
etc.)
Who to talk to about financial
questions and concerns.

0
0
0

1
1
1

2
2
2

3
3
3

4
4
4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

0
0

1
1

2
2

3
3

4
4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

What other financial information do you think would be helpful to give to patients
when they are diagnosed with cancer? _______________________________________

How much do you agree with these statements?
Not at
all
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A little
bit

Sometimes

Quite a
bit

Very
Much

Doctors should consider treatment
costs and insurance coverage before
making treatment recommendations.
Patients should consider treatment
costs and insurance coverage before
making treatment decisions.
During my cancer experience, I had all
the information I needed to make a
decision about treatment.
I would seek cancer treatment for no
matter what the cost.

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

During your cancer experience, did you receive tangible financial support or
assistance from:
Not at
A little Somew Quite a
all
bit
hat
bit

Parents/Parents-in-law
Children
Friends
Co-workers/Employer
Faith-based Community
Non-Profit Organizations
Medical Center
Pharmaceutical Company
Other

0
0
0
0
0
0
0
0
0

1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3

Ver
y
muc
h
4
4
4
4
4
4
4
4
4

Section II Financial Toxicity Scale (Cost-Prom)
Below is a list of statements related to the financial impact of your illness. Please place
an X in the box that best describes how you feel about that statement.
Not at
A little Some- Quite a Very
all
bit
times
bit
Much
I feel financially stressed.
0
1
2
3
4
I am satisfied with my current
0
1
2
3
4
financial situation.
I worry about the financial problems I
0
1
2
3
4
will have in the future as a result of
my illness or treatment.
I am frustrated that I cannot work or
0
1
2
3
4
contribute as much as I usually do.
My cancer or treatment has reduced
0
1
2
3
4
my satisfaction with my present
financial situation.
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I feel in control of my financial
situation.
I am able to meet my monthly
expenses.
I know that I have enough money in
savings, retirement or assets to cover
the costs of my treatment.
I am concerned about keeping my job
and income, including working at
home.
I feel I have no choice about the
amount of money I spend on care.
My out of pocket medical expenses are
more than I thought they would be.

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

Section III Perceived Social Support
PROMIS -Emotional Support (Please respond to each item by marking one box per
row.)
Never
Rarely Some- Usually Alw
times
ays
I have someone who will listen to me
1
2
3
4
5
when I need to talk.
I have someone to confide in or talk to
1
2
3
4
5
about myself or my problems.
I have someone who makes me feel
1
2
3
4
5
appreciated.
I have someone to talk with when I
1
2
3
4
5
have a bad day.
PROMIS - Informational Support (Please respond to each item by marking one box
per row.)
Never
Rarely Some- Usually Alw
times
ays
I have someone to give me good
1
2
3
4
5
advice about a crisis if I need it.
I have someone to turn to for
1
2
3
4
5
suggestions about how to deal with a
problem.
I have someone to give me
1
2
3
4
5
information if I need it.
I get useful advice about important
1
2
3
4
5
things in life.
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PROMIS - Instrumental Support (Please respond to each item by marking one box
per row.)
Never
Rarely Some- Usually Alwa
times
ys
Do you have someone to help you if
1
2
3
4
5
you are confined to bed?
Do you have someone to take you to
1
2
3
4
5
the doctor if you need it?
Do you have someone to help with
1
2
3
4
5
your daily chores if you are sick?
Do you have someone to run errands if
1
2
3
4
5
you need it?
Section IV Received Social Support
We are interested in learning about some of the ways that you feel people have helped you
or tried to make life more pleasant for you over the past four weeks. Please read each item
carefully and indicate how often these activities happened to you during the past four
weeks.
Not at Once or About Several Abou
all
twice
once a times a
t
week
week every
day
Gave you some information on how to
1
2
3
4
5
do something.
Helped you understand why you didn’t
1
2
3
4
5
do something well.
Suggested some action you should
1
2
3
4
5
take.
Gave you feedback on how you were
1
2
3
4
5
doing without saying it was good or
bad.
Made it clear what was expected of
you.
Told you what he/she did in a situation
1
2
3
4
5
that was similar to yours.
Told you that he/she feels close to you.
1
2
3
4
5
Let you know that he/she will always
1
2
3
4
5
be around if you need help.
Told you that you are OK just the way
1
2
3
4
5
you are.
Expressed interest and concern in your
1
2
3
4
5
well-being.
Comforted you by showing you some
1
2
3
4
5
physical affection.
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Told you that he/she would keep the
1
2
things you talk about private.
Agreed that what you wanted to do
1
2
was the right thing.
Did some activity together to help you
1
2
get your mind off things.
Gave or loaned you over $25
1
2
Provided you with a place to stay.
1
2
Loaned you or gave you something (a
1
2
physical object) that you needed.
Pitched in to help you do something
1
2
that needed to get done.
Went with you to someone who could
1
2
take action.
Section V Financial Social Support

3

4

5

3

4

5

3

4

5

3
3
3

4
4
4

5
5
5

3

4

5

3

4

5

Usually
4

Alw
ays
5

Never

Rarely

I have someone to talk to about my
financial concerns.

1

2

Sometimes
3

I know where to get information about
financial assistance to help with my
cancer expenses.
I know where to get information about
financial assistance to meet my
everyday obligations (rent, food,
utilities, etc.).
I am able to request financial help when
needed.
I have friends or family who can help
me financially if needed.

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

During your cancer experience, did you talk to a family member or friend about your
financial concerns about treatment costs, lost wages, out-of-pocket expenses, etc.? 0No; 1- Yes
•
•

If No, what prevented you from talking about your financial concerns or stress?
(open-ended) _________
If yes, who did you talk to (spouse, child, parent, best friend, pastor, etc.)
__________

Section VI Quality of Life (Fact-G Version 4)
Below is a list of statements that other people have said are important. Please circle or
mark one number per line to indicate your response as it applies to the past 7 days.
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Physical Well-Being
Not at
all
0
0
0

A little
bit
1
1
1

Somew
hat
2
2
2

Quite a
bit
3
3
3

Very
much
4
4
4

Not at
all

A little
bit

Somew
hat

Quite a
bit

0
0

1
1

2
2

3
3

Ver
y
muc
h
4
4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

I have a lack of energy.
I have nausea.
Because of my physical condition, I
have trouble meeting the needs of my
family.
I have pain.
0
1
2
3
4
I am bothered by side effects of
0
1
2
3
4
treatment.
I feel ill.
0
1
2
3
4
I am forced to spend time in bed.
0
1
2
3
4
Please circle or mark on number per line to indicate your response as it applies to
the past 7 days.
Social/Family Well-Being
Not at
A little Somew Quite a Very
all
bit
hat
bit
much
I feel close to my friends.
0
1
2
3
4
I get emotional support from my
0
1
2
3
4
family.
I get support from my friends.
0
1
2
3
4
I am satisfied with family
0
1
2
3
4
communication about my illness.
I feel close to my partner (or the
0
1
2
3
4
person who is my main support).
Regardless of your current level of sexual activity, please answer the following
question. If you prefer not to answer it, please mark this box ☐ and go to the next
section.
I am satisfied with my sex life.
0
1
2
3
4
Emotional Well-Being

I feel sad.
I am satisfied with how I am coping
with my illness.
I am losing hope in the fight against
my illness.
I feel nervous.
I worry about dying.

254

I worry that my condition will get
worse.

0

1

2

3

4

Not at
all

A little
bit

Somew
hat

Quite a
bit

Ver
y
muc
h
4

Functional Well-Being

I am able to work (include work at
0
1
2
3
home).
My work (include work at home) is
0
1
2
3
4
fulfilling.
I am able to enjoy life.
0
1
2
3
4
I have accepted my illness.
0
1
2
3
4
I am sleeping well.
0
1
2
3
4
I am enjoying the things I usually do
0
1
2
3
4
for fun.
I am content with the quality of my
0
1
2
3
4
life right now.
Please circle or mark on number per line to indicate your response as it applies to
the past 7 days.
Economic Well-Being
Not at
A little Somew Quite a Very
all
bit
hat
bit
much
I believe that being sick will hurt me
0
1
2
3
4
financially.
People like me are able to get the
0
1
2
3
4
healthcare they need.
I am able to make enough money to
0
1
2
3
4
pay for my healthcare.
I have to pay more for my medical
0
1
2
3
4
care than I can afford.
I am able to pay for my medical bills.
0
1
2
3
4
I can easily get information about
0
1
2
3
4
healthcare.
I can afford medical check-ups even
0
1
2
3
4
when I am not sick.
I have enough money to take care of
0
1
2
3
4
my healthcare needs.
I can get the health insurance we need.
0
1
2
3
4
My family thinks good healthcare is
0
1
2
3
4
important.
I know how to get the healthcare
0
1
2
3
4
services I need.
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I know people who will help me out
when I am sick.
People I know best have healthy
habits.
I understand the healthcare system.
The medicine I need is too expensive
for me.
I am treated the same as other patients
when I go for medical care.
Healthcare services are easy to get in
my neighborhood.

0

1

2

3

4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

0

1

2

3

4

0

1

2

3

4

Section VII Social Constraints
How often in the PAST MONTH has someone:
Not at
all

A little
bit

Some
-times

Qui Very
te a often
bit
3
4

Changed the subject when you tried to
discuss your illness?

0

1

2

How often did it seem that other people
did not understand your situation?

0

1

2

3

4

How often did other people avoid you?

0

1

2

3

4

How often did other people minimize
your problems?

0

1

2

3

4

How often did other people seem to be
hiding their feelings?

0

1

2

3

4

How often did other people act
uncomfortable when you talked about
your illness?

0

1

2

3

4

How often have other people trivialized
your problems?

0

1

2

3

4

How often have other people complained
about their own problems when you
wanted to share yours?

0

1

2

3

4
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How often did other people act cheerful
around you to hide their true feelings and
concerns?

0

1

2

3

4

How often did other people tell you not
to worry so much about your health?

0

1

2

3

4

How often did other people tell you to try
not to think about the cancer?

0

1

2

3

4

How often did you get the idea that other
people didn’t want to hear about your
financial concerns?

0

1

2

3

4

How often did you feel as though you
had to keep your feelings about your
cancer to yourself because they made
other people uncomfortable?

0

1

2

3

4

How often did other people make you
feel as though you had to keep your
feelings about your cancer to yourself,
because it made others upset?
How often did you feel other people let
you down by not showing you as much
love and concern as you would have
liked?
How often did you feel that you could
discuss your feelings about your cancerrelated financial concerns with (other
people/important other) when you wanted
to?

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

Section VIII Brief Health Literacy Screening Tool (BRIEF)
Please circle the answer that best represents your response.
How often do you have someone help you
read hospital materials?
How often do you have a problem
understanding the written materials about your
medical condition?
How often do you have a problem
understanding what is told to you about your
medical condition?

Always

Often

Sometimes

Rarely

Nev
er

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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How confident are you filling out medical
forms by yourself?

Not at
all

A little
bit

Somewhat

Quite a
bit

Extr
emel
y

1

2

3

4

5

Do you have any final thoughts or advice you would like share regarding the
financial impact you have experienced due to your cancer experience? ___________

________________________________________________________________________

Section IX Demographic Questions
Home zip code:
How old are you? ____ (age in years)
Gender:
Are you male or female?
1- Male
2- Female
Race/Ethnicity
What is your racial/ethnic group?
7- African-American/Black
8- Asian
9- American Indian/Alaskan Native
10- Caucasian/White
11- Hispanic
12- Native Hawaiian/Other Pacific Islander
13- Other __________________________
What is your current marital status?
6- Single, never married
7- Married
8- Not married, but in a relationship with significant other
9- Separated or divorced
10- Widowed
How many children under the age of 18 are living in your home? _____
What is your current job status?
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7- Employed full-time
8- Employed part-time
9- Unemployed
10- Homemaker
11- Disabled
12- Retired
Before your cancer diagnosis, what was your job status?
7- Employed full-time
8- Employed part-time
9- Unemployed
10- Homemaker
11- Disabled
12- Retired
If your job status changed, did it change because of your cancer? 0 – No 1- Yes
Did you have to leave your job temporarily to receive cancer treatment or recover?
0 – No 1- Yes
Did you have to leave your job permanently due to your cancer? 0 – No 1- Yes
What was your insurance status at your first cancer diagnosis? (Check all that
apply)
1- Employer paid private insurance
2- Self-paid private insurance
3- Veteran’s Administration coverage
4- Medicare disability insurance
5- Medicaid
6- No insurance
Has your insurance status changed since your first cancer diagnosis? 0 – No 1- Yes
If yes, which of the following insurance changes did you experience?
1- I lost my because I can no longer work
2- I lost my insurance because I can no longer afford it
3- I became eligible for Medicaid
4- I became eligible for Medicare disability
What is your current insurance status? (Mark all that apply)
1- Employer paid private insurance
2- Self-paid private insurance
3- Veteran’s Administration coverage
4- Medicare disability insurance
5- Medicaid
6- No insurance
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What is the highest level of formal education that you have completed?
6- Less than high school
7- Completed high school or GED
8- Some college or technical school (includes technical, vocational, or certificate
program and Associate’s degree)
9- Bachelor’s degree
10- Postgraduate or professional degree (includes Master’s, MD, PhD, and JD)
What is your occupation?
7- Homemaker
8- Executive of manager
9- Professional or technical
10- Clerical, sales or service work
11- Occupation in agriculture, forestry or fisheries
12- Occupation in crafts, repair, manufacturing, transportation or operation of
machinery
What were your household (family) gross wages or income last year (before taxes)?
7- Less than $25,000
8- $25,001-$40,000
9- $40,001-$60,000
10- $60,001-$80,000
11- Over $80,000
12- I don’t know

Thank you for your help.
If you would be willing to participate in any follow-up questions or related studies please
provide your name and email address/method to contact you.
_______________________________________________
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APPENDIX K: QUANTITATIVE STRAND TABLE OF VARIABLES

Study 2 overview of variables, measurements, and level of measure.
Variables
Independent Variable
Financial Burden of Cancer

Moderator/Mediator
Variable
Social Support – Perceived

Social Support - Received

Criterion/Dependent
Variable
Quality of Life
• Domains: Physical,
Functional, Social &
Emotional
•

Doman:
Socioeconomic

Contextual Characteristics
• Cancer type,
• Cancer treatment,
• Disease status,
• Elapsed time since
cancer Treatment

Measure

Level of
Measure

COST – Comprehensive Score for
Financial Toxicity
• 11-item, self-rated Likert scale
(0 = Not at All to 5 = Very
Much)

Interval

PROMIS – Emotional, Informational,
& Instrumental short scales
• Each scale has 8-items, 5-point
Likert scale

Interval

Inventory of Socially Supportive
Behaviors (ISSB)
• 40-item, 5-point Likert scale

Interval

FACT-G
• 28 –item Likert scale (0 = Not
at All to 4= Very Much).

Interval

Interval
Socioeconomic Well-Being Scale
• 17-item Likert scale (0 = Not at
All to 4= Very Much)
See questionnaire for specific
questions.
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Nominal/
Ordinal

Covariate
• Social Constraint

Covariate/Descriptive
• Age,
• Gender,
• Race/Ethnicity,
• Marital Status,
• Employment,
• Education
• Insurance Status,
• Income

Social Constraint Scale
• 16 item Likert scale.

Interval

See questionnaire for specific
questions.

Interval/
Nominal/
Ordinal
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APPENDIX L: PREPARING DATASET

Overview of Steps
1. Downloaded responses – n=131 – one deleted for missing data; deleted 4 for
various types of cancer other than blood or breast (Colon, Kidney, Lung, Othernot specified).
2. Created SPSS database with blood and breast cancer patients.
3. Reverse coded variables and calculated scales.
4. Created Composite variable for Social Support.
5. Tested for assumptions.
6. Dummy variables were created for control variables.
Calculate Scales and Handling Missing Values
Cost scale
Missing values (4) were replaced with a simple mean substitution. This is the
method the developers of the scale specified to use for missing data (de Souza).
Following guidelines, items 2,6,7,8 were reverse scored and all items were totaled using
SPSS (reverse codes 0-4, 1-3,2-2). In review of the data an outlier was found. Upon
review of that case it was determined that a response was not entered correctly into SPSS.
The correct response was determined by reviewing the original excel data file. Possible
score range is 0-44. The higher the score, the worse the financial toxicity. A standard
frequency distribution was conducted using SPSS. A mean score of 19.14 (SD = 8.56)
range 0-44. See tests for assumptions and table for skewness and kurtosis for more
information.
PROMIS Social Support scales
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Guidelines for scoring the three PROMIS Social Support scales were followed.
The short form for each domain was used. Two responses were missing and these where
replaced with the mean score of participants responses as directed by the scale guidelines
obtained from the Assessment Center (assessmentcenter.net). Raw scores were calculated
and then translated to the designated T-score for each scale. The T-score allows the
evaluation against the general U.S. population. A score of 50 (SD – 10) was determined
by scale developers to be the average of the reference.
Composite Variable. A social support composite variable was created out of
Social Support PROMIS scales following the direction of Song, Lin, Ward and Fine
(2013). The variables created a meaning full grouping and were correlated but not highly
correlated. A simple average approach was used as the scales are continuous. Z scores
should be used when the original variables differ in variance with the outcome variable.
This was not an issue but to verify such a second composite variable was created using Z
scores and both composite variables were compared showing similar distribution.
Creating a composite variable can control for Type 1 errors (rejecting the null hypothesis
– supporting the hypothesis when it should be rejected). Power analysis were conducted
to justify creating a composite variable opposed to using the Bonferroni correction.
Power was high for all variables.
Steps used to create an equal weighted composite in SPSS: Transform à
Compute variable à (Add each scales )/3.
Received Social Support
The short form for the Inventory of Socially Supportive Behaviors (ISSB) was
used to measure the amount of social support received. Following study guidelines for
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scoring, 7 missing values were replaced with a simple mean substitution. Per scale
tabulation instructions, mean substitution was calculated from all participant responses
for that item. To obtain a total score, all items were then summed.
Social Constraint
Social Constraint required recoding of question 16. Mean substitution was used
for 3 missing responses. All items were summed. The higher the score the more social
constraint.
Quality of Life
Functional Assessment of Cancer Therapy scale (FACT-G) and the FACT-G plus
socio-economic well-being scales were used to determine quality of life. Reversal of
questions were followed: Physical Well-being subscale all 7 items; Emotional Well-being
subscale item 1,3,4,5,6; Economic Well-being subscale items 1,4,15. Followed scale
guidelines for missing data which involved adding up the individual’s responses for that
subscale and dividing by the number responded to.
Tests for Assumptions
Prior to conducting the analyses for the study aims, the data was reviewed to
determine if it met the assumptions for analysis. Box and Whisker plots were created to
identify outliers. Outliers were identified; therefore, additional analysis used histograms,
skewness and kurtosis values, and the interquartile range (IQR). Outliers were all within
the 1.5 IQR range so these observations stayed in the data pool.
Tests for normal distribution were conducted. Shapiro-Wilks raised concern over
all scales expect the FACT-G. Upon further inspection of (histograms, skewness and
kurtosis values) all scales appeared to meet expectations for normality except for social
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constraint. Final decision as based off the robustness of the sample size being large
enough to advert issues of normality. Further, the PROCESS model used for the Mediator
analysis uses bootstrap technique at 5000 samples to handle issues of non-normal
distribution.
Issue of multicollinearity were examined through Pearson’s Correlations.
Variables were not too highly correlated. The received support variable in the blood and
breast cancer dataset was not properly correlated with other variables; more information
can be found in Chapter 6 and 7. To determine if the data had issues of linearity or
heteroscedasticity, scatter plots and linear regressions were used. All data appeared to be
linear and homoscedastic.
Outliers
Outliers can lead to Type I and Type II errors (Tabachnick, et al., 2013);
therefore, careful review of the data was conducted. The presence of outliers was
assessed a box and whisker plot assessment. The box and whisker plot in SPSS indicate if
an observation is over 1.5 Inter-quartile Range (IQR) rule. SPSS calculates the upper and
lower quartiles and then multiplies the difference by 1.5. Any observation beyond this
calculation would be indicated as an outlier. According to Hoaglin and Iglewicz (1987),
this IQR rule can be incorrect about 50% of the time and a more appropriate indicator is
at a multiplication of 2.2. This requires that the researcher review any outliers indicated
by SPSS. Box and whisker plots were reviewed and assessed for outliers.
Creating Box and Whisker Plot for Outliers.
Steps in SPSS:
1) Select Graphs
2) Legacy Dialog
3) Boxplot
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4) Simple
5) Define
6) Select the variable you want to examine into the Variable box.
7) Select a categorical variable for the x-axis.
8) Select OK
Normal Distribution
Distribution was check by using the Shapiro-Wilks Analysis, Skewness and
Kurtosis and if the absolute value was less than the value of the standard error multiplied
by 3. The data size is large enough (n= 126) that the assumption of normality is not a
concern (reference Lawson email and StatistisHowTo.com)
Shapiro-Wilks. SPSS Steps:
Analyze
Descriptive Statistics
Explore
Select data into Dependent List
Select Plots
a. Select Normality plots with tests
6) Significance indicates not normal distribution.
In order to check for normality a normal distribution of data a Shapiro-Wilks analysis
1)
2)
3)
4)
5)

was conducted on all scales. The Quality of Life FACT -G scale was found to be not
significant (p < 0.118). This indicated that the data was normally distributed. The
remaining scales were found to be significant: FACT-G with Economic Well-being (p <
0.02), COST (p <0.001), Social Constraint (p < 0.000), Received Social Support (p <
0.03), Emotional, Informational and Instrumental Social Support each (p < 0.001),
Composite Social Support (p < 0.001).This infers that the data for these scales is not
normally distributed and required further investigation.
Skewness and Kurtosis. In order to check for normal distribution of data a
descriptive analysis was conducted to identify skewness and kurtosis. When assessing for
skewed data, a zero value indicates the distribution tail is equal on both sides. A
positively skewed data has the tail on the right and negatively skewed has the tail on the

267

left. The further the calculated value is from zero the more likely it indicates a nonnormal distribution. A value between -1 and +1 is typically within normal range. Another
method to determine normal distribution is to determine interquartile range (i.e., if the
absolute value is less than the value of the standard error multiplied by 3). For this later
assessment, two scales raise some concern as their values are slightly above the
acceptable range (see table for values). For these two scales, bootstrapping analysis will
need to be implemented. Kurtosis is the assessment of the peak of the distribution. It
indicates if the peak is too sharp or too flat. Using the same assessment as above, there
does not appear to be any issues with kurtosis. All scales were further viewed using
scatter plots and histograms for interpretation of normative data.
Table Appendix.1: Skewness and Kurtosis Values.
Variable
COST
Emotional Support
Informational Support
Instrumental Support
Composite Support
Received Support
Social Constraint
FACT-G
FACT-G Plus

Skewness
0.354
-0.303
-0.232
-0.159
-.265
0.1.43
0.755
-0.353
-0.351

Kurtosis
0.732
-0.830
-0.658
-0.90
-.954
-0.835
-0.481
-0.376
-0.456

COST Comprehensive Score for Financial Toxicity, FACT-G Functional Assessment of
Cancer Therapy scale for QoL, FACT-G Plus Socioeconomic Well-being scale.

Linearity
SPSS steps to create scatter plot using criterion variable (predicted variable).
1) Graphs à Legacy Dialog à Scatter/Dot à Select Simple à Define
2) Move dependent variable to Y Axis and independent variable to X Axis
3) Double click on chart. Select fit line.
4) Scatter plots looked acceptable. (Received social support looked concerning but
had a slight linear relationship.)
Test for Homoscedasticity
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Homoscedasticity results if you have a consistent relationship across the page.
Heteroscedasticity exists if the relationship is erratic which is not desired. Scatter plots
were conducted on all scales with no issues of heteroscedasticity.
SPSS steps to create plot to examine homoscedasticity.
1) Analyze
2) Select Regression
3) Select Linear
4) Put scale interested in Dependent and another variable in the Independent
5) Plots – put ZRESID in Y axis and ZPred in X axis
6) Continue and OK
7) Double click on the table and select “fit line” on the plot. Want line to be flat.
This provides the predictor on the x axis and error on the y axis.
Multicollinearity
Multicollinearity occurs when two IVs are highly correlated. Pearson’s
Correlation was run to check for correlations (desired r < .80). All scales were below r =
.80 except FACT-G and FACT-G Plus. This is expected as they are partially the same
scale and will not be run in the same analysis.
Reliability
Scale reliability analysis were conducted to ensure the scale reflects the construct
it is measuring.
Steps in SPSS:
1) Analysis
2) Scale
3) Reliability analysis
4) Select all items of each scale.
5) Model: Alpha
6) Select Run
Dummy Variables
Multiple regression cannot handle a nominal variable with more than 2 levels.
Dummy variables were created for variables that theoretically may impact the outcome
variable. Items were recoded with 0 or 1 with zero = other and 1 = category of interest.
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APPENDIX M: PEARSON BIVARIATE CORRELATIONS

Pearson’s bivariate correlations were used to determine if relationships between
interval/ratio level variables exist (Meyers et al., 2013; Field, 2013; Lawson et al., 2014).
Pearson’s correlation report if items are negatively or positively correlated. Accepted
affect values are basic Cohen conversions: -1 to -0.51 equals strong negative correlation;
-0.5 to -0.20 equals moderate negative correlation; -0.19 to -0.01 equals weak negative
correlation; 0.00 equals no correlation; 0.01 to 0.19 equals weak positive correlation; 0.2
to 0.50 equals moderate positive correlation; 0.51 to 1 equals a strong positive
correlation. If assumptions are not met and the data contains outliers or is not normally
distributed, correlations can be determined using a rank order method: Spearman’s rho or
Kendall’s tau (Lawson et al. 2014; Fields, 2013).
Analysis Plan to Determine Co-variables (adapted from Lawson et al., 2014 Chapter 6)
Study Question:
What is the relationship between quality of life and
interval/ratio variables listed below?
• Age
• Social Support
• Financial Burden
• Social constraint
Hypothesis:
Experimental: There is a relationship between quality of
life and variables.
Null: There is no significant relationship.
Expected:
There will be no relationship between quality of life and the
identified variables.
Assumptions:
Interval level data, normal distributions
SPSS steps for analysis:
Analyze à Scroll down to correlate à Bivariate à Pearson
(1) Select variables
(2) OK to run
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APPENDIX N: ANALYSIS OF VARIANCE

Analysis of Variance (ANOVA) was used to determine if there are relationships
between quality of life (DV) and any nominal/ordinal variables in this study. The
ANOVA will report if any significant differences occur between the groups in the
analysis; therefore, indicating a variable that may affect the outcome.
Analysis Plan (adapted from Lawson, et al., 2014 – Chapter 2)
Study Question:
Is there a difference in quality of life between
[nominal/ordinal variable categories]?
• Disease Status
• Gender
• Race/Ethnicity
• Marital Status
• Education
• Employment
• Insurance Status
• Treatment
Hypothesis:
Experimental: There is a difference in quality of life
between [nominal/ordinal variable categories].
Null: There is no significant difference.
Expected:
There will be no significant difference.
Type of Design:
Non-Experimental Ex Post Facto
Assumptions:
Nominal/Ordinal IV, Interval/ratio DV, normal
distributions
SPSS Steps for Analysis:
Analyze à Select General Linear Model à Univariate
(3) Move Quality of life (DV) into Dependent box
(4) Move [nominal/ordinal level variable] (IV) into Factor box
(5) Select options: Descriptive, Estimates of Effect Size, Observed Power
and Homogeneity of Variance Test
(6) Run Analysis
Partial eta-squared effect sizes (Lawson, et al., 2014):
0.010 = small effect size
0.059 = medium effect size
0.138 = large effect size
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Power
As the statistical power increase the chances of making a Type II error and
wrongly rejecting the null hypothesis decreases. More power to decrease risk of Type II
error.
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APPENDIX O: MODERATION ANALYSES IN PROCESS
Hierarchical stepwise multiple regression analysis will be simulated through the
Introduction to Mediation, Moderation, and Conditional Process Analysis (PROCESS)
macro.
Analysis Plan (adapted from Lawson, et al., 2014 – Chapter 7)
Level of Measurement:
Type of Design:
Number of Samples:
Assumptions:

Possible control variables:

IV interval/ratio level; DV interval/ratio level
Non-Experimental Ex Post Facto
One sample
Interval/ratio level data, normal distributions, linear
relationship (scatter plot), homoscedasticity (error and
model fit), not multicollinearity. Sample size,
misspecification of variables?
Interval: social constraint,
Ordinal/Nominal: cancer treatment, education,
employment, insurance status, and marital status.

SPSS Steps for PROCESS Moderation Analysis
1. Select Analysis
2. Select Regression
3. Select PROCESS
4. Put Social Support in Proposed Moderator W box and Financial burden in X
variable Box
5. Put Quality of life in the Y Variable box
6. Select Model #1 (or 3 for Moderated Moderator)
7. Select Options
a. Select Mean Center, Visualizing Interactions, Regression Coefficients,
Heteroscedasticity
8. Click continue
9. OK to run
10. Moderator effect is indicated by significant model fit (overall, for each variable
and for interaction).
11. If significant – run again with covariates (dummy variable covariates)
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12. Move: Cancer Treatment, Education, Employment, Insurance and Marital Status
(items selected due to outcomes of ANOVA analysis to see if these variables
played a role).
13. OK to run
14. Remove non-significant variables from the equation.
15. Add Social Constraint to Moderator Z box.
16. Select Model 3 (Model 3 used because Social Constraint is a continuous
variables)
Example: SPSS Output for Moderation Analysis
Received Social Support moderates the relations between Financial Toxicity and Quality
of Life (Fact-G).
*************** PROCESS Procedure for SPSS Version 3.3 *******************
Written by Andrew F. Hayes, Ph.D.
www.afhayes.com
Documentation available in Hayes (2018). www.guilford.com/p/hayes3
************************************************************************
**
Model : 1
Y : QoL
X : COST
W : RecSS
Sample
Size: 106
************************************************************************
**
OUTCOME VARIABLE:
QoL
Model Summary
R
R-sq
MSE F(HC0)
df1
df2
p
.6213 .3861 253.5251 18.1830 3.0000 102.0000

.0000

Model
coeff se(HC0)
constant 67.0876 1.5141
COST
-1.4101 .2153
RecSS
.3198 .1041
Int_1
.0335 .0141

t
44.3072
-6.5484
3.0733
2.3773

p
LLCI
.0000 64.0842
.0000 -1.8372
.0027 .1134
.0193 .0056

Product terms key:
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ULCI
70.0909
-.9830
.5262
.0615

Int_1

:

COST

x

RecSS

Covariance matrix of regression parameter estimates:
constant
COST RecSS
Int_1
constant 2.2926 .0743 -.0319 -.0020
COST
.0743
.0464 -.0012 -.0017
RecSS
-.0319 -.0012 .0108 .0003
Int_1
-.0020 -.0017
.0003 .0002
Test(s) of highest order unconditional interaction(s):
R2-chng F(HC0)
df1
df2
p
X*W .0287 5.6515 1.0000 102.0000
.0193
---------Focal predict: COST (X)
Mod var: RecSS (W)
Conditional effects of the focal predictor at values of the moderator(s):
RecSS Effect se(HC0)
t
-15.5233 -1.9303 .3825 -5.0470
1.4767 -1.3606 .2046 -6.6506
16.3567 -.8619 .2115 -4.0757

p
LLCI
ULCI
.0000 -2.6890 -1.1717
.0000 -1.7664 -.9548
.0001 -1.2814 -.4425

Data for visualizing the conditional effect of the focal predictor:
Paste text below into a SPSS syntax window and execute to produce plot.
DATA LIST FREE/
COST
RecSS
QoL
.
BEGIN DATA.
-8.1406 -15.5233 77.8370
1.7394 -15.5233 58.7652
5.7394 -15.5233 51.0438
-8.1406 1.4767 78.6360
1.7394 1.4767 65.1931
5.7394 1.4767 59.7507
-8.1406 16.3567 79.3353
1.7394 16.3567 70.8195
5.7394 16.3567 67.3718
END DATA.
GRAPH/SCATTERPLOT=
COST WITH QoL BY

RecSS

.

*********************** ANALYSIS NOTES AND ERRORS ******************
******
Level of confidence for all confidence intervals in output:
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95.0000
W values in conditional tables are the 16th, 50th, and 84th percentiles.
NOTE: A heteroscedasticity consistent standard error and covariance matrix estimator wa
s used.
NOTE: The following variables were mean centered prior to analysis:
RecSS COST
------ END MATRIX -----
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APPENDIX P: MEDIATION ANALYSIS IN PROCESS
The PROCRESS macro for SPSS was used to simulate the linear regression
analyses to determine mediation.
Analysis Plan (adapted from Lawson, et al., 2014)
Level of Measurement:
Type of Design:
Number of Samples:
Assumptions:

Interval/ratio (DV), Interval/ratio (IV)
Non-Experimental - Ex Post Facto
One sample
Normal distributions, linear relationship

SPSS Steps for Analysis Hypotheses 2.1 – 2.4
(1) Open Data Set
(2)
Analyze
(3)
Regression
(4)
PROCESS v3.3 by Hayes (2017)
(5)
Move variables in to respective boxes
a. DV into X Variable box
b. IV into Y variable box
c. Mediator Variable into Mediator(s) M box.
d. (Moderated Mediator model 14 add to box Moderator W
box – for social constraint)
(6)
Select appropriate Model (4 or 14)
(7)
Click on Options
a. Select Show covariance, generate code for visualizing,
show total effect (model 4 only), effect size, standardized
coefficients, Heteroscedasticity (Huber-White).
(8)
Continue
(9)
OK to run
Example: SPSS Output for Moderation Analysis
Perceived Social Support mediates the relations with Financial Toxicity and Quality of
Life (Fact-G).
*************** PROCESS Procedure for SPSS Version 3.3 *******************
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Written by Andrew F. Hayes, Ph.D.
www.afhayes.com
Documentation available in Hayes (2018). www.guilford.com/p/hayes3
************************************************************************
**
Model : 4
Y : QofL
X : COST
M : CompSS
Sample
Size: 126
************************************************************************
**
OUTCOME VARIABLE:
CompSS
Model Summary
R
R-sq
.4596 .2112

MSE F(HC0)
54.6455 34.1629

df1
df2
p
1.0000 124.0000

.0000

Model
coeff se(HC0)
t
p
LLCI
ULCI
constant 60.0540 1.3842 43.3844 .0000 57.3142 62.7938
COST
-.4384 .0750 -5.8449 .0000 -.5868 -.2899
Standardized coefficients
coeff
COST -.4596
Covariance matrix of regression parameter estimates:
constant
COST
constant 1.9161 -.0927
COST
-.0927 .0056
************************************************************************
**
OUTCOME VARIABLE:
QofL
Model Summary
R
R-sq
MSE F(HC0)
df1
df2
p
.6794 .4616 213.3253 48.3349 2.0000 123.0000
Model
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.0000

coeff se(HC0)
t
p
LLCI
ULCI
constant 38.6393 11.0004 3.5125 .0006 16.8645 60.4140
COST
-.9472 .1664 -5.6930 .0000 -1.2766 -.6179
CompSS
.9004 .1783 5.0498 .0000 .5475 1.2534
Standardized coefficients
coeff
COST
-.4169
CompSS
.3780
Covariance matrix of regression parameter estimates:
constant
COST CompSS
constant 121.0099 -1.1063 -1.8931
COST
-1.1063 .0277
.0119
CompSS
-1.8931 .0119
.0318
************************** TOTAL EFFECT MODEL ***********************
*****
OUTCOME VARIABLE:
QofL
Model Summary
R
R-sq
MSE F(HC0)
df1
df2
p
.5907 .3489 255.9078 72.2851 1.0000 124.0000

.0000

Model
coeff se(HC0)
t
p
constant 92.7123 2.9718 31.1970
COST
-1.3419 .1578 -8.5021

LLCI
ULCI
.0000 86.8302 98.5944
.0000 -1.6543 -1.0295

Standardized coefficients
coeff
COST -.5907
Covariance matrix of regression parameter estimates:
constant
COST
constant 8.8318 -.4169
COST
-.4169 .0249
************** TOTAL, DIRECT, AND INDIRECT EFFECTS OF X ON Y *******
*******
Total effect of X on Y
Effect se(HC0)
t
-1.3419 .1578 -8.5021

p
LLCI
ULCI
c_ps
c_cs
.0000 -1.6543 -1.0295 -.0680 -.5907
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Direct effect of X on Y
Effect se(HC0)
t
-.9472
.1664 -5.6930

p
LLCI
ULCI
c'_ps
c'_cs
.0000 -1.2766 -.6179 -.0480 -.4169

Indirect effect(s) of X on Y:
Effect BootSE BootLLCI BootULCI
CompSS -.3947 .1147 -.6580 -.2112
Partially standardized indirect effect(s) of X on Y:
Effect BootSE BootLLCI BootULCI
CompSS -.0200 .0054 -.0322 -.0109
Completely standardized indirect effect(s) of X on Y:
Effect BootSE BootLLCI BootULCI
CompSS -.1737 .0434 -.2680 -.0972
*********************** ANALYSIS NOTES AND ERRORS ******************
******
Level of confidence for all confidence intervals in output:
95.0000
Number of bootstrap samples for percentile bootstrap confidence intervals:
1000
NOTE: A heteroscedasticity consistent standard error and covariance matrix estimator wa
s used.
------ END MATRIX -----
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APPENDIX Q: NON-SIGNIFICANT ANALYSIS TABLES

Hypothesis 1.1: Received social support did not moderate the relationship between
COST and QoL (FACT-G) in the dataset with both Blood and Breast cancers.
Table Q.1 Hypothesis 1.1 Non-significant Interaction Variable for Hypothesis 1.1.
Variable
b
SE
95% CL
p
F (df)
R2
Predictor Variables
Constant
Financial Toxicity
(centered)
Received Support
(centered)
Interaction
Financial Toxicity
x Received Support

67.07 1.37

[64.35, 69.79]

0.001 25.23 (3, 122)
0.001

-1.37

0.18

[-1.72, -1.02]

0.001

0.21

0.10

[0.02, 0.40]

0.3

0.01

0.01

[-0.01, 0.04]

0.24

0.38

1.38 (1, 122)

Hypothesis 1.2: Perceived social support did not moderate the relationship between
financial toxicity and QoL (FACT-G).
Table Q.2: Moderator Analysis of Perceived Social Support (Composite*) and FT on
QofL.
R2 = 0.47, F (3, 122) = 40.56, p = 0.001
Variable

b

SE

t

p

95% CL

Constant

66.33

1.4

47.33

0.001

[63.55, 69.10]

COST (centered)

-0.93

0.17

-5.55

0.001

[-1.25, -0.60]

Composite Support (centered)

0.94

0.17

5.36

0.001

[0.59, 1.28]

COST x Composite Support

-0.02

0.02

-0.99

0.32

[-0.07, 0.02]
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D R2

0.01

Table Q.3: Emotional Perceived Support and Financial Burden Linear Model
Predicting QoL.
R2 = 0.46, F (3, 122) = 35.87, p = 0.001
Variable

b

SE

t

p

95% CL

Constant
COST (centered)

67.17
-1.04

1.36
0.16

49.25
-6.68

0.001
0.001

[64.47, 69.87]
[-1.35, -0.73]

Emotional Support (centered)

0.82

0.17

4.84

0.001

[0.48, 1.15]

COST x Emotional Support

0.004

0.02

0.22

0.82

[-0.03, 0.04]

Table Q.4: Informational Perceived Support and Financial Burden Linear Model
Prediction QoL.
R2 = 0.43, F (3, 122) = 32.01, p = 0.001
Variable

b

SE

t

p

95% CL

Constant
COST (centered)

66.89
-1.03

1.42
0.17

47.25
-6.12

0.001
0.001

[64.09, 69.69]
[-1.36, -0.70]

Informational Support (centered)

0.63

0.16

4.08

0.001

[0.33, 0.94]

COST x Informational Support

0.004

0.02

-0.26

0.8

[-0.38, 0.03]

Table Q.5: Instrumental Perceived Support and Financial Burden Linear Model
Prediction QoL.
R2 = 0.44, F (3, 122) = 41.17, p = 0.001
Variable

b

SE

t

p

Constant
COST (centered)

65.92
-1.09

1.44
0.16

45.78
-6.78

0.001
0.001

[63.07, 68.77]
[-1.42, -0.77]

Instrumental Support (centered)

0.59

0.15

3.97

0.001

[0.30, 0.88]

COST x Instrumental Support

-0.33

0.02

-1.88

0.06

[-0.069, 0.00]
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95% CL

Hypothesis 1.3: Received social support will moderate the relationship between
financial burden and QoL (FACT-G Plus).
Table Q.6 Received Social Support and Financial Burden Linear Model of QoL
with economic well-being.
Variable
Constant
COST (centered)
Received Support
(centered)
COST x
Received Support

b

SE

t

p

95% CL

111.42
-2.54

1.89
0.25

58.99
-9.93

0.001
0.001

[107.68, 115.16]
[-3.05, -2.04]

0.37

0.12

3.06

0.03

[0.13, 0.62]

0.03

0.02

1.63

0.11

[-0.05, 0.06]

Hypothesis 1.4: Perceived social support will moderate the relationship between
financial burden and QoL (FACT-G Plus).
Table Q.7: Composite Perceived Support and Financial Burden Linear Model for QoL
with Socio-economic Well-being.
R2 = 0.59, F (3, 122) = 61.61, p = 0.001
Variable
Constant
COST (centered)
Composite Support
(centered)
COST x Composite
Support

b

SE

t

p

95% CL

110.43
-1.87

1.91
0.24

57.88
-7.68

0.001
0.001

[106.66, 114.21]
[-2.35, -1.38]

1.41

0.25

5.71

0.001

[0.92, 1.89]

-0.03

0.03

-1.02

0.31

[-0.04, 0.04]

Table Q.8: Emotional Perceived Support and Financial Burden Linear Model for QoL
with Socio-economic Well-being.
R2 = 0.58, F (3, 122) = 57.99, p = 0.001
Variable
Constant
COST (centered)
Emotional Support
(centered)
COST x Emotional
Support

b

SE

t

p

111.59
-2.05

1.91
0.24

58.35
-8.52

0.001
0.001

[107.81, 115.38]
[-2.53, -1.57]

1.2

0.24

4.9

0.001

[0.71, 1.68]

0.01

0.03

0.3

0.77

[-0.04, 0.06]
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95% CL

Table Q.9: Informational Perceived Support and Financial Burden Linear Model for
QoL with Socio-economic Well-being.
R2 = 0.57, F (3, 122) = 51.27, p = 0.001
Variable
Constant
COST (centered)
Informational Support
(centered)
COST x Informational
Support

b

SE

t

p

95% CL

111.46
-2.01

1.96
0.25

56.92
-8.06

0.001
0.001

[107.59, 115.34]
[-2.50, -1.52]

0.98

0.22

4.51

0.001

[0.55, 1.42]

0

0.02

0.11

0.91

[-0.38, 0.04]

Table 7.20: Instrumental Perceived Support and Financial Burden Linear Model for
QoL with Socio-economic Well-being.
R2 = 0.56, F (3, 122) = 64.07, p = 0.001
Variable
Constant
COST (centered)
Instrumental Support
(centered)
COST x Instrumental
Support

b

SE

t

p

109.62
-2.12

1.96
0.23

55.87
-9.33

0.001
0.001

[105.73, 113.50]
[-2.57, -1.67]

0.88

0.2

4.38

0.001

[0.48, 1.27]

-0.05

0.02

-2.11

0.04

[-0.101, 0.003]
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PEER REVIEWED PUBLICATIONS SUBMITTED
Archuleta, A., Cotton, S., & Smith, L. C. (submitted). Examining an instrument for assessing
organizational capacity readiness among non-profit organizations through a grant review
process. Human service Organizations: Management, Leadership, & Governance.
Harris, L., Smith, L.C., & Thang, N.D. The career: Caregiving processes for grandparents raising
grandchildren in the wake of the AIDS epidemic in Vietnam.
Kayser, K. Harris, L., Head, B., Smith, L. C., & Washington, A. (submitted). Living with the
financial consequences of cancer: A life course perspective.
PUBLICATIONS IN PROGRESS
Kayser, K., Anderson, G*., Randall, J.*, Smith, L.*, Washington, A* & LaJoie, S. Investigating
the effectiveness of cervical cancer interventions: A meta-analysis. (* Equal Contribution)
Smith, L.C., Kayser, K., Harris, L., Head, B., & Washington, A. A role for medical professionals
in addressing costs of cancer.
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Ranja, S., Kayser, K., Smith, L.C., & Kloecker, G. A patient-centered approach to address fears
of cancer recurrence during surveillance after treatment for lung cancer.
PRESENTATION & POSTERS
INVITED ORAL PRESENTATIONS - Webinar
Smith, L. C. (January 16, 2019). Invitation to participate in cancer care access panel: PCORI
Metastatic Cancer Series Webinar 2: Access Disparities in Cancer and Cancer Research.
Topic: Financial Toxicity of Cancer. University of Kansas Medical Center, Kansas City,
KS.

PEER REVIEWED CONFERENCE PRESENTATIONS – ORAL
Schapmire, T., Head, B., Faul, A. C., Pfeifer, M., & Smith, L. C. (2016). Silos to synergy:
Initiating, implementing, and integrating inter-professional education in the health
sciences. Counsel on Social Work Education (CSWE), Atlanta, GA. (Oral Presentation)
Head, B., & Smith, L. C. (2016). Lights, cameras, action! Use of contemporary film to stimulate
higher level learning. 2016 Celebration of Teaching and Learning, University, of
Louisville, Delphi Center for Teaching & Learning, Louisville, KY.
PEER REVIEWED CONFERENCE PRESENTATIONS – POSTER
Smith, L. C., Kayser, K., Head, B., Harris, L., & Washington, A. (2017) Financial toxicity of
cancer: A role for social work educators & practitioners. Council on Social Work
Education, Dallas, TX.
Kayser, K., Smith, L. C., Washington, A., Harris, L., and Head, B. (2017). The process of
financial toxicity due to cancer: Why age matters. International Psycho-Oncology Society
- World Congress (IPOS), Berlin, Germany.
Faul, A., Cotton, S. G.*, & Smith, L. C.* (2016). Serving nutritional needs of older adults.
Society for Social Work and Research (SSWR), Washington D. C. (*Equal Contribution)
Smith, L. C., Kayser, K., Washington, A., Ranja, S., & Kloecker, G. (2015). A patient-centered
approach to address fears of cancer recurrence during surveillance after treatment for
lung cancer. International Psychosocial Oncology Society/American Psychosocial
Oncology Society World Congress (IPOS/APOS), Washington, D.C. (Student Award)
Smith, L. C.*, Cotton, S.*, Lawson, T. & Faul, A. C. (2014). Beyond Nutritional Needs: LowIncome, Older Adults Aging in Place. Evaluation of the Impact of Nutritional
Programming for Older Adults. The Fall Graduate Research Symposium, University of
Louisville, Louisville, KY. (*Equal Contribution)
Faul, A. C., Lawson, T. R., D’Ambrosio, J. G., Boamah, D. A., Cotton, S., Alkohaiz, M., Smith,
L. C., Lewis, S. N., Brown, L., & Zheng, Y. (2014). Collaborative Teaching and
Learning as a Tool to Ignite the Spark in Students. 2014 Celebration of Teaching and
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Learning, University, of Louisville, Delphi Center for Teaching & Learning, Louisville,
KY.
Washington, A., Kayser, K., Smith, L. C., Ranja, S., & Kloecker, G. (2014). Is There a
Relationship between Patient Worry and Preferences for Follow-up Care after Curative
Treatment for Lung Cancer? Research!Louisville, University of Louisville, Louisville,
KY.
RESEARCH EXPERIENCE
Graduate Research Assistant, University of Louisville, Kent School of Social Work
Financial Implications of Cancer Treatment on Patients, Multiple Methods (2013-present)
Patient’s Preferences and Quality of Life during Surveillance after Curative Treatment for
Lung Cancer, Quantitative Methods (2013-2015)
Surveillance after Curative Treatment for Lung Cancer: Physicians’ Perspectives on
Decision-Making, Quantitative Methods (2013–2015)
Other Research Experience, University of Louisville, Kent School of Social Work
Cervical Cancer Interventions in Rural Communities: Meta-analysis, 2018-2019
Online Teaching Methods Incorporating Film, 2015-2016
Scale Development in Critical Thinking and Social Work, 2015
Caregiving Processes for Grandparents raising Grandchildren in the Wake of the AIDS
Epidemic in Vietnam, 2015-present
Inter-rater Agreement among Grant Reviewers, 2014-2015
Examining Capacity-Building Needs Across the Greater Louisville Area, 2014-2015
Using Structural Equation Modeling to Assess Health Access in Kentucky, 2014-15
Assessing Meal Programs in Meeting Psychosocial Needs of Older Adults, 2013-2014
TRAINING EXPERIENCES
Delphi U Online Teaching, University of Louisville Delphi Center for Teaching and Learning,
June 2015
Financial Navigation for Cancer Patients, Financial Advocacy Network Regional Meeting-IL,
Association of Community Cancer Centers, November 2014
Cancer Treatment: How to Make Informed Choices About Standard Care and Clinical Trials,
Leukemia & Lymphoma Society, October 2014
PLAN Professional Development Program, School of Interdisciplinary and Graduate Studies,
University of Louisville, 2013-2014
Mental Health First Aid, Gilda’s Club, August 2014
Principles of Epidemiology in Public Health Practice, The Centers for Disease Control and
Prevention (CDC), May 2014
iCOPE: Interdisciplinary Curriculum for Oncology Palliative Care Education, University of
Louisville, June 2013- March 2014
TEACHING & MENTORSHIP
TEACHING
Instructor - Online
University of Louisville, Kent School of Social Work
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Fall-Spring 2018-2019
2017-2018

MSSW Program: Advance Research Practice 1 & 2

2016-2017
2015-2016

Instructor - Online
University of Louisville, Kent School of Social Work
MSSW Program: Advanced Social Work Practicum 1 & 2

Fall-Spring 2018-2019
2017-2018
2016-2017
2015-2016

Instructor - Online
University of Louisville, Kent School of Social Work
MSSW Program: Foundation Social Work Practicum 1& 2

Fall-Spring 2018-2019
2017-2018
2016-2017
2015-2016

Instructor - Online
University of Louisville, Kent School of Social Work
MSSW Program: Psychosocial Oncology Seminar

Fall-Spring 2018-2019
2017-2018
2016-2017
2015-2016

Instructor - Online
Spring 2018
University of Louisville, Kent School of Social Work
MSSW Program: Psychosocial Practice in Oncology II: Community Approaches to Promote
Health Equity
Instructor - Online
University of Louisville, Kent School of Social Work
MSSW Program: Research Methodology & Design
Instructor – On Campus
University of Louisville, Kent School of Social Work
MSSW Program: Human Behavior in the Social Environment 1 & 2

Summer 2018
Summer 2017
Summer 2016
Fall-Spring 2014-2015

Substitute Instructor - Online
University of Louisville, Kent School of Social Work
MSSW Program: Death and Grief

Summer 2017

Teaching Assistant - Online
University of Louisville, Kent School of Social Work
MSSW Program: Death and Grief

Spring 2015

Teaching Assistant – On Campus
Fall 2013
University of Louisville, Kent School of Social Work
MSSW Program: Psychosocial Practice in Oncology II: Community Approaches to Promote
Health Equity
MENTORSHIP
Practicum Faculty Mentor

Fall - Spring 2018-2019

SERVICE
COMMUNITY ENGAGEMENT
American Cancer Society - Cancer Action Network,
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Legislative Team Ambassador, 2016-present
State Lobby Day, Jefferson City, MO – 2018
State Lobby Day, Jefferson City, MO – 2017
National Lobby Day, Washington DC - 2016
Advocacy activities throughout the years (2016-present).
Gilda’s Club Kansas City, Volunteer, Jan 2016 – Sep 2016
Gilda’s Club Louisville, Outreach Volunteer, May 2013-2015
EDITORIAL ACTIVITY
Ad-hoc Reviewer, Journal of Psychosocial Oncology, 2017-present
Grant Reviewer, Community Foundation of Louisville Fund for Louisville, 2014
PROFESSIONAL MEMBERSHIPS
Current
AOSW, Association of Oncology Social Work, Member, 2015-present (ID 99441)
NASW, National Association of Social Work, Member, 2016 – present (ID 886577658)
CSWE, Council on Social Work Education, Member, 2016- present (ID 800162)
SSWR, Society for Social Work and Research, Member, 2015- present (ID 6151)
Past
IPOS/APOS, International-American Psychosocial Oncology Society, Member, 2015-2016
PROFESSIONAL LICENSURE
Current
Licensed Master Social Worker, Missouri Board of Social Work 2017-present (ID
2017003504)
Past
Certified Social Worker, Kentucky Board of Social Work, 2014-2017
PROFESSIONAL EXPERIENCE
Practicum Faculty Instructor
August 2015- present
University of Louisville, Kent School of Social Work
Practicum Faculty Liaison
Oversee 8-16 students per semester in health-related practicum placements.
Adjunct Faculty Instructor
August 2014- present
University of Louisville, Kent School of Social Work
Master’s Level Social Work Core-Curriculum & Psychosocial Oncology Specialization
Coursework
Social Work Intern
August 2012 – April 2013
Uspiritus-Bellewood Campus
Adolescent Program
Psychosocial Intake/Assessments, Individual and Group Therapy, Grant Writing, Program
Evaluation.
Social Work Intern
August 2011 – April
2012
Seven Counties Services – Hope Now Hotline
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Crisis Intervention Counselor
Suicide and Crisis Assessment/Intervention, Individual Therapy, Community Resource Referral.
Regional Placement Coordinator
Jan. 2007-February
2012
Children's Review Program
Child & Adolescent Foster Care Placements
Case Management, Referral and Placement Coordination of Children and Adolescents in Foster
Care Homes or Residential Treatment Centers.
Mental Health Technician
2006
Willow Springs Mental Health Rehabilitation Treatment Center
Child & Adolescent In-patient Mental Health Treatment
Behavioral and Case Management

March 2003 – August

Assistive Technology Technician
1998
Assistive Technology Center
State Disability Resource Center
Physical and Mental Assessment of Disability Needs

August 1997 – August

Mental Health Technician
1997
Willow Springs Mental Health Rehabilitation Treatment Center
Child & Adolescent In-patient Mental Health Treatment
Behavioral and Case Management
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March 1995 -August

